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Abstract 
Vascular smooth muscle cells (VSMCs) are major contributors to regulation of vascular 
tone through their contractile flexibility. Along with other stimulus, they are exposed to 
mechanical cyclic strain. It is thought such stimulus can be a major regulator of 
phenotypic modulation in smooth muscle cells. Differentiated SMCs are 
characteristically quiescent and adapt elongated spindle morphology. In this state the 
cell expresses an extensive range of contractile proteins such as SM α-actin, Smoothelin 
and Calponin. SMCs in the synthetic end of the phenotype spectrum adapt a rhomboid 
morphology and display increased growth rate and higher migratory activity. 
Expression of the contractile proteins are significantly decreased and replaced with 
organelles involved in protein synthesis. 
Studies have shown that several non coding micro RNA (miRNA), which negatively 
regulate gene expression, are differentially expressed in altered SMC phenotypes. 
However, work into the effect of mechanical stimulus such as shear stress or cyclic 
strain on miRNA expression is scarce with only a handful so far identified. This study 
hypothesizes that “cyclic mechanical strain modulates vascular smooth muscle 
phenotype and ultimately function, mediated by miRNA regulation”  
This hypothesis was tested by exposing primary derived human aortic smooth muscle 
cells (HAoSMCs) to cyclic strain in an in vitro model. Results show cyclic strain at 5% 
and 10% levels of amplitude increases the abundance of contractile phenotype markers. 
A temporal study of the miRNA profile of SMCs exposed to 10% strain revealed a 
significant change in expression was evident after 24 hours of strain.  
Novel chemotaxis experiments demonstrated cyclic strain reduced cell migration, the 
effect of which was most evident at 24 hours where migration of the cells was less than 
half that of the static culture. To implicate miRNA as key coordinators in the reduced 
cell migration observed after cyclic strain, siRNA were targeted against an essential 
miRNA biogenesis molecule, Argonaute2 (Ago2). Cells transfected with siRNA for 
Ago2 negated the physiological stimulus of strain and had a marked increase in 
migration even over the static control. These investigastions highlight the physiological 
importance of cyclic strain on SMC phenotype and function how the cellular response 
to this stimulus is orchestrated via miRNA. 
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CHAPTER ONE: Introduction 
1.1 microRNA (miRNA) 
Since their discovery in 1993 (Lee et al., 1993) during experimentation on the nematode 
Caenorhabditis elegans (C. elegans) to present day genome wide studies, research into 
miRNA has grown exponentially. Opinion ranges from fine tuners of molecular systems 
(J. Chen et al., 2012) to global regulators of every biological process in both plant and 
animal (M. S. Ebert et al., 2012). Study into miRNA spans across all areas of research 
in biological science, as diverse as industrial bioprocessing (N.Barron, P. Kelly et al., 
2010) to cancer (A.G. Bader et al., 2012) to cardiovascular disease (M. von 
Brandenstein et al., 2012; E. Scalbert et al., 2008; T. Thum et al., 2012). Here they have 
been implemented in a range of biological functions from regulators of metabolic 
processes (B. Wilfried et al., 2007) to diagnostic markers for disease (V Di Stefano et 
al., 2011). 
         
Figure 1.1: Primary, Precursor and Mature miRNA: Shows stages of miRNA biogenesis. 
Left - Primary miRNA as it exists in the nucleus following transcription by RNA Polymerase II. 
Middle – Precursor miRNA is generated following processing by Drosha which cleaves the 3’ 
polyadenylated tail and 5’ methylated cap. Right – Finally a mature miRNA is produced as a 
result of the stem loop has being cleaveded by Dicer and strands separated to yield two single 
stranded templates, one a passenger miRNA and the other a mature miRNA which will be 
incorporated into RISC for gene repression. (http://www.origene.com/MicroRNA/) 
 
What are they? 
The current understanding of miRNA depicts them as short 18-24 nucleotide long non 
coding RNAs. Classically, they negatively control gene translation by binding to the 3’ 
UTR (untranslating region) of their target mRNA. Here, depending on the 
complementarity, the miRNA promote either translational repression or degradation of 
their target mRNA. This results in silencing or suppression of many genes. 
However, recent research has shown they may not solely bind to the 3’UTR. Fang et al., 
(2011) has pertained that miRNA can also bind to both coding regions and the 5’ UTR 
of mRNA targets. Several studies have also shown that negative miRNA regulation may 
not always be the case as some miRNA have up regulated or stimulated gene expression 
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as much as 100 fold (Vasudevan et al., 2007, Cordes et al., 2009, M Kozak et al., 
2008). 
Collectively, more than 4000 miRNA sequences exist in a wide range of species of 
which up to a 1000 are encoded by the human genome, with considerable conservation 
across many of the species (S. van Dongen et al., 2008). 
Depending on the location of their encoding genes, miRNA can be categorised as 
intronic, exonic and intergenic miRNAs. As the name suggests, intronic and exonic 
miRNA are located within the intron and exon regions respectively and are typically co 
transcribed with their hosts (Wang et al., 2009). Intronic miRNA account for ~ 50% of 
all miRNA and have been known to contain their own cis elements where they 
orchestrate transcription of the miRNA in the opposite direction of their host genes 
(Bartel et al., 2004). When a miRNA is coded in a small intron it is deemed a “miRton,” 
and these small miRNA are able to bypass initial processing by Drosha/DGCR8 and be 
exported straight to the cytoplasm for maturation. 
Intergenic miRNA are found between two protein-coding genes and employ their own 
promoters and regulatory molecules, they are the most widely characterized and studied 
of the miRNA families. These miRNA can be transcribed by be either RNA 
PolymeraseII (RNAPII) or PolymeraseIII (RNAPIII). They can also exist either as 
monocistronic or polycistronic genes (Sarnow et al., 2006). 
 
 
 
Figure 1.2: Transcription of Monocistronic, Dicistronic and Polycistronic miRNA. 
Intergenic miRNA genes can exist as monocistronic, dicistronic or polycistronic units. These 
are then transcribed by either RNA Polymerase II or III into pri-miRNAs (Sarnow et al., 2006).  
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1.2 Canonical miRNA Biogenesis 
The micro RNA population in a given cell can be highly concentrated, with tens of 
thousands present per cell. They also possess a long half life and are very stable. A half 
life of over 1 week has been reported in some cells (VanRooji et al., 2007). 
Intragenetic miRNA are transcribed by RNA polymerase II from miRNA coding genes 
into long, hair pin stem looped, primary miRNA (pri-miRNA) hundreds of nucleotides 
long. They are 5’ 7- methylguanosine capped and poly-adenylated at the 3’ end (Han et 
al., 2004). The poly-adenylated tail allows recognition by the microprocessor complex. 
This complex is made up of the ribonuclease III type protein, Drosha which is bound to 
the protein DGCR8 (Pasha). Interaction with this complex results in cleavage of both 
the 3’ poly-A tail and the 5’ cap. As well as cleavage Pasha (DGCR8) is also 
responsible for orientation of the pri-miRNA. This gives rise to a hair pin looped pre 
cursor miRNA or pre-miRNA of about 70bp in length (Ambros et al., 2003) with a 
monophosphate at the 5’ terminus and a 2-nucleotide overhang with a hydroxyl group at 
the 3’ terminus (Sarnow et al., 2006).  
The pre-miRNA is then exported from the nucleus to the cytoplasm in a RAN-GTPase- 
dependant manner by the transport protein Exportin 5 (Bohnsack et al., 2004). The 
binding of the pre-miRNA to this protein is facilitated by the 3’ and 5’ overhangs 
produced earlier by the Drosha/DGCR8 complex.  
 
The next step to maturation is processing by the RNAse III like protein, Dicer. This 
removes the hair pin loop and cleaves the pre-miRNA into a ~ 22 nucelotide duplex 
(Zhang et al., 2002, Bartel et al., 2004). This duplex is unwound by the Argonaute 2 
complex producing a mature and passenger or star strand. Following unwinding the 
Argonaute 2 complex incorporates the mature strand into the RNA Induced Silencing 
Complex (RISC). The RISC then binds the miRNA to the 3’ UTR of the target mRNA. 
This binding occurs on what is known as the “seed sequence” of the miRNA. This is 
typically 6-8 nucleotides long and starts at the second nucleotide. Typically, the star 
strand is rapidly degraded after incorporation of the mature strand into RISC, however, 
occasionally it is possible for both strands to be cleaved into mature, functional miRNA 
(M. K. Bhayani et al., 2012).  
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Depending on the strand side incorporated, 3’ or 5’, the nomenclature follows as 
miRNA 3’ or miRNA 5’ (M. Von Brandenstein et al., 2012).  
The degree of complimentarity between the target mRNA and miRNA deciphers 
whether the mRNA either undergoes translation repression or degradation (Miranda et 
al., 2006, Van Rooij et al., 2007).  In most mammals miRNA induce mRNA 
degradation in 87% of the cases (H Guo et al., 2010). 
 
 
 
 
Figure 1.3: Pathway of miRNA Biogenesis - Transcription of miRNA is typically mediated by 
RNA polymerase II. This produces a stem looped primary miRNA with a 3’ poly adenylated tail 
and a 5’ 7-methylguanosine cap.The poly adenylated tail is recognized by the Drosha/DGCR8 
(Pasha) ribonuclease partnership and cleaved to yield ~ 70 nucleotide “pre-miRNA”. This is 
then exported from the nuclease to the cytoplasm in RanGTPase manner by Exportin5. Here it 
undergoes further processing by Dicer in which the stem loop is cleaved yielding a ~ 22nt 
duplex.  This is unwound and incorporated into RISC via the Argonaute 2 (Ago2) protein. From 
here, depending on sequence complementarity, the target mRNA either undergoes translational 
repression or degradation through cleavage or deadenylation. (Diagram adapted from Cordes et 
al., 2009) 
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Regulation of miRNA maturation occurs at multiple stages throughout their biogenesis 
(Y. Junming et al., 2012) including the following; 
miRNA editing; which regulates the conversion of pri-miRNA to pre-miRNA by 
converting adenosine to inosine. This leads to an accumulation of edited pre 
miRNA which blocks processing by RISC and complete maturation of the 
miRNA.  
Hair pin loop binding; a form of regulation in which a mutation of the loop 
reduces binding efficiency for processing. 
Epigenetic regulation; where miRNA genes located near CpG islands in the 
genome is found to be hyper methylated by neighbouring chromatin. 
Self-regulation; The components of the microprocessor complex, Drosha and 
DGCR8 can regulate expression of each other. The Drosha-DGCR8 complex 
can degrade the mRNA of DGCR8 itself, whereas DGCR8 stabilises Drosha in a 
feedback loop manner. Evidence of this regulatory feedback loop is shown when 
a miRNA binds to a 3’UTR of an mRNA that is in fact a transcription factor for 
regulating the miRNA itself. miRNA have also been shown to be heavily 
involved in supplying robustness to many diverse biological pathways via feed 
forward and feedback loop mechanisms in such a manner as this (M.S. Ebert et 
al., 2012). 
Cross talk between other signalling pathways; Pathways such as p53 have 
shown to assist in the cleavage of pri-miRNA to pre-miRNAs.  
 
1.3 miRNA Clusters 
As previously stated miRNAs can be transcribed from a single polycistronic 
transcriptiome, so that one polycistronic unit produces the sequence for multiple 
miRNA and functions where they function as a miRNA family. These contain the same 
seed sequence but different flanking bases which allow them to bind to the same mRNA 
(Lau et al., 2001). These miRNA are deemed as clusters. A micro RNA cluster is a set 
of two or more miRNAs, which are transcribed from physically adjacent genes. To 
qualify as a cluster, each miRNA must be transcribed in the same orientation and must 
not be separated by a transcription unit or miRNA in the opposite direction. Typically 
miRNA clusters are composed of two or three miRNA such as the miR-143/miR-145 
miR-221/miR-222 cluster, but larger clusters also exist, the miR-17-92 cluster is found 
on human chromosome 13 and is composed of six miRNAs. 
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1.4 miRNA Regulation of Cellular Networks 
Similar to transcriptional repressors, miRNA are most likely to be embedded in a large 
number of biological processes, pathways and regulatory networks. To ensure constant 
survival of a biological entity it is imperative that these systems run continuously and 
reliably. A view has emerged that a primary role for miRNA may have evolved to 
buffer and attenuate a diverse range of biological pathways and systems. This is the case 
in which a biological system or pathway is able to hold its function during alterations in 
environment and under stress conditions (Kitano et al., 2004). For example, following a 
vascular injury a sub population of vascular cells may need to undergo differentiation 
allowing the cells to migrate and repair the wound. Here miRNA can modulate the 
phenotype of a cell to facilitate in wound repair while maintaining tissue specificity of 
the cells by ensuring a return to a quiescent differentiated state following repair of the 
wound (M. S. Ebert et al., 2012). To reinforce this theory, genes with tissue-specific 
expression have displayed longer 3’ UTR regions and more binding sites for miRNA 
(Stark et al., 2005). miRNA expression has also shown to increase and diversify as the 
complexity of an organism and pathways within that organism increases (Lee et al., 
2007, Heimberg et al., 2008).  
 
Often biological pathways or processes will contain a failsafe or control which allows 
continued function even when conditions change or a component fails. One such 
example is the use of feed forward and feedback loops, which often implement miRNA 
(J. Tsang, 2007). In a coherent feed forward loop, component A inhibits (or activates) 
component C and respectively component B is activated (or inhibited) which also serves 
to inhibit (or activate) component C. In other words, components A and B both work to 
either inhibit or activate component C. If either component A or B is transiently lost the 
other will continue the inhibition or activation of component C. This not only 
incorporates a failsafe within a biological system during times of stress but also works 
to increase the fidelity of the action, in the case of miRNA enhancing gene suppression.  
 
This is demonstrated in the production of granulocytes, a type of white blood cell. 
CCAAT enhancer binding protein alpha (C/EBPα) inhibits transcription of the cell-
cycle regulator E2F1 during granulopoiesis. C/EBPα also induces miR-223 which also 
inhibits E2F1.  
As is often the case, this feed-forward loop is interlocked with a feedback loop in which 
E2F1 also inhibits production of miR-223.  Combining these fail safes allows the cell to 
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distinguish between once off fluctuations which should be counteracted or evolutionary 
changes which should be enhanced (M.S. Ebert et al., 2012, Pulikkan et al., 2010). 
Another example of feedback loop is the interaction between miR-146a and Kruppel-
life-factor-4 (KLF4). Here they regulate each other’s expression while also regulating 
VSMC proliferation (Sun et al., 2004). 
 
 
Figure 1.4: (A) Feed Forward Loop (B) Feed Back Loop – Diagram showing example of FF 
& FB loops involving miRNA. These are used in cellular networks to both attenuate and control 
signaling. Diagram modified from (M.S. Ebert et al., 2012). 
 
1.5 Level of Gene Suppression by miRNA 
Although deeply conserved, many miRNA express a modest effect on their target 
mRNA often less than 2 fold and many miRNA can be deleted without any obvious 
effect on phenotype (Bartel et al 2004). However, several miRNA often work together 
to co-target an mRNA. This is possible as many mRNA 3’UTRs have more than four 
highly conserved seed sequences, particularly transcripts involved in embryogenesis 
and tissue development. Combined with the previously described positive feed-forward 
and feedback loop systems, miRNA can exert enough change on the mRNA to 
constitute a large physiological effect (Mukherji et al., 2011, Lliopoulos et al., 2009, 
Friedman et al., 2009, Baek et al., 2008). miRNA can also amplify their potency by 
targeting mRNA contained in pathways (Linsley et al., 2007).   
 
For the reasons described, it is obvious why many in vitro and indeed, in vivo models 
using loss and gain function with individual miRNA have yielded disappointing results. 
To witness a considerable phenotype change it may be advantageous to target all 
27 
 
members of a seed family and non-seed family members who co target an mRNA (M.S. 
Ebert et al., 2012). 
It has also been outlined that mRNA 3’ UTRs demonstrate considerable evolutionary 
degeneration with increased numbers of mutations. Therefore, potential 3’UTR target 
sequences that are conserved across species are thought to most likely represent genuine 
miRNA recognition motifs whose function confer an evolutionary advantage, targeting 
of these mRNA with miRNA could therefore yield the desired gene repression (B. R. 
Wilfred et al., 2007)  
 
1.6 miRNA Isolation & Analysis  
1.6.1 Isolation 
Isolation of miRNA for analysis is now possible from a vast range of sources including, 
but not limited to, tissue, cell culture, body fluids such as blood plasma, semen 
ejaculate, urine, breast milk, menstruation blood, sweat, cerebrospinal fluid and serum 
(Etheridge et al., 2011, et al., Gilad 2008, et al., Hanson 2009, et al., Kosaka 2010, 
Mitchell et al., 2008). The principles for isolating miRNA are generally the same for 
isolating total RNA, with the exception that some miRNA extraction methods enrich for 
the small RNA fraction. Widely used commercially available products typically rely on 
chemical extraction using chaotropic salts, such as guanidinium thiocyanate, followed 
by a solid phase extraction on silica columns (C.C. Pritchard et al., 2012)  
miRNA expression profiling- quantification and qualification- are carried out using 
several techniques with the most common being quantitative real time PCR, Northern 
Blot analysis or micro array analysis (Planell, Sauger and Rodicio et al., 2011). 
Quantitative Real Time PCR (qRT-PCR) remains the most frequently employed method 
for expression analysis and involves the reverse transcription (RT) of miRNA to cDNA 
followed by quantitative PCR (qPCR). However, many properties that are unique to 
miRNA pose challenges to their accurate detection and quantification while using qRT-
PCR (A. Wark et al., 2008). Their short length, ~ 22nucleotides, makes it difficult for 
traditional primers to anneal for the reverse transcriptase reaction. Also, unlike mRNA, 
miRNA lack a common structure or sequence, such as a poly adenylated tail which is 
typically used for enrichment or as a binding site for primers. This is cleaved by the 
Drosha/DGCR8 microprocessor complex during biogenesis. miRNA within a seed 
family also pose difficulties for qRT-PCR as they may only differ from one another by 
as little as one nucleotide making specificity of the primer particularly crucial.  
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To overcome these problems two different technologies can be used for preparing 
miRNA for RT. These include enzymatic addition of a poly adenylated tail on to the 3’ 
end of the miRNA with consquent binding using universal linear primers. 
The second method creates a RT binding primer site using a stem loop specific primer 
set binding to the 3’ end of the miRNA. This is followed by individual reverse 
transcription and a TaqMan miRNA assay (Pritchard et al., 2012). 
 
 
Figure 1.5: Left – Stem Loop RT Primer, Right – Linear RT Primer – Diagram of stem 
loop primer (left) binding to mature miRNA for cDNA synthesis and traditional linear primer 
(right) binding to mature miRNA for cDNA synthesis. Diagram modified from C. Chen et al., 
(2005). 
 
The use of stem loop primers has now become the more adopted approach for the 
majority of researchers. This method has shown to have a high specificity and dynamic 
range of at least 7 logs and is capable of detecting as few as 7 copies of product in a 
PCR reaction. Use of stem loop primers can also differentiate between mature and 
pre/pri miRNA as well as miRNA which differ by only a single nucleotide. The 
advantageous characteristics of stem loop primers over linear is attributed to the base 
stacking and spatial constraint of the stem-loop structure. This improves thermo 
stability and extends the effective footprint of the RT primer/RNA duplex, which is 
required for effective RT from shorter RT primers. The spatial constraint of the stem 
loop prevents binding of genomic double stranded DNA (C. Chen et al., 2005).  
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1.6.2 Data Analysis 
 
The workflow for miRNA profiling typically consists of;  
 
 
For initial handling of the raw data, the software being used should be fully investigated 
to determine if there is any pre-processing of the data by the instrument software, for 
example automatic ROX dye normalisation used in TaqMan qRT-PCR. Following this, 
the output data is assessed for employability by investigating the performance of 
internal controls and analyzing replicates for bias, which could arise from such 
mitigating factors as plate geography (D. Sarka et al., 2009) 
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Arguably the most important step is normalisation of the data, the goal at this point is to 
adjust the data to remove any bias or change in expression not arising from the 
biological conditions under examination. 
Various approaches have been utilisied; one of the most commonly employed is the use 
of one or a few endogenous controls on the micro-fluidic plate.  These are typically 
small nuclear RNAs (U-24, U-26) or miRNAs (miR-191 & miR-103) which are found 
to be largely invariant in a given sample set (J.H. Peltier et al., 2008). The 
methodological limitation of such an approach is that it relies on the assumption that the 
selected controls are completely independent to the biological variation being studied. 
An alternative approach relies on the mean global expression of miRNA from a large 
scale study. This strategy is based on the assumption that although specific miRNAs 
may vary across biological samples owing to biological causes, the overall pattern of 
expression is expected to be invariable and therefore can be used as a normaliser (P. 
Mestdagh et al., 2009). This was shown in several studies to outperform use of 
endogenous controls in terms of better reduction of technical variation and more 
accurate appreciation of biological changes and is the strategy adopted in the 
experimental design for this thesis (P. Mestdagh et al., 2009, D. Wiley et al., 2011). 
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1.6.3 Calculating Differential Expression 
miRNA profiling experiments typically involve making comparisons between two or 
more groups, following normalisation the next stage of analysis is calculation of the 
differential expression of miRNA across the samples. Consideration needs to be taken 
however into the statistical significance of these changes and also the dynamic range 
and accuracy of the platform used in the quantification. Generally qRT-PCR has the 
widest dynamic range and highest accuracy. Never the less control of the false 
discovery rate should be considered when generating statistical significance for example 
using the Benjamini-Hochberg procedure, this uses an adjusted P value for significance. 
The adjusted P value method allows for controlling the rate of false positives. To begin, 
an acceptable false discovery rate is selected, for example 10%. This means 10% of the 
significant miRNA will be false positives. This is acceptable in a large screening 
experiment like presented in this thesis as any false positives will be found in follow up 
experiments on short listed miRNA. Next P values of miRNA are placed in order from 
smallest to largest. The smallest P value has a rank of i=1, the next has i=2, etc. Each 
individual P value is then compared to  
       
   
Where m is the total number being tested and Q is the chosen false discovery rate. The 
miRNA which has the largest P value but is         is significant and all P values 
less than this are also significant (Y. Benjamini., Y. Hochberg et al., 1995). This results 
in a shortlist being generated of statistically significant miRNA with an adjusted P value 
of a pre-determined level. This short list can then be utilised in silico for full 
bioinformatic profiling. Such as target prediction, biological processes and also 
involvement in cellular pathways.   
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1.7 Bioinformatics 
1.7.1 Target Prediction 
Following differential expression analysis, often the next stage in miRNA profiling is 
target prediction of the short listed miRNA. In silico target prediction is facilitated by an 
array of freely available on line algorithm suites.  
Complementarity between the seed region of the miRNA and the 3’UTR of an mRNA 
is the underlying method used for in silico prediction of targets. However, there are 
many other parameters that can influence and facilitate binding which are used by the 
online resources. These include thermodynamic stability (decided via the Vienna RNA 
folding routines), free energy,  AU content, conservation across species (typically at 
least two), size of the 3’ UTR and the amount of binding sites or tandem repeats and site 
location, miRNA are more likely to bind if they are located at the beginning or end of 
the 3’UTR.  
Each online resource has a unique selling point, for example, PicTar can provide co-
expressed miRNA and mRNA targets if conservation across species is not evident. 
Consequently, overlapping of putative targets is small and a combination of different 
databases is often the best method in this initial step of target prediction.  
Databases include: 
 Target Scan   http://www.targetscan.org/ 
 PicTar   http://pictar.mdc-berlin.de/ 
 Micro Inspector  http://www.imbb.forth.gr/microinspector 
 miRNA.org  http://www.microrna.org/microrna/home.do 
 MicroCosm  http://www.ebi.ac.uk/enright-        
                                    srv/microcosm/htdocs/targets/v5/ 
 RNA hybrid                http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/ 
 RNA22  http://cbcsrv.watson.ibm.com/rna22.html 
 PITA   http://genie.weizmann.ac.il/pubs/mir07/index.html 
 Diana   http://diana.cslab.ece.ntua.gr/microT/  
 GenMir  http://www.diana.pcbi.upenn.edu/miRGen.html 
These target prediction tools are an excellent resource and solid first step in deciphering 
the roles of specific miRNA, however they do not take into account individual cell 
types, availability of genes within that cell or if the miRNA is even expressed. In 
addition, as the name suggests they are just predictions and thus need to be 
experimentally validated in the lab. This can be carried out by a number of techniques 
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including western blot, luciferase assays, RIP-CHIP pull down assay, in which the RISC 
is co-immunoprecipitated and bound mRNAs are sequenced and identified.  Another 
form of this is a technique in which miRNA are tagged with biotin and pulled down in a 
streptavidin-biotin pulldown system to see miRNA:mRNA interactions (UA Orom et 
al., 2007). 
1.7.2 Gene Annotation  
Further bioinformatics may be carried on putative gene lists generated from target 
prediction software. For this thesis, enrichment of genes in biological processes and 
pathways were deduced using an online bioinformatics database, DAVID (Database for 
Annotation, Visualisation and Integrated Discovery). DAVID bioinformatics resources 
consist of an integrated biological knowledge base and analytical tools aimed at 
extracting meaning from large protein or gene lists. The first stage is to upload putative 
targets containing any number of gene identifiers i.e. official gene symbol or entrez 
gene ID. Following this, analysis is carried out taking advantage of the vast pathway 
miming tools such as Gene Ontology (GO) biological processes or KEGG biological 
pathways.  
 
 
1.7.2.1 Gene Ontology (GO) is a major bioinformatics initiative which attempts to unify 
and standardise the representation of genes and their involvement in cellular processes 
across all species. The initiative was set up to aid scientists in the search for biological 
data and information on a myriad of research areas. It achieves this by maintaining and 
developing a controlled vocabulary and nomenclature of genes and gene products 
(RNA/protein). In addition, information pertaining to individual genes, such as 
involvement in cellular processes and functions is pooled to allow easy access for the 
user. The database is constructed of three controlled vocabularies (ontologies). Each of 
these ontologies describes gene products in terms of their associated biological 
processes, cellular components and molecular functions in a species-independent 
manner. The database, therefore aims to eliminate the hindrance of different 
terminology and nomenclature found across scientific disciplines, in addition to 
providing as much information as possible on the gene and gene products.  
1.7.2.2 The Kyoto Encyclopedia of Genes and Genomes (KEGG) is a database resource 
for understanding high level gene functions. Developed as a result of the Japanese 
genome project, its developers believe it is a computer representation of a full biological 
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system. Unlike the GO database, KEGG, among other functions, can determine 
enrichment of genes within pathways and utilities of the biological system. This is 
available as a result of gene catalogues from completely sequenced genomes which 
being linked to higher level systemic functions such as the cell, the organism and the 
ecosystem. As with GO, by entering large data sets or gene lists, it is possible to access 
this information for that given data set or list. KEGG is comprised of 16 main databases 
which outputs into 3 categories; System information, Genomic information and 
Chemical information. Work for this project was concerned with the involvement of 
predicted miRNA targets in cellular pathways. The KEGG pathway database is found 
within the system information category. The full lists of databases are found in table 
1.1. 
Table 1.1: KEGG Database Table shows the 16 databases making up KEGG online resource 
which are divided across three categories System information, Genomic information and 
Chemical information  
Systems Information 
KEGG Pathway 
KEGG Brite 
KEGG Module 
KEGG Disease 
KEGG Drug 
KEGG Environ 
Genetic Information 
KEGG Orthology 
KEGG Genome 
KEGG Genes 
KEGG SSDB 
Chemical Information 
KEGG Compound 
KEGG Glycan 
KEGG Reaction 
KEGG Rpair 
KEGG Rclass 
KEGG Enzyme 
 
By taking advantage of these vast data miming suites it is possible to gain an in-depth 
understanding of the biological themes in lists of genes enriched in large profiling 
studies such as the work carried out in this thesis. 
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1.8 The Cardiovascular System 
The 16
th
 century English Physician, William Harvey is credited with being the first 
person to describe in detail the existence of a blood circulatory system in vessels. Since 
then, our understanding of the vasculature system has increased exponentially, credited 
to the continual developments of cell and molecular biology methods and techniques.     
With the exception of cells found in the cornea, the estimated 100 trillion cells which 
make up the human body rely on the blood in the circulatory system to provide oxygen 
and nutrients for survival as well as removing metabolic waste products. In addition, the 
circulatory system maintains an optimum cellular environment by regulating body 
temperature and pH (Gimbrone et al., 1987). Humans have evolved an incredibly 
complex, closed and pressurized circulatory system in which the heart is responsible for 
pumping the 5 – 5.5 liters of blood throughout the entire network of blood vessels 
(Hahn & Schwartz et al., 2009). During a human lifespan the heart will beat about 3 
billion times and pump well over 200 million liters of blood. This circulatory system 
can essentially be subdivided into the vasculature and lymph system. In the broadest 
sense, the vascular system is composed of the heart, blood and blood vessels while the 
lymphatic circulatory system consists of lymphatic microvessels (capillaries) and larger 
lymph vessels (M.K. Pugsley et al., 2000). 
The blood vessels within the body are classified into three categories; arteries, veins and 
capillaries. Oxygenated blood returning from the lungs is ejected from the left ventricle 
into a large network of arteries. Arteries can be further categorised into two distinct 
types: elastic and muscular (Borysenko & Beringer et al., 1984). Elastic arteries are 
found proximal to the heart as they are able to carry large volumes of blood and also 
“dampen” the oscillatory force of blood flow due to a beating heart. This is credited to 
their composition, consisting of many layers of perforated elastic membrane, this helps 
to create a more homogenous movement of blood as the artery bifurcates or divides into 
smaller vessels (Lusis et al., 2000). The larger populations of arteries, muscular arteries, 
are responsible for the complete distribution of blood to all the organs and tissues within 
the body. The continual bifurcation of these arteries leads to the formation of smaller 
arterioles, which serve to reduce blood flow and therefore prevent damage to the fragile 
capillaries, of which there are over 40 billion in the human body.  
 
 
36 
 
 
 
Figure 1.6: Three Categories of Blood Vessels - Shows cross sectional diagram of the three 
categories of blood vessels within the vasculature. From left to right; cross section of artery, 
capillary and vein. Main features highlighted in this figure include; thicker vessel wall in the 
artery compared to veins or capillaries. Valve is present in the lumen of the vein to prevent back 
flow of low pressure blood; this is not in the other blood vessel types. The capillary shows only 
an endothelial layer with no smooth muscle or elastic membranes, emphasizing the delicate 
nature of this vessel. 
(http://legacy.owensboro.kctcs.edu/gcaplan/anat2/notes/APIINotes5%20Circulatory%20Anatomy.htm) 
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These capillaries, which lack smooth muscle, form fine vascular networks between 
tissues and cells allowing blood perfusion (Cines et al., 1998). The total surface area of 
capillaries alone in the body equates to approximately 1000m
2
 - roughly the size of a 
tennis court (M.K. Pugsley et al., 2000). As a result of this large surface area of the 
capillary bed, water, solutes and nutrients from blood are able to defuse into the 
surrounding tissue. Capillaries also connect the arterial vascular tree to the venous 
system allowing a return of deoxygenated blood to the right atrium of the heart via the 
superior vena cava. The transition from capillary to vein is marked by the gradual 
reappearance of smooth muscle. 
Blood returned to the right atrium in turn flows through the tricuspid valve into the right 
ventricle then up to the lungs via the pulmonary artery. Through gaseous exchange, the 
lungs oxygenate the blood which then returns to the left atrium via the pulmonary vein. 
Circulation of deoxygenated blood flowing from the heart to the lungs and back to the 
heart is known as the pulmonary circulation. The oxygen rich blood now enters the left 
ventricle and is pumped into the aorta as the entire process begins again. The circulation 
of blood from the heart to the rest of the body is known as the systemic circulatory 
system.  
The physical size and geometry of each blood vessel type differs considerably. 
Capillaries typically range between 5-8 µm in diameter, followed by veins, which vary 
between 1-10 mm which are also trumped by the motorways of the vasculature system, 
the arteries. At over 2.5cm in diameter and travelling the entire length of the torso, the 
aorta is the largest artery in the body. 
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The Aorta 
The aorta also has the thickest walls of any blood vessel and originates from the left 
ventricle of the heart. It arches over to the back of the heart and to the left, from here it 
descends inferior to the heart and anterior to the spinal column. The first section of the 
aorta is known as the ascending aorta. The ascending aorta branches into the left and 
right coronary arteries. The coronary arteries carry blood to the surface of the heart 
supplying it with oxygen and nutrients. 
The second portion of the aorta, the aortic arch, branches into three major arteries: 
 The brachiocephalic trunk 
 The left common carotid artery 
 The left subclavian artery 
 
 
Figure 1.7: Schematic of the heart and surrounding vessels. Diagram shows the major veins 
and arteries which are proximal to the heart. The aortic arch branches into three major vessels 
the brachiocephalic trunk, the left common carotid and the left subclavian. The left and right 
coronary arteries, which branch from the ascending aorta, are not shown. The pulmonary system 
is shown in blue and the systemic system is shown in red. 
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The brachiocephalic trunk supplies blood to the right arm and right side of the head, 
including the brain. The left common carotid artery supplies blood to the left side of the 
head and brain. Finally the subclavian carries blood to the left arm. 
The descending aorta carries blood through the thoracic and abdominal cavities of the 
body until it splits into the left and right common iliac arteries, which supply blood to 
the legs. The descending aorta is broken down into two sections – the thoracic aorta and 
abdominal aorta – named after the body cavities that it passes through. The abdominal 
aorta branches off into many smaller arteries that feed the major abdominal organs. The 
aorta carries all of the oxygenated blood exiting the heart in the systemic loop of the 
circulatory system. Thus, the aorta provides oxygenated blood flow to all the tissues of 
the body. The wall of the aorta is very thick and elastic; this allows it to withstand the 
high blood pressure produced by the heart and to stretch with every heartbeat to receive 
a large volume of blood. After filling with blood, the stretched aorta contracts to its 
original diameter and pushes blood into the arteries that branch off from it. 
Blood Vessel Composition 
In general, most blood vessels consist of three histologically distinct regions 
(Borysenko & Beringer et al., 1984). Each region of a blood vessel is termed a “tunic” 
from the latin term meaning “a membrane”. Anatomically (from the lumen of the blood 
vessel out), these regions or layers are called the tunica intima, tunica media, and the 
tunica adventia (Vita & Keaney et al., 2002). 
The tunica intima is the thinnest layer of just 0.2-4 µm; this consists of a single 
monolayer of endothelial cells mounted on the basement membrane. The endothelial 
cells are directly exposed to blood flow. Below this there is a sub-endothelial 
connective tissue layer composed of elastic fibres which provide flexibility and stability 
for endothelial cells. Also within close proximity are perivascular cells, or pericytes, 
which are multipotential stem cells capable of differentiating into an array of vascular 
cell types (Sims et al., 1986; Hirschi & D’Amore et al., 1996; Schor & Canfield et al., 
1995). 
The tunica media contains predominantly smooth muscle cells and elastin fibres. This 
layer is primarily responsible for vascular tone and the movement of large volumes of 
blood throughout the circulatory system. Circumferential to this, we find an external 
elastic lamina that provides structural support. The tunica adventitia is the last and 
outermost layer of a blood vessel. This is mainly composed of connective fibrous tissue 
and fibroblasts along with various amounts of collagen. The collagen serves to anchor 
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the blood vessel to nearby organs giving it stability. The main focus of this thesis is on 
vascular smooth muscle cells, the principle component of the tunica media. Specifically 
human aortic smooth muscle cells (HAoSMCs) taken from the thoracic region of the 
aorta. 
 
 
Figure 1.8: Illustration of Layers which Compose Blood Vessels – Artery: Tunica Intima 
Endothelium composed of endothelial cells, Subendothelial layer and internal elastic membrane, 
Tunica Media Composed of smooth muscle cells and elastic fibers exterior to this exists an 
elastic membrane, Tunica Externa Composed primarily of collagen fibers and fibroblasts. Vein: 
Similar composition to an artery without the internal and external elastic membrane in the 
tunica intima and tunica media which provide the elasticity needed in arteries to accommodate 
the haemodynamic forces of blood flow. Other differences include a thinner vessel wall due to 
the lower tensile pressure of deoxygenated blood and addition of valves to prohibit back flow of 
the lower velocity blood flow. Capillary: Smallest of the blood vessels composed of endothelial 
cells and a basement membrane, these vessels facilitate blood perfusion into surrounding tissue 
and cells. 
(http://legacy.owensboro.kctcs.edu/gcaplan/anat2/notes/APIINotes5%20Circulatory%20Anat
omy.htm) 
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1.9 Cardiovascular Disease (CVD) 
Cardiovascular Disease (CVD) is a name given to a group of disorders of the heart and 
blood vessels. Although there are many conditions associated with this disease, the 
Global Burden of Disease Study (GBD) reported that ischemic heart disease is the 
leading cause of death worldwide, representing 63% of all deaths. It is also the 
prevailing cause of death in Ireland. The World Health Organisation (WHO) predicts 
that the number of people who die from CVDs, mainly from heart disease and stroke, 
will reach 23.3 million by 2030. As CVDs remain the leading cause of death they are 
projected to spread further and further into middle and low income countries.  CVD 
often exists as an underlying complication; indeed the first foundation and initiation of 
CVD will appear well before any clinical threshold or horizon, for example before any 
acute conditions such as myocardial infarction or stroke.  
 
Figure 1.9: Chart Representing Causes of Mortality in Ireland 2010.World Health 
Organisation (WHO) statistics for 2010 of the causes of mortality in the Irish population.  
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There are many contributing factors to this disease. For example economic 
development, urbanisation and westernisation during the late 19
th
 and early 20
th
 century 
meant that people began to be exposed to tobacco smoking, high fat content diets and 
physical inactivity- all increasing the risk of CVD. Most CVDs can however be 
prevented by addressing these environmental risk factors. If left untreated, these risk 
factors can result in complications such as hypertension (high blood pressure).  
9.4 million Deaths each year, or 16.5% of all deaths can be attributed to high blood 
pressure. This includes 51% of deaths due to strokes and 45% of deaths due to coronary 
heart disease. It is estimated that over 40% of the world’s population has high blood 
pressure (S.S. Lim et al., 2010). 
High levels of vessel wall strain found in arterial hypertension can damage the 
endothelium and lead to the development of aneurysms or diseases such as 
atherosclerosis. Atherosclerosis refers to the development and progression of 
atherosclerotic plaques. This results in gradual narrowing of blood vessel lumens 
restricting blood flow. Obstructed blood flow can lead to a myriad of complications 
such as stroke, kidney failure, angina or a myocardial infarction.  These plaques can be 
classified as either stable or unstable, depending on their composition. Stable plaques 
are predominantly composed of synthetic migrating SMCs which have transcended 
through the endothelium into the luminal space. The focus of the work undertaken in 
this thesis was to investigate the effect of varying strain conditions on the differentiation 
and migration of Human Aortic SMCs (HAoSMCs).  
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Figure 1.10: Atherosclerosis. Figure shows a schematic of a healthy blood vessel on the left 
with an unobstructed lumen. Blood vessel on the right shows a developed atherosclerotic plaque 
which is occluding the lumen resulting in restricted blood flow. Plaques are classified to be 
unstable or stable depending on their composition. Stable plaques are typically composed of 
migrated smooth muscle cells and a fibrous cap layed down by deposited ECM molecules. 
Unstable plaques consist of macrophages which have transformed into foam cells along with 
cellular debris, fats and calcium deposits. Plaque development can be brought on by conditions 
such as hypertension, damaging the endothelium and encouraging SMC migration. 
(http://www.pharmaceutical-networking.com/merck-mk-0524b-treatment-of-atherosclerosis/) 
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1.9.1 miRNA and Cardiovascular Disease 
A plethora of studies now implicate miRNA deregulation and expression in 
cardiovascular diseases, such as hypertrophy, myocardial infarction angiogenesis and 
atherosclerosis. Of the 700 plus miRNA encoded by the human genome some 150-200 
are expressed in the heart where they are dynamically regulated in response to disease 
(De-Li Dong et al., 2011). 
In the early stages of atherosclerosis the endothelium, made up of a monolayer of 
endothelial cells, is the first line of defense against harmful lesions and plaque 
formation. This becomes more apparent in the fact that endothelial dysfunction 
represents a common link among all known cardiovascular risk factors, including 
dyslipidemia, smoking, diabetes, obesity, mental stress and hypertension (Grover et al., 
2009). Endothelial dysfunction is characterised by a reduced bioavailability of nitric 
oxide, increased expression of adhesion molecules, increased levels of proinflammatory 
and prothrombotic factors, oxidative stress and abnormal modulation of vascular tone 
(Chen et al., 2012).  
Initial evidence that miRNA were involved in endothelial cell function surfaced when 
Keubacher et al., (2007) silenced Dicer in endothelial cells in vitro to yield impaired 
angiogenesis on a matrigel substrate. Later endothelial cell specific Dicer knockout 
mice showed leaky vessel membranes and eventual lethality (Suarez et al., 2008). 
Deregulation of several miRNA is now associated with endothelial dysfunction. 
miR-21 has shown to be one of the most dynamically regulated miRNAs in various 
pathological processes, ranging from cancer to cardiovascular disease (Zhou et 
al.,2011). This miRNA has shown to be significantly up regulated in atherosclerotic 
plaques compared to non-atherosclerotic arteries (Raitoharju et al., 2011). 
The most ubiquitously expressed miRNA in ECs is the endothelial specific miR-126. 
This miRNA regulates the influx of monocyte adhesion to areas of atherosclerotic 
lesions by directly targeting vascular cell adhesion molecule-1 (VCAM-1), thus 
controlling vascular inflammation (Harris et al., 2008). Accordingly miR-126 may exert 
an antiatherosclerotic effect by reducing inflammation. 
Endothelial cell senescence, often seen in aging, is also a major risk factor in 
progression of cardiovascular disease. miR-217 has been shown to be largely expressed 
in aged but not young endothelial cells (Menghini et al.,2009). This suggests a negative 
role of miR-217 by promoting senescence in ECs.  
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As previously stated alterations in haemodynamic force, such as increase in magnitude 
as found in hypertension, can lead to development and progression of atherosclerosis. 
This is also seen in parts of the vessel which experience disturbed shear stress or blood 
flow. This typically happens at bifurcations of arteries where the blood flow is no longer 
laminar and ceases to have an atheroprotective stimulus on the endothelium (Passerini 
et al., 2004).  Fang et al., (2010) found expression of miR-10a was lower in athero-
susceptible region of the endothelium, such as the inner aortic arch. Knockdown of 
miR-10a in endothelial cells was also shown to induce inflammation mediated by 
nuclear factor kappa B (NF-kB) (Fang et al., 2010). 
 
Following endothelial dysfunction, the phenotypic modulation of VSMCs to a 
migratory synthetic state is at the forefront of neointima and plaque formation in 
atherosclerosis. There are several contributing factors which influence phenotype 
switching including; a wide variety of growth factors, such as platelet derived growth 
factor (PDGF) and insulin derived growth factor-1 (IDGF-1) (Wang et al., 1994), extra 
cellular matrix components such as collagen type I and type IV (Orr et al., 2010) and 
mechanical factors, including shear stress and cyclic strain resulting from the pulsatile 
nature of blood flow. Studies now suggest miRNA play a key role in facilitating this 
phenotype switch of VSMCs by targeting transcription factors and components of the 
cytoskeleton. 
 
Perhaps the most characterised miRNA involved in SMC biology are miR-143 and 
miR-145. They exist as a clustered bicistronic primary transcript, which is located on 
chromosome 5. Their expression levels are now widely accepted as a marker of VSMC 
phenotype. The cluster has been shown to be highly expressed in VSMCs in the normal 
vascular wall while their expression is significantly reduced in proliferating VSMCs in 
vivo and in vitro. Like other VSMC markers their expression has shown to influenced 
by the serum response factor (SRF) co-activator, myocardin (Sebastian et al., 2010). 
miR-145 has also shown to function in a feed forward loop regulating both its own 
expression and miR-143. Here the miRNA cluster targets multiple transcription factors 
which are involved in VSMC differentiation, including KLF4, calmodulin kinase II δ 
(CamKIIδ) and ELK1 (a member of the ETS oncogene family), this results in 
promotion of the SRF co activator, myocardin, consistent with a contractile phenotype 
(Cordes et al., 2009). Studies of in vitro and in vivo down regulation of these miRNA in 
VSMCs resulted in the formation of actin rich membrane protrusions deemed 
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podosomes via a pathway involving Src and p53, these are indicative of a migratory 
synthetic VSMC (Quintavalle et al ., 2010). 
 
 
Figure 1.11: Regulation of VSMC phenotype by miR- 143 and miR-145. miR-143 and miR-
145 are positively regulated by SRF and function to repress multiple factors that normally 
promote a synthetic phenotype (purple). These include Klf4, which also represses myocardin 
(“Myocd”). miR-145 has a positive effect on Myocd enhancing a contractile phenotype (pink), 
thereby also functioning to reinforce miR-143 and its own expression in a feed forward loop. 
Effects of miR-145 and miR-143 converge on SRF-dependent transcription by regulation of co-
activators and co-repressors to dictate the proliferative or differentiated phenotype of VSMCs 
Diagram modified from Cordes et al., (2009). 
 
Despite having high expression in ECs in atherosclerotic lesions, miR-21 was actually 
shown to promote differentiation of VSMCs in response to transforming growth factor-
β (TGF-β) and bonemorphogenetic protein (BMP) stimulation via a decrease in 
programmed cell death protein 4 (PDCD4) expression (Sebastian et al., 2010). TGF-β 
activates transcription of the miR-143/145 gene cluster through the CArG box via 
myocardin expression, while BMP exerts a similar effect via nuclear translocation of 
myocardin-related transcription factor-A (Chen et al., 2012).  Interestingly miR-21 
promotes both proliferation and differentiation of VSMCs as well as reducing apoptosis 
by down regulating phosphatase and tensin homolog (PTEN) and up regulating B-cell 
lymphoma 2 (Bcl-2) (Cheng et al., 2007). While BMP and TGF-β signaling pathways 
promote a contractile phenotype in VSMCs, the PDGF signaling pathway modulates 
47 
 
VSMCs to a synthetic state. Here miR-24 has shown be up regulated in atherosclerotic 
lesions where it targets Tribbles like protein 3 (Trb3) in the PDGF pathway (Chan et al., 
2010). 
Other cluster genes such as miR-1 and miR-133 have also shown to be involved in 
VSMC differentiation, over expression of this cluster was shown to inhibit proliferation 
by targeting KLF4 and SP1 (Chen et al., 2011; Torella et al ., 2011). Conversely 
however Jiang et al., (2010) suggested miR-1 reduced VSMC contractility by impairing 
the actin cytoskeleton, highlighting the complexity of regulation by miRNA.  
A long with miR-24 there are also several other miRNA which have shown to promote 
a more synthetic phenotype. miR-221 and miR-222, also clustered, have shown to be up 
regulated in injured vascular walls and in areas of atherosclerotic plaques (Liu et al ., 
2009). The cluster’s expression was also increased in PDGF stimulated proliferating 
VSMCs. Over expression of miR-221/miR-222 was shown to reduce contractile 
markers by inhibition of c-Kit, which is a positive regulator of myocardin (Sebastian et 
al., 2010). Another well characterised miRNA, miR-26a, was shown to promote a 
proliferative migrating VSMC phenotype by targeting targeting transforming growth 
factor- α (TGF-α) (Leeper et al., 2011). miR-26a was also shown to inhibit cell 
apoptosis by targeting expression of SMAD1 and SMAD4 genes (Chen et al., 2012).  
 
The myriad of studies involving specific miRNA in VSMC phenotype switching is 
perhaps not surprising as it is such a complex process. Therefore it should be noted the 
miRNA highlighted in this section must be looked at as a representation of the most 
characterised as opposed to a definitive list of miRNA involved in VSMC phenotypic 
modulation. To elucidate a clearer concept as to how miRNA facilitate phenotypic 
switching it is important to look at the complexity of a vascular smooth muscle cell and 
the factors which influence this phenotype plasticity.   
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1.10 Vascular Smooth Muscle Cells 
As previously stated, smooth muscle cells (SMCs) predominantly make up the tunica 
media layer of arteries and veins. They are responsible for controlling vascular tone, 
which regulates blood pressure and also facilitates blood flow in the vessel. They can 
carry out these functions due to a unique plasticity where they can reversibly modulate 
their phenotype between that of a synthetic and a contractile state in a process known as 
phenotypic modulation (G.K. Owen et al .,2004). This results in relaxation or 
contraction of the cell, adjusting the vascular tone which in turn alters the diameter of 
the vessel lumen ultimately regulating blood pressure.  
1.10.1 Contractile SMCs 
The majority of SMCs making up the tunica media of a vessel wall exist primarily in a 
differentiated or contractile phenotype. Differentiated SMCs are characteristically 
quiescent and proliferate and migrate at an extremely slow rate. They also express a 
unique repertoire of contractile proteins, ion channels and signaling molecules which 
are required for contraction. Contractile SMCs adapt elongated spindle morphology. In 
this state the cell expresses an extensive range of contractile proteins which maintain the 
differentiated state. Some of the most commonly used to identify SMC phenotypes 
include; SM α-actin, Smoothelin, Calponin and myosin heavy chain (MHC). 
 
Figure 1.12 A &B: SMC Phenotype Morphology A shows diagram of a contractile SMC with 
slender spindle shaped morphology (top) and contractile HAoSMCs in culture (below). B shows 
diagram of a synthetic SMC with “cobble stone” shaped morphology (top) and synthetic, 
proliferating HAoSMCs in culture (below). 
 
 
A. B. 
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Myosin Heavy Chain 
Differentiated SMCs express cell specific isoforms of myosin such as myosin heavy 
chain (MHC). Myosin is an essential component of the contractile system that is present 
in all muscle and non-muscle cells. SMC specific variants of this protein termed, SM1 
and SM2 are rigorous markers for SMC differentiation. Expression of SM1 and SM2 
has never been detected in non SMCs in vivo and remains the only marker that is SMC 
specific during embryogenesis (J.M. Miano et al., 1994).  
Alpha Actin 
This is one of the 6 isoforms of actin found in mammalian cells (J. Vandekerckhove & 
K. Weber et al., 1979). Mature, fully differentiated SMCs express four actin isoforms 
including smooth muscle α-actin, non-muscle β-actin, non-muscle γ-actin and smooth 
muscle γ-actin (G.K. Owens & M. Schwartz et al., 1986). The 42 kDa α-actin is the 
most abundant, comprising up 70% of all SMC actin and over 40% of the total cell 
protein (V. Fatigati & R. A. Murphy et al., 1984). This is essential for the cells high 
force generating capability. Originally thought to be solely expressed in SMCs, it is now 
known to be expressed in several other cell types. The protein is transiently expressed 
during development of cardiac and skeletal myocytes (J. Woodcock et al., 1988). It can 
also be expressed by non-SMCs in culture such as endothelial and mesenchymal 
progenitor cells (R. M. Gordon et al., 2007 & M. Cevallos et al., 2006). Thus, α-actin 
expression alone does not provide definitive evidence of smooth muscle cell lineage. 
However, its expression is highly specific in mature tissues and is the first known 
marker of differentiated SMCs that is expressed during vasculogenesis (J.E. Hungerford 
et al., 1993; J.J. Mitchel et al., 1990). 
Calponin 
Calponin is a 28-34 kDa protein that interacts with F-actin and tropomyosin in a CA
2+ 
independent manner. It also interacts with calmodulin in a CA
2+ 
dependent manner. 
Furthermore, it has been shown to inhibit actin activated MG
2+ 
ATPase activity of 
myosin in vitro (S.J. Winder et al 1991). On this basis it is postulated to act as a SMC 
contractile regulator (G.K. Owens et al., 1995).  
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Smoothelin 
Smoothelin is a cytoskeletal protein which is exclusively expressed in differentiated or 
contractile SMCs. Two isoforms have been detected termed smoothelin A and B. These 
are 59kDa and 100kDa respectively. Following vascular injury, Eys et al., (2007) 
reported that smoothelin was the first smooth muscle marker to disappear. They also 
correlated smoothelin deficiency with considerable loss in contractile function 
suggesting it is an essential part of the contractile apparatus. 
1.10.2 Synthetic SMCs  
During vasculogenesis, however, SMCs are mostly synthetic where their principal 
function is proliferation, migration and production of matrix components of the vascular 
wall. The synthetic SMC state essentially boasts a contradictory phenotype to the 
contractile. They take on a more cobblestone appearance, which is referred to as 
epithelioid or rhomboid. Expression of the contractile proteins are significantly 
decreased and replaced with organelles involved in protein synthesis. They have 
increased growth rate and higher migratory activity. The contractile markers gradually 
decrease as SMC are cultured, and passage number increases (Fagar et al., 1989). 
However expression of the different contractile markers, in SMCs undergoing 
modulation towards the synthetic phenotype, does not diminish uniformly and 
expression of some contractile proteins, α-actin, calponin and SM22α is still evident in 
fully synthetic SMCs. Expression of SM-MHC and smoothelins, however, is rapidly 
lost (S.M Rensen et al., 2006).Unlike the contractile counterpart increase in synthetic 
proteins is difficult to characterise, quantify and qualify; instead a decrease in 
contractile markers is taken as an indicator of transition into a synthetic phenotype. 
Nevertheless expression of some proteins has shown to be increased in the synthetic 
state these include; Moesin, Osteopontin, Cellular Retinol Binding Protein 1 (CRBP1) 
and formation of Collagen I. Typically information on at least two contractile markers 
complemented with data on morphology, proliferation and migratory characteristics is 
sufficient for characterising a SMC population phenotype (S.M Rensen et al., 2006). In 
addition, studies show that contractile SMC proteins are not the only indicators of SMC 
phenotype (S.S.M. Rensen et al., 2007). Integrins such as α1β1, α7β1 and the 
dystrophin-glycoprotein complex (DGPC) have shown to be predominantly present on 
the surface of a contractile SMC, while ICAM-1 and VCAM-1 along with the 
α4β1integrin are found only on synthetic cells emphasizing the role of cell adhesion and 
cell membrane molecules in SMC differentiation. 
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It is important to note that SMCs should not be solely viewed as being in either one 
phenotypic state or the other, but rather at varying stages along a phenotypic spectrum. 
A fully contractile and synthetic SMC should be seen as representatives of the two ends 
of this phenotype spectrum 
 
Figure 1.13: Phenotypic Spectrum of VSMCs Schematic highlights the phenotypic spectrum of 
VSMCs. Smooth muscle cells can reversibly modulate their phenotype to varying states across a 
spectrum flanked by a fully synthetic or fully contractile SMC. As the smooth muscle cell phenotype 
modulates towards either state change in expression of specific proteins is observed. In a fully 
contractile state (left) there is a high expression of contractile proteins such as; smoothelin A and B, 
smooth muscle Myosin Heavy Chain variants SM1 and SM2 (SM MHC SM1/SM2), Calponin, SM α-
actin and SM 22. A shift towards a synthetic state (right) is evident by loss of smoothelin A / B and 
SM 1/ SM2, along with reduced expression of Calponin, SM α-actin and SM 22. SMCs which are 
further modulated towards a synthetic state will not show expression of calponin and have 
significantly diminished expression of SM α-actin and SM 22 compared with more contractile 
counterparts. An increase in synthetic specific proteins may also be expressed such as moesin. Cells 
which are in a fully synthetic state will have higher expression of moesin, CRBP-1 and Smemb  as 
well as significantly lower expressions of SM α-actin and SM 22. Change in cell morphology is also 
observed between that of a slender elongated contractile cell to a cobble stoned synthetic phenotype. 
Along with a change in expression of specific proteins the miRNA profile within the cell is also 
altered in the different phenotype states. miR-145, miR-143, miR-21 and miR-1 are all up regulated in 
contractile SMCs whereas  miR-221, miR-26a, miR-24 and miR-146a are up regulated in SMCs with 
a more synthetic phenotype. Factors which regulate SMC phenotype can be divided into three 
categories biochemical, ECM components and mechanical forces. Note this is not a conclusive list of 
SMC phenotype markers or factors which influence SMC phenotypic modulation rather a 
representation of the best characterised.   
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Studies have demonstrated that the population of SMCs which make up the tunica 
media of the vessel wall display considerable heterogeneous phenotypes. Even after in 
vitro culture of varying phenotype populations from the same artery, distinctions can 
still be made between the populations based on phenotype (M.G. Frid et al., 1997; P. 
Bochaton et al., 1996; H. Hao et al., 2002 & Y.S. Ko et al., 1999). A particularly 
illustrative example of these differences is evident in SMCs isolated from the thoracic 
artery (S. Li et al., 2001). These phenotypic variations become even more attenuated 
following vascular injury (T. Christen et al., 1999) and vessel remodeling. It is likely 
that a sub-population of synthetic migratory SMCs is required for vessel reorganization 
alongside a layer of contractile quiescent SMCs, which maintain vessel homeostasis.  
S.S.M. Rensen et al., (2007) postulated that although the full spectrum of phenotypic 
diversity is covered by the entire SMC population within a blood vessel, in a given 
population it may only be possible to cover a limited area of this spectrum. This 
indicates some populations of cells may not possess the epigenetic programming to 
move from a fully differentiated state to a fully contractile one or vice versa. 
Essentially, although each VSMC has the genetic make-up or DNA to cover the full 
phenotypic spectrum the cells environmental and hereditary influence such as, location 
in vessel e.g. thoracic or abdominal (in the case of SMCs from the aorta), surrounding 
cells, ECM composition haemodynamic force etc may be a limiting factor for full 
phenotypic modulation. Epigenetics is concerned with the post translational 
modification of genes. There are two main methods of epigenetic programming, DNA 
methylation and histone modification. 
DNA methylation is a reversible modification of DNA in which a methyl group is 
added to a cytosine residue. The majority of methylation occurs at regions where a 
cytosine is directly followed by a guanine residue known as CpG sites. There are 
regions within the genome, termed CpG islands (CGIs), where there is an abundance of 
the C+G sequence. It is here that continued methylation of CpGs can result in specific 
gene silencing (Clifford et al., 2012). 
Histone modification, the nucleosome of chromatin is composed of an octamer of four 
core histones (H3, H4, H2A and H2B) around which 147 base pairs of DNA are 
wrapped. These core histones contain multiple residue sites which are susceptible to 
modification. At least eight types of post-translational histone modifications have been 
identified including acetylation, methylation, phosphorylation, ubiquitylation and 
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sumoylation. Histone acetylation and histone methylation are the best characterized, 
with the modifications being regulated by the enzymes; histone acetyltransferases 
(HATs), histone deacetylases (HDACs) and histone methyltransferases (HMTs), histone 
demethylases (HDMTs) respectively. These post translational modifications can 
influence gene silencing or gene expression within cells (Clifford et al., 2012).   
Although vast, transcription factors which regulate SMC phenotype are becoming more 
defined, the stimulants that can activate or inhibit these however continues to expand. 
Studies suggest a combination of both environmental cues and genetic hereditary are 
responsible for determining in vivo cell phenotype. As stated previously these 
represented by a diverse lineup of biochemical factors, ECM components and 
mechanical factors resulting from the pulsatile nature of blood flow. 
 
1.11 Factors Influencing VSMC Phenotype 
1.11.1 Biochemical factors 
Numerous elegant studies over the past few decades have identified and characterised 
an extensive repertoire of biocompounds that affect phenotypic modulation and 
expression of SMC phenotype markers. These include; PDGF, TGF-β, activin A, 
retinoids, angiotensin II, TNF- α, FGF-2, insulin growth factor (IGF)-I and -II, 
endothelin-I, Nitric Oxide (NO), Reactive Oxidase Species (ROS), peroxisome 
proliferator activated receptor-gamma (PPAR) ligands and complement 3 protein 
(Rensen et al., 2007). These biocompounds have shown to be released during both 
pathophysilogical growth states and through cell-cell interactions. 
Release during pathophysiological growth states 
Platelet-derived growth factor is a dimeric glycoprotein composed of two A (-AA) or 
two B (-BB) chains or a combination of the two (-AB). PDGF-A and -B were identified 
as important for initial stage SMC differentiation during vascular development in 
murine models. This was shown by recruitment of multipotent stem cells to endothelial 
tubes. Here in the presence of PDGF the cells differentiated towards a SMC lineage as 
shown by expression of SM α-actin. In PDGF -/- embryos however there was no 
evidence of recruitment of multipotent stem cells to endothelial tubes and subsequent 
SMC differentiation (Hellstrom et al., 1999, Schattemann et al., 1996). Studies by 
Owens et al., (1995) established that PDGF-BB caused a marked suppression of 
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contractile markers while inducing a synthetic proliferating phenotype in VSMCs in 
vitro. These results were also confirmed in vivo studies showing that inhibition of either 
PDGF A or B reduced SMC proliferation and migration following arterial injury in 
adults, reducing neointima formation (Kotani et al., 2003). In contrast TGF-β isoforms 
(TGF-β 1&2) were shown to induce a contractile phenotype by increasing α-actin, SM-
MHC and calponin in cultured VSMCs (Hao et al., 2002; Hautmann et al., 1997). 
Cultured neural crest cells were also shown to differentiate towards spindle-shaped 
SMCs when treated with TGF-β (Shah et al., 1996).  
Cell-Cell Interactions 
As discussed earlier, the tunica media made up of SMCs is positioned just below the 
layer of endothelial cells making up the tunica intima. Cultured endothelial cells have 
been illustrated to secrete growth factors such as PDGF and FGF-2 (Collins et al., 1987; 
Gajdusek et al., 1982; Hannan et al., 1988) as well as growth suppressors such as 
heparin and TGFβ (J.H. Campbell et al., 1986; J.J. Castellot et al., 1982). These can 
either stimulate or inhibit the growth of cultured SMCs. Conditioned media from 
confluent ECs placed on cultured SMCs was shown to either inhibit or delay the onset 
of SMC de-differentiation in culture (J.H. Campbell et al., 1986). Heparin contained 
within the conditioned media was reported to be largely accountable for this response 
and it was further demonstrated to increase expression of α-actin in cultured SMCs 
(A.L. Desmouliere et al., 1991). In contrasting studies M.S. Schwartz et al., (1987) and 
M.S. Vernon et al., (1993) showed EC conditioned media stimulated growth of cultured 
rat SMCs along with almost complete suppression of α-actin expression. These 
conflicting studies demonstrate that ECs can secrete biocompunds which can modulate 
SMC phenotype in either direction. Following secretion, these soluble growth factors 
can be trapped and stored within the ECM due to membrane bound glycoproteins. 
Changes in physiological conditions can trigger protease activities that cause a local 
release of these stored growth factors (Cheng et al., 1997).  
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1.11.2 Extracellular Matrix Components 
Research has shown that the ECM in which SMCs are seeded has as a profound impact 
on phenotype modulation. Most of the medial ECM is made up of collagen isoforms 
predominantly type I and III, elastin and proteoglycans such as heparin. Fibrillar 
collagen type I, IV and laminin have been shown to promote a contractile phenotype in 
VSMCs, however, monomeric collagen type I is known to activate SMC proliferation 
and induce a synthetic phenotype. Both of these forms of Collagen promote a different 
response by VSMCs to PDGF-B as well as altering gene pool expressions, highlighting 
the influential nature of the ECM in which VSMCs adhere (Raines et al., 2000; Ichii et 
al., 2001). Other ECMs which have shown to promote a synthetic phenotype include 
fibronectin and hyaluronan, a glycosaminoglycan (Hedin et al., 1988; Evanko et al., 
1999). 
Vascular SMCs cultured in a 3D matrix compared with the more common 2D have 
shown differential expression of contractile markers. This highlights the importance of 
ECM alignment as well as composition. Cells cultured in a 3D collagen matrix are less 
proliferative than those cultured in 2D and also express higher amounts of TGF-β1 (S. 
Li et al., 2003). This would suggest the ECM could also be viewed as an intracellular 
reservoir of cytokines and growth factors, which bind to various cellular receptors and 
elicit specific signal transduction responses (S.S.M. Rensen et al., 2007). 
Orr et al., (2010) demonstrated that SMCs plated on collagen IV expressed higher levels 
of contractile proteins compared with VSMCs coated on collagen I. In the same study 
collagen type IV stimulated binding of serum response factor (SRF) to CArG boxes in 
the promoter regions of α-actin and smooth muscle myosin heavy chain (SM-MHC) as 
well as promoting the expression of the SRF coactivator, myocardin, all of which drive 
SMCs towards a contractile state. In contrast Orr et al., (2010) found collagen I 
enhanced expression of the inflammatory protein, vascular cell adhesion molecule-1 
(VCAM-1) again demonstrating the highly specific role of ECM ligands in modulating 
VSMC phenotype. 
Another category of SMC phenotype stimulants are haemodynamic forces. Studies now 
show this mechanical parameter can hold an equal or greater command over VSMC fate 
as biochemical factors and extracellular matrix. 
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1.11.3 Haemodynamic Force 
The mechanical or haemodynamic forces present in all blood vessels, as a direct result 
of blood flow, plays a pivotal role in vasculogenesis, vascular remodeling and SMC 
differentiation. Not only do haemodynamic forces aid in driving the physical changes 
seen in the developing embryo, they are also one of the major regulators of cell 
signaling, gene expression and cell function in adulthood (M. A. Schwartz et al., 2009). 
Alteration in magnitude or any parameter of this force may have pathological 
consequences for vasculature homeostasis. 
These forces are a permanent feature of the in vivo environment of all vascular cells. 
They can be categorized in to two forms, shear stress and cyclic strain. The former is as 
a result of the dragging frictional forces of blood flow and directly impacts on the 
endothelium. The magnitude of this force is directly proportional to the viscosity and 
velocity of the blood and is inversely proportional to luminal diameter. The latter, cyclic 
strain is a tensile force perpendicular to the lumen felt by both endothelial and smooth 
muscle cells (Lehoux et al., 2006). This has a repeated temporary stretch effect on the 
vessel wall and is the stimulus used for work in this thesis. 
  
 
Figure 1.14: Flud Dynamics of Blood Flow Illustration shows cross section of a blood vessel 
with cells most exposed to haemodynamics present (endothelial and smooth muscle). Direction 
of mechanical forces are also shown, Shear stress given asTau (τ) and force by cyclic strain 
given as (P) pressure. Image taken from C. Hahn et al., 2009. 
 
 
Smooth Muscle Cells 
Endothelial Cells 
Direction of Cyclic Strain 
Direction of Shear Stress (Blood Flow) 
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Shear Stress 
The endothelium experiences friction shear stress as a result of blood flow across the 
endothelial layer. Unlike cyclic strain which affects both VSMCs and ECs, shear stress 
impacts predominantly on the endothelial cell layer. It is characterized as a longitudinal 
frictional force which runs parallel to the endothelium. Shear stress can be expressed in 
either units of force per unit of area Newton/meter squared (N/m
2
), Pascal (Pa) or 
Dynes/cm
2
. 
1N/m
2 
= 1 Pa = 10 dynes/cm
2
 
Under normal physiological conditions the shear stress in which the endothelium is 
exposed is in the range of 10-20 dynes/cm
2
.Laminar shear stress can be expressed as: 
  
   
   
 
Where τ =shear stress, µ =blood viscosity, Q = blood flow rate and r = radius. 
Physiologically the flow rate is highest at the centre of the lumen and decrease closer to 
the vessel wall.  
Laminar shear stress (LSS), found mostly in straight vessels, can be classified as an 
atheroprotective stimulus. This is characterized by reduced EC growth as evident 
through proliferation and DNA synthesis studies (Levesque et al., 1990; Traub and Berk 
et al., 1998). A reduction in apoptosis is evident by up regulation of nitric oxide (NO) 
production (Dimmeler et al., 1997). Laminar shear stress also fortifies EC tight 
junctions, reducing the permeability of the endothelium (Colgan et al., 2007). 
Contrary to LSS is disturbed flow, this usually occurs in areas of bifurcations or 
branching points as well as arterial curvatures. At such sites, flow separation leads to 
transient vortex formations and even flow reversal, leading to a variety of different flow 
patterns such as oscillatory flow, low flow velocities and multi-frequency/multi 
directional secondary flows. Cells exposed to these areas of disturbed flow exhibit 
altered cell function such as proliferation, DNA synthesis and migration (Levesque et 
al., 1990, Chiu et al., 1998). Under these conditions, ECs lose their ability to maintain 
homeostasis and become dysfunctional, leading to the infiltration of lipids and 
leukocytes (monocytes and T-lymphocytes) into the sub-endothelial space. The 
resultant inflammatory response leads to formation of fatty streaks, the first stage in 
atherosclerotic plaque formation (Taniyam & Griendling et al., 2003.)
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Cyclic Strain  
Periodic contraction of the heart causes large pulsatile changes in blood pressure on the 
arterial side of the vascular network. Larger elastic arteries, particularly the aorta, 
expand at the peak of the systolic cardiac cycle and then gradually contract during the 
diastolic low pressure cycle which moves blood down into the muscular arteries. A 
healthy adult typically has a blood pressure of no lower than 90/60 mmHg and no 
higher than 120/80 mmHg. The first number represents the systolic pressure during 
contraction and the second is the residual diastolic pressure after the cardiac cycle, 
measured in millimeters of mercury (mmHg). A repeated stretch of 16% and relaxation 
back to 10% of cell length was demonstrated by J. O’Callaghan et al., (2000) to 
represent a blood pressure of 120/80 mmHg. 
Blood pressure causing cyclic stretching of vessel walls is determined by the lumen 
diameter in muscular arteries. VSMCs in these arteries and arterioles actively respond to 
acute changes in blood pressure through a mechanism known as the “myogenic tone” or 
“the Bayliss effect” (Hahn & Schwartz et al., 2009). Stretch of the muscle membrane 
opens a mechano-sensitive activated ion channel. The cells then become depolarized 
resulting in a Ca
2+
 signal and trigger muscle contraction. This phenomenon was 
discovered by Sir William Bayliss in 1902. This contraction narrows the lumen of 
smaller arteries to keep blood flow constant and prevent damage to downstream 
capillaries. If the pressure remains elevated over long periods of time the vasculature 
undergoes remodeling, resulting in a thickened arterial wall to resist the higher blood 
pressure (Geng & Libby et al., 2002; Hahn & Schwartz et al., 2009). 
 
According to the Law of Laplace the magnitude of cyclic strain is determined by the 
change of blood pressure. The tension (T) of the wall is proportional to the difference in 
pressure (P) across the vessel times the radius (r) of the vessel and is inversely 
proportional to the thickness (h) of the wall (Laplace et al., 1899; H. Lamb et al., 1928). 
  
  
 
 
Thus a higher pressure difference and a larger radius results in high wall tension 
requiring the vessel to have a thickened wall to become mechanically stable. 
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This mechanical cyclic strain regulates a myriad of vascular cell biological processes 
including proliferation, apoptosis and migration along with the synthesis, degradation 
and reorganization of the ECM (J.H. Haga et al., 2006).  
Over chronic periods of high blood pressure, vessel remodeling will eventually 
compromise the elasticity of the artery resulting in an inability to regulate blood flow 
during acute phases of altered blood pressure (Folkow et al., 1993). This vascular 
dysfunction can lead to disease such as atherosclerosis in which the higher pathological 
strain results in proliferation and migration of VSMCs through the now permeable 
endothelium into the lumen. This becomes the basis of stable plaque initiation and 
formation. 
Due to the staggering complexity of the in vivo environment, the majority of studies of 
cellular responses to biomechanical stimulus have relied on in vitro systems. Pioneering 
work from Glucksmann et al., (1939) using hanging drop cultures to study tensile 
pressure has evolved to present day vacuum deformation of flexible membrane 
substrates over fixed loading posts (T.D. Brown et al., 2000). Modern apparatus make it 
possible to simulate a range of strain parameters including steady equibiaxial strain, 
cyclic equibiaxial strain, cyclic uniaxial strain, amplitude or magnitude of the strain and 
also frequency and duration of the cyclic strain (Lee et al., 1996; Sotoudeh et al., 1998; 
Kaunas et al., 2005; Wang et al., 2000 & 2001). These stimuli can be used as models 
for pressure-induced cardiac hypertrophy and vascular hypertension (A. Katsumi & W. 
Orr et al., 2004). Studies have shown that a range of vascular cells including fibroblasts, 
SMCs and cardiac myocytes re-locate and orientate in response to cyclic strain. 
However, direction of alignment can be either parallel or perpendicular, depending on 
cell type and nature of the strain (S. Lehoux et al., 2003 J. Sadoshima et al., 1997). 
Recent studies using in vitro models have elucidated the importance of strain 
parameters, showing that variance in frequency, amplitude, direction and duration can 
elicit different molecular and cellular responses. This includes regulation of the 
expression or activation of numerous second messenger molecules such as PI3K/Akt, 
PKC, NFκB, Rho family of GTPases and MAPKs (J.H. Haga et al., 2007). 
Although this thesis focuses on HAoSMCs it should be noted that cyclic strain also 
impacts on ECs and many other vascular cells, activating and regulating similar 
pathways within them. 
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1.12 Mechano Sensors of VSMCs 
Mechanotransduction is the process by which cells convert the mechanical forces 
discussed earlier into biochemical signals. These signals are necessary to maintain 
homeostasis within the vessel. (A. Katsumi & W. Orr et al., 2004; P.A. Jammey et al., 
2004; H. Huang et al., 2004; K.S. Ko et al., 2001). This section will focus primarily on 
membrane bound mechano-sensors of VSMCs, which respond to haemodynamic force, 
in particular cyclic strain (J. H. Haga et al., 2006). It should be noted there are many 
similarities between these and the EC mechano-sensors of shear stress. Several 
membrane proteins have been found to be mechano-sensitive to strain including 
integrins, receptor tyrosine kinases (RTKs), ion channels, cadherins, cell adhesion 
molecules, syndecans and α-dystroglycan. 
1.12.1 Integrins 
Integrins are one of the major families of cell adhesion receptors (Hynes et al., 2000). 
Integrin mediated cell adhesions are intrinsically mechano-sensitive as they are the main 
receptor that connect the cell cytoskeleton to the extracellular matrix (ECM) (A. 
Katsumi & W. Orr et al., 2004). The interaction of VSMC integrins with the ECM plays 
a significant role in the initiation of mechanotransduction by strain (Wang et al., 1993; 
Wilson et al., 1995). Integrins are non-covalently linked heterodimeric molecules and 
are made up of either an alpha () or beta () glycoprotein sub unit; to date there have 
been 18 alpha and 8 beta subunits identified. This allows for a total of 24 different α-β 
integrin compositions, based on various combinations and permutations of both  and  
subunits. They are a type I transmembrane molecule consisting of a short intracellular 
and larger extra cellular domain (Wang et al., 2004; Arnaout et al., 2005).   
 
Figure 1.15: Illustration of α sub unit (left) and β subunit (right). Integrins are cell 
membrane bound glycoproteins made of a α (left) and β (right) sub unit. 
(http://www.mechanobio.info/Home/glossary-of-terms/proteins/integrin) 
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Figure 1.16: Illustration of Integrin Heterodimer Structure. Shows integrin as found on cell 
surface with two non-covalently linked α and β sub units. Extracellular surface domain shows 
binding site for ligands such as the RGD motif found in many ECM proteins. Intracellular 
domain shows binding site for recruitment of effector proteins such as talin. When an integrin 
becomes activated, these effector proteins bind to initiate a signaling cascade within the cell. 
Image taken from “Becker’s World of the Cell” Hardin, Bertoni & Kleinsmith et al., 2012 
 
Integrins are capable of both “inside-out” and “outside–in” signaling. For example, 
tractional forces generated in the cytoskeleton during migration are transmitted across 
the plasma membrane to the ECM to allow re-organisation. Simultaneously, the external 
cyclic strain stimulus due to pulsatile blood flow applied to cells is transmitted 
intracellularly via integrins, resulting in biochemical signals and activation of signaling 
pathways (A. Katsumi & W. Orr et al., 2004; S. Huang et al., 1999; M. A. Schwartz et 
al., 2001). Although not fully elucidated, integrins are the best studied transducer of 
mechanical force into a cellular response by cells.  
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On the cytoplasmic face of the plasma membrane, integrins organise and coordinate the 
assembly of cytoskeletal polymers and signaling complexes. On the extracellular side, 
integrins bind with high affinity to either ECM ligands or counter receptors on adjacent 
cell surfaces (J.D. Humphries et al., 2006). A characteristic feature of most integrin 
receptors is their ability to bind a wide variety of ligands from both the ECM and other 
cell surface receptors (Plow et al., 2001; Van der Flier & Sonnenberg et al., 2001). 
Despite their wide variety and diversification, it is possible to class integrin/ligand 
combinations into four main classes; LDV binding integrins which bind to an acidic 
LDV motif that is functionally similar to RGD, A- domain β1 integrins which bind to 
laminin and collagen, Non α A domain containing laminin binding integrins which are 
laminin selective and finally RGD Binding integrins. 
      
Figure 1.17: Schematic of the four main classes of ligand binding integrins. Schematic of 
the four main classes of integrin/ligand combinations found on the cell membrane. The RGD 
and LDV binding integrins interact with the largest number of ligands. Ligands for the RGD 
binding integrins include; Thrombospondin, Fibronectin, Osteopontin, BSP, MFG-ES (Del-1), 
Vitronectin, vWF, Tenascin, LAP-TGF-β, Fibrillin, Fibrinogen and PECAM-1. LDV binding 
integrins find ligands with MadCAM-1, VCAM-1, Fibronectin, Tenascin, Fibrinogen, Factor X, 
iC3b, Collagen, ICAM, Thrombospondin, E-Cadherin and Osteopontin. The α A domain 
containing β1and non α A domain containing laminin binding integrins interact with far fewer 
ligands. These include Collagen, Laminin, Thrombospondin and Laminin, Thrombosponsin 
respectively (J.D. Humphries et al., 2006).  
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1.12.1.2RGD Binding Integrins 
The arginine-glycine-aspartic acid (RGD) sequence was discovered as a cell attachment 
site in fibronectin over 20 years ago. Unexpected at the time, this 3 amino acid sequence 
motif proved to be a fundamental recognition site for cells and proteins (Pierschbacher 
& Ruoslahti et al., 1984; Ruoslahti et al., 2003). Since then, RGD-recognition sites 
were reported in a host of other ECM proteins (Grant et al., 1989; Lawler et al., 1988; 
Miyauchi et al., 1991; Pytela et al., 1988).  
All five αV integrins, two β1integrins (α5, α8) and αIIbβ3 are capable of binding 
ligands containing the RGD sequence motif. The RGD motif binds at an interface 
between the α and β subunits, the R residue fitting into a cleft in a β-propeller module in 
the α sub unit and the D coordinating a cation bond in a von Willerbrand factor A 
domain in the β subunit. 
The RGD binding integrins can bind a vast array of ligands however; there exists a rank 
order of affinity depending on the complementarity of the fit. Blocking integrins by 
using specific antibodies or synthetic RGD peptides can significantly affect strain 
induced integrin activation, negating any strain induced effects on cell function (Wernig 
et al., 2003; Wilson et al., 1995).  
Initial interactions between integrins and their ligands occur irrespective of mechanical 
stimulus. Following initial ligation, integrins attach to the actin cytoskeleton, inducing a 
2-pN(pico Newton) talin dependent increase in adhesion strength. These early adhesions 
initiate signals that include activation of Rac and Cdc42, which in turn induce formation 
of lamellipodia and filopodia which drives the progression of early focal contacts (FC) 
(A. Katsumi & W. Orr et al., 2004; C. Galbraith et al., 2002; J. Giang et al., 2003; M. 
A. Schwartz et al., 2000). Progression of early focal contacts is marked by recruitment 
of paxillin, various phospho-proteins and vinculin (C. Galbraith et al., 2002).    
When integrins are activated by a stimulus such as strain they undergo a conformational 
change which results in a higher affinity for their ligand. This can have a direct impact 
on SMC function such as adhesion and migration (E. P. Moiseeva et al., 2001). 
Activation of the integrin families is also mediated by contact with specific ECM 
components such as fibronectin and collagen which lead to the formation of focal 
adhesion structures. These focal adhesions contain anchorage points for the cell where 
the cytoplasmic tail of the integrin is physically tethered to the actin microfilaments of 
the cytoskeleton. They also contain signaling molecules, which become activated in an 
64 
 
adhesion dependent manner (K. Burridge et al., 1996). Recruitment of the protein Focal 
Adhesion tyrosine kinase, FAK, to the integrin rich sites appears to be central to focal 
adhesion formation. Vascular injury is known to deactivate integrins to allow cell 
motility and facilitate in repair (N Koyama et al., 1996; J. Seki et al., 1996). 
1.12.2 Dystrophin-Glycoprotein Complex  
The dystrophin-glycoprotein complex (DGPC) is expressed in all types of muscle and is 
critical for correct muscle function as it serves as a structural tether between the cell and 
the ECM (E. P. Moiseeva et al., 2001). The dystrophin gene is one of the longest human 
genes known covering over 2.2 mega base pairs (C.N. Tennyson et al., 1995). 
Disruptions in this gene can lead to forms of muscle dystrophy and cardiomyopathy 
(J.A. Towbin et al., 1998; R. Baressi et al., 2000). Its function is to provide mechanical 
stability to the cell membrane during contraction and also to prevent over stretching 
(B.J. Petrof et al., 1993). The DPGC serves as a link between the basement membrane 
around muscle cells and the actin filaments. The glycoprotein, α-dystroglycan, serves as 
the cell surface receptor for DGPC on SMCs. It connects other components of the 
DPGC with the ECM laminin and perlecan (E. P. Moiseeva et al., 2001). 
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1.12.3 Syndecans 
Studies now suggest that syndecans, members of the proteoglycan family of adhesion 
transmembrane receptors, may also be involved in cell signaling (A.C. Rapraeger et al., 
1998 & 2000). There are four known mammalian syndecans. These adhesion molecules 
bind to an array of ligands including ECM proteins, cell adhesion molecules, growth 
factors, lipoproteins, lipases and components of the blood coagulation cascade (E. P. 
Moiseeva et al., 2001). They interact with their ligands via polysaccharide chains which 
are covalently bonded to the extracellular domain of the receptor. These receptors 
facilitate cell-cell and cell-ECM based adhesion and migration. They also bind to PDZ 
(PSD-95, DlgA, and ZO1) containing proteins, linking syndecans to the cytoskeleton, 
thus they are potential mechano- sensors. They provide additional binding sites for 
ECM ligands which strengthens cell adhesion. Although more research is required 
around the area of Syndecans in VSMC, all four are present on the cell membrane and 
undoubtedly play apart in mechanotransduction. 
 
Figure 1.18: Schematic of Syndecan Structure. Structural domains of tansmembrane 
syndecan are highlighted in this figure as well as polysaccharide strands which bind to syndecan 
ligands. The core protein domains are similar in all 4 members except for the length. The 
ectodomain contains heparan sulphate (HS) binding domains and regions that directly or 
indirectly interact with integrins. The transmembrane spanning region is responsible for 
oligomerization along with residues in the ectodomain and is enhanced by C2 interactions. The 
cytoplasmic domain C1 mainly binds with proteins that link to the actin cytoskeleton. The V 
domain interacts with signaling proteins such as PKCα (Multahupt et al., 2009).  
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1.12.4 Cell Adhesion Molecules (CAM) 
CAMs belong to the immunoglobulin family of cell-cell adhesion receptors. So far the 
adhesion molecules VCAM-1 (Vascular Adhesion Molecule-1) and ICAM-1 
(Intracellular Adhesion Molecule-1) have been detected in VSMCs. ICAM-1 is known 
to interact with cytoskeletal proteins α-actinin and ezrin (O. Carpen et al., 1992). It 
binds to fibrinogen allowing interaction between cell and ECM, thus facilitating 
mechanotransduction (L.R Languino et al., 1993). VCAM-1 is a counter receptor for 
α4β1, α9β1, α4β7 and αDβ2 integrins present on monocytes and lymphocytes 
highlighting and emphasizing its role in inflammatory response (I. Stuiver et al., 1995). 
Both of these adhesion molecules are only present in synthetic SMCs, especially 
following vascular injury. 
1.12.5 Cadherins 
With the exception of T-cadherin (Cadherin 13), all other cadherin’s belong to a family 
of transmembrane Ca
2+
 dependent homophilic cell-cell adhesion receptors. T-Cadherin 
is anchored to the cell membrane via glycosylphosphatidylinositol (GPI), lacking an 
intracellular domain. Cadherin homodimers form a “zipper” structure at the intercellular 
contact zone on the cell surface (B.M. Gumbiner et al., 1996). These receptors bind to 
the cytoplasmic plaque proteins catenins which provide a link with vinculin and the 
actin cytoskeleton. However, as contractile SMCs in the normal vasculature are 
predominantly linked to the ECM, adhesion via cadherins is mostly evident during 
vascular remodeling or following vascular injury where the basement membrane is 
degraded exposing ECs (E. P. Moiseeva et al., 2001). 
  
 
Figure 1.19: Schematic of Cadherin Each cadherin has a small cytoplasmic component, a 
transmembrane component, and the remaining bulk of the protein is extra-cellular. This 
mediates the cell-cell binding of calcium dependent cadherins. Image taken from “Becker’s 
World of the Cell” Hardin, Bertoni & Kleinsmith et al., (2012) 
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1.12.6 Receptor Tyrosine Kinases 
Receptor Tyrosine Kinases are membrane bound cell surface receptors. They have a 
high affinity for many polypeptide growth factors, cytokines and hormones. RTKs are 
typically monomeric subunits but many exist in multimeric complexes (J. Sadoshima et 
al., 1993). Each RTK has a single hydrophobic transmembrane spanning domain 
composed of 25-38 amino-acids, an extracellular N-terminal region and an intracellular 
C-terminal region.  
 
The principal functions of the tyrosine kinase family include cell-cell signalling, 
adhesion and motility. In order to elicit a response, the monomeric subunits must bind 
to a ligand which causes a conformation change in the receptors. The monomeric 
subunits join to form an unphosphorylated dimer. At this point the tyrosine kinases are 
activated and each subsequently recruits a phosphate group from an ATP molecule, 
giving rise to an ADP molecule. A fully active, phosphorylated tyrosine kinase is now 
formed which can elicit multiple cell signalling cascades by recruitment of a relay 
protein to the now phosphorylated tyrosine docking site. Such proteins include Src and 
Shc which can activate the intracellular transduction pathways like phosphatidylinosityl 
3-kinase (PI3K)/Akt, mitogen activated protein kinase (MAP) kinase and Protein kinase 
C (PKC) (D.R. Robinson et al., 2000; Blume Jesnsen & Hunter et al., 2000; Cantley & 
Cantley 1995). 
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Cyclic straining of VSMCs was shown to induce a rapid phosphorylation of PDGF 
receptor α (PDGFRα) in a magnitude dependant manner (Hu et al., 1998). Strain also 
induces the phosphorylation of EGF receptor (EGFR) and it recruitment of relay protein 
Shc and Grb2, which in turn lead to ERK activation (Iwasaki et al., 2000). These results 
highlight the role RTKs play in mechanotransduction. 
 
  
 
  
 
 
Figure 1.20 A&B: Inactive and activated states of Receptor Tyrosine Kinases. (A) inactive 
monomeric subunits of RTKs. Tyrosine sites are un-phosphorylated and sub units are not 
linked. (B) activated form of RTKs from binding a signal molecule ligand. Monomeric subunits 
have relocated together and phosphorylation of tyrosine binding sites from the molecule ATP 
occurs. This ultimately elicits a cellular response. 
Image taken from “Becker’s World of the Cell” Hardin, Bertoni & Kleinsmith et al., (2012) 
  
A. B. 
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1.12.7 Ion Channels  
Ion channels have also been identified as sensors of mechanical stimulus. They create 
an open channel in response to stretching of the plasma membrane. They are cell 
surface membrane complexes that enable transport of ions across biological membranes 
and in doing so establish and control voltage gradients. The passage of large fluxes of 
cations non-specifically allows the cell to accommodate swelling as a result of being 
stretched. Due to their diversity of functions, numerous ion channels are involved in 
cardiac, skeletal, and smooth muscle contraction along with epithelial nutrient and ion 
transport (Hahn and Schwartz, 2009; Lehoux and Tedgui, 2003; Martinac, 2004).  
Straining of VSMCs activates a non-selective cation channel that is permeable to K
+
, 
Na
+
 and Ca
2+
 (Davis et al 1992). More recent experiments have shown that the strain 
induced increase of cystolic Ca
2+
 concentration in SMCs results from the release of 
intracellular Ca
2+
 stores via a stretch activated Ca
2+
 channel (Mohanty & Li et al., 
2002).  
 
 
 
Figure 1.21: Transport of Ions through cell membrane Ion channels control voltage 
gradients across cells by allowing the influx of ions through the cell membrane. They maintain a 
resting membrane potential and have shown to opened upon stretch or cyclic strain.  Image 
taken from “Becker’s World of the Cell” Hardin, Bertoni & Kleinsmith et al., (2012) 
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From the literature, it is clear that the manners in which cells, particularly smooth 
muscle cells, adhere to and sense their substratum is a complex process which involves 
an orchestra of cell signaling and cell adhesion molecules. To maintain homeostasis 
cells also need to be able to functionally respond to external stimuli, this often requires 
motility of the cell. This is facilitated by an array of traction proteins which interact 
with a scaffolding type structure within the cell deemed the cytoskeleton.  
1.13 The Cytoskeleton and Cell Migration 
A cell can change from a stationary to a mobile phase depending on signals received by 
the microenvironment in which it lies. These signals which evoke cell motility include 
ECM molecules, growth factors or chemokines and haemodynamic force (B. Wehrle-
Haller et al., 2003). Actual traction of the cell is achieved by the cytoskeleton. 
1.13.1 The Cytoskeleton 
The cytoskeleton is made up of three types of protein filaments, large microtubules, 
medium sized intermediate filaments and thin microfilaments. The cell relies on the 
cytoskeleton for an array of functions including structural scaffolding, signalling, 
motility and cell division. All three proteins structures are interconnected and cross-
linked with actin binding proteins such as lasp-1 and palladin (Lee and Gotlieb et al., 
2003). 
Microfilaments or actin filaments, with a diameter of approximately 7nm, are flexible 
and easily cross-linked into bundles that absorb external forces acting on the cell along 
with the internally exerted contractile myosin based forces (Higgs and Pollard et al., 
2001). Microtubules are the largest of the three systems with a diameter of 
approximately 25nm. They act as rigid, hallow reinforcing rods that sustain both 
compression and tension and made up of readily available tubulin. It is the ability of 
microfilaments along with microtubules to resist deformation and to transmit forces that 
allow the cytoskeleton to determine cell shape and ultimately the structure of both 
tissues and organisms.  
Intermediate filaments have a diameter between that of actin filaments and microtubules 
of approximately 10 nm (Desai and Mitchison et al., 1997). The main function of 
intermediate filaments is to prevent excessive stretching of cells by external forces. If 
intermediate filaments are defective, tissues become mechanically fragile. They also 
fixate the cell nucleus within the cytoplasm.  
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Figure 1.22: Classes of Cytoskeleton protein fibers. Diagram demonstarates the relative scale 
of each protein filament. 
Image adapted from (http://library.thinkquest.org/C004535/cytoskeleton.html) 
 
To add perspective, if microtubules were enlarged one million fold to a diameter of 
25mm, they would have mechanical properties similar to a steel pipe: quite stiff locally 
but flexible over distances. On the same scale, actin filaments would be similar to 8-mm 
steel wires and intermediate filaments would be likened to braided steel cables 
(Goldman et al., 1999). 
1.13.2 Cell Adhesion and Migration 
Cell migration is a complex and highly orchestrated process between a cell and the 
substratum on which it is attached and over which it migrates. Cell migration can range 
from single cell movement to collective cell migration, where intercellular interactions 
are retained and groups of cells move coordinately Friedl and Wolf et al., 2010. Cell 
surface adhesion molecules are central to the migratory process as they bind interactions 
with the substratum to the interior cell cytoskeleton. There are several families of 
adhesive receptors on the cell surface as discussed earlier however the most 
characterised and paramount to cell motility is the integrin family of receptors. The 
dynamic polarized ability of integrin adhesions to form and turn over is essential to 
facilitate cell migration and directional persistence Huttenlocher and Horwitz et al., 
2011. 
72 
 
Integrins attach to the actin cytoskeleton, inducing a 2 pico Newton (2pN) talin 
dependent increase in cell adhesion strength (A. Katsumi & W. Orr et al., 2004). These 
early adhesions initiate signals from the rho subfamily of small GTP- binding proteins. 
These are a sub family of the Ras super family of GTP-binding proteins. Members of 
the rho family include rho, rac and cdc42. 
It is the activation of cdc42 and Rac, following these early integrin adhesions, that 
induces formation of protruding cellular structures that form the leading edge of the cell. 
These include filopodia and lamellipodia (J.V. Small et al., 2002). The directional 
protrusion of these structures, composed of numerous actin filaments, marks the 
initiation of cell locomotion. Their protrusion and movement are as a result of actin 
polymerization. Orientation of actin filaments during polymerisation can be detected by 
the cleaved myosin heads which bind laterally to the F-actin filament giving a “barbed” 
impression at one end, and an arrow or pointed appearance at the other.  
Monomeric G-actin polymerises F-actin at their “barbed end”. G-actin is then liberated 
from the pointed end by de-polymerisation via an actin depolymerising factor (ADF) 
(C. Pantaloni et al., 2001). This process is referred to as treadmilling and, in a 
lamellipodium it operates towards the interior of the cell where actin molecules are 
added at the periphery and then released towards the cell centre. In general, the 
orientation of treadmilling indicates the polarity of each actin filament (B. Wehrle-
Haller et al., 2003).  
In order to transform the treadmilling action into cell movement the actin filaments 
must also be anchored at their pointed end to sites called focal complexes at which point 
the cell can pull or push itself forward (K. Rottner et al., 1999, B. Geiger et al., 2001). 
The transition from early adhesions (focal contacts) to focal complexes is marked by the 
recruitment of paxillin, phosphor-proteins and vinculin (C. Galbraith et al., 2002). 
Expression of vinculin in cell adhesions is proportional to the level of tractional force 
by the cell. This adhesion must be sufficient enough to allow the cell generate traction 
and the force required for migration. 
 
 
 
73 
 
Focal Complexes are a precursor to focal adhesions. These are longer, elongated 
structures which form in response to Rho activation. They require an increase in cellular 
contractility mediated by the Rho effector, Rho kinase; this in turn induces increased 
phosphorylation of the myosin light chain. This increased force at adhesion sites results 
in an increase in the density of activated integrins (avidity regulation), the recruitment 
of adhesion structural proteins and the elongation of the adhesion site. (Katsumi & W. 
Orr et al., 2004). When focal complexes mature into focal adhesions at the leading edge 
of the cell, they become stationary relative to the ECM. This provides an anchor from 
which the cell can pull itself over the ECM. 
Parrallel to the extension of a lamellipodium and formation of stable adhesions for 
traction, migration also requires mechanisms that regulate the release of adhesions 
especially at the cell rear to allow detachment and facilitate movement of the cell in the 
direction of migration. These adhesions are inheriently weaker. There appears to be two 
fates offered to integrins tracking at the rear of the cell.  A substantial population of 
them will remain assosciated with the substratum. Cytoskeleton associated adhesive 
proteins such as vincullin are not present in these suggesting a severing of integrin 
cytoskeleton linkages. The other fate, the integrin is disassembled and carried forward 
to the front of the advancing cell to participate in newly formed focal adhesions 
Huttenlocher et al., 1995. 
As the cell progresses along its chosen path, a given focal adhesion moves closer and 
closer to the trailing edge of the cell. Once at the trailing edge, the focal adhesion must 
be dissolved to facilitate continued cell migration. All rear assemblies retract and slide 
towards the protruding lamellipodia and filopodia where new adhesions are formed. As 
the process is repeated it has the effect of pulling the cell forward, similar to the way 
tank tracks work.  
Cells which are typically slow to migrate such as fibroblasts and contractile SMCs 
exhibit actin filaments which are bundled into stress fibers. These are anchored within 
focal contacts located at the cell periphery. These stress fibers are often found orientated 
along lines of tension, strapping the cell to the substrate. In comparison to the actin 
filaments in lamellipodia of migrating cells, actin stress fibers have a reversed 
orientation in that they are anchored to focal contacts by their barbed ends and not the 
pointed end. This also means the monomeric G actin is incorporated at the opposite end 
of the filament.  
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In order to switch from a stationary stress fibre rich state, to a migratory, lamellipodia 
rich state, the actin cytoskeleton must reorganise by recruiting G-actin. The monomeric 
protein can be recruited by depolymerisation of F-actin, however, the actin pool within 
in a cell is limited and migration is most likely constrained by the G actin: F actin ratio. 
 
 
 
Figure 1.23: Dynamics of cell migration. As actin polymerises it extends lamellipodium in the 
direction of migration. Along with this integrins bind to the polymerised actin and form focal 
contacts which work as a molecular clutch. These provide an anchorage point from which the 
cell can gain traction and pull itself forward. Simultaneously to this adhesion points at the rear 
of the cell disengage and retract to allow cell motility.  Image taken from 
(http://www.cytochemistry.net/Cell-biology/actin_filaments.htm) 
In 2D culture systems rate of cell migration is maximum at intermediate levels of cell-
substratum adhesion where both adhesion formation and release are efficient DiMilla et 
al., 1993. Too low an adhesive strength and the cell can not generate the sufficient 
traction for migration in contrast at higher adhesive strength the rear assembly of the 
cell is not released inhibiting movement. In 3D in vivo other factors such as the release 
of matrix metalloproteinases (MMPs) facilitate migration by breaking down the ECM 
barrier. The concentration of substrate and ligand receptors on the cell surface also 
dictates the magnitude of adhesion. In environments of low ligand concentration smooth 
muscle cells and do not migrate on fibronectin. Whereas a high fibronectin environment 
causes cell spreading, focal adhesion formation and inhibiton of cell movement 
Huttenlocher et al., 1995. Indicating that balanced concentrations of lignad substrate 
and cell receptor is required for cell movement. 
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Figure 1.24: Diagram of Cell Migration - Actin driven cell migration in the front and 
microtubule controlled retraction in the rear. A schematic view of a migrating cell is shown that 
illustrates the main features of the actin and microtubule cytoskeleton. At the cell front, 
Cdc42/Rac1 induced actin polymerization results in the formation of filopodia and lamellipodia 
that drive the cell edge forward. The advancing lamellipodia is anchored to the substrate by 
stationary focal complexes .While the cell moves forward, low-density focal complexes located 
at the lateral edges of the lamellipodium transform into high-density focal contacts that are 
linked to actin stress fibers in a RhoA dependent manner. When the focal contacts localize to 
the rear of the cell, a microtubule controlled inward sliding, release and retraction takes place 
(arrows), which allows the cell to move forward (B. Wehrle-Haller et al., 2003). 
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Study Background, Hypothesis and Objectives  
Study Background 
Vascular smooth muscle cells (VSMCs) are primarily responsible for regulating 
vascular tone and blood pressure. They achieve this through a unique plasticity which 
allows them to reversibly differentiate between a synthetic and contractile phenotype. 
This is known as phenotypic modulation. Differentiated SMCs are characteristically 
quiescent and adapt elongated spindle morphology. In this state the cell expresses an 
extensive range of contractile proteins such as SM α-actin, Smoothelin and Calponin. 
SMCs in the synthetic end of the phenotype spectrum adapt a rhomboid morphology 
and their expression of contractile proteins is significantly decreased and replaced with 
organelles involved in protein synthesis. Synthetic SMCs also display increased 
migration and cell motility, a precursor too many cardiovascular diseases and 
complications such as atherosclerosis and restenosis. 
Cell migration is a complex and highly orchestrated process between a cell and the 
substratum on which it is attached and over which it migrates. Cell migration can range 
from single cell movement to collective cell migration, where intercellular interactions 
are retained and groups of cells move coordinately Friedl and Wolf et al., 2010.  
In brief cell migration is characterised by a multistep cycle initiating with protrusion, 
adhesion formation and stabilization at the leading edge. This is achieved by integrins 
attaching to the actin cytoskeleton, which stimulates the formation of filopodia and 
lamellipodia. These are composed of actin containing cytoskeletal filaments, primarily 
microfilaments. This is followed by translocation of the cell body where by the actin 
filaments polymerise and present the membrane to the leading edge of the cell. From 
here focal adhesions are formed which establish a site of traction from which the cell 
can anchor and pull itself forward.  At this point, a combination of actin treadmilling 
and release of adhesions at the cell rear, allowing for detachment, facilitate cell motility 
in the direction of migration Abercrombie et al., (1971).  
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The phenomenon of SMC phenotype switching appears to be as a result of both innate 
genetic pathways and environmental cues, such as haemodynamic pressure (Owens et 
al., 1995). Haemodynamic force is a permanent feature of the in vivo environment of all 
vascular cells as a result of the dynamic nature of blood flow. This pressure can be 
categorized in to two forms, shear stress and cyclic strain. The latter, cyclic strain is a 
tensile force perpendicular to the lumen felt by both endothelial and smooth muscle 
cells (Lehoux et al., 2006). This has a repeated temporary stretch effect on the vessel 
wall and is the stimulus used for work in this thesis. 
Studies have shown that several non coding micro RNA (miRNA) ,which negatively 
regulate gene expression, are differentially expressed in these altered SMC phenotypes 
(W. Sessa et al., 2010, N. J. Leeper et al., 2010, X. Lin et al., 2010). However, work 
into the effect of mechanical stimulus such as shear stress or cyclic strain on miRNA 
expression is scarce and only a handful have been identified (Y.J. Guan et al., 2011, J. 
Shaik et al., 2010).  
Study Hypothesis  
This study hypothesizes that “cyclic mechanical strain, mediated by miRNA regulation, 
modulates vascular smooth muscle phenotype and ultimately function,”  
Study Objectives 
The objectives for this project were to: 
 Establish if cyclic mechanical strain and its properties, namely duration and 
amplitude, influenced HAoSMC phenotype.  
 Determine a miRNA signature or “miRNOME” for HAoSMCs and test if this 
alters with application of cyclic strain. 
 Monitor the rate of migration of HAoSMCs in culture vs cells exposed to cyclic 
strain. 
 Implement miRNA as mediators of any alteration observed in HAoSMC 
phenotype or migration as a result of cyclic strain.  
 
 
  
  
78 
 
CHAPTER TWO: Materials and Methods 
2.1 Materials  
2.1.1 Reagents, Chemicals and Cell Culture 
The listed companies provided the following chemicals, reagents and cell culture 
material: 
Applied Biosystems / Ambion (Life Technologies), CA, USA: 
 
miRNA Isolation and Analysis; 
mirVana™ miRNA isolation kit (40 Isolations)      Product# AM1560 
TaqMan® miRNA Reverse Transcription Kit                                      Product# 4366596 
(200 reactions)           
Megaplex™ RT Primers Human Set (A & B) v2.0 10X                      Product# 4400928 
(50 reactions)   
Megaplex™ PreAmp Primers, Human Se (Pool A & B)v2.0               Product # 4400927 
TaqMan® Pre Amp Master Mix 2X (40 reactions)       Product# 4391128 
TaqMan® Array Human miRNA Cards Set v2.0 (A & B)     Product# 4400238 
Taqman® Universal Master Mix II, no UNG 5- Pack (5 X 5ml)     Product # 4440048 
DNA ZAP™           Product # 9892G 
Real Time qPCR  
High Capacity cDNA Reverse Transcription Kit (200 Reactions)    Product # 4368814 
Argonaute 2 siRNA: 
1) siRNA ID s25931        Cat#4392420 (5nm)    
2) siRNA ID s25932        Cat# 4392420 (5nm) 
3) Custom siRNA         ID # ADAAYKB   
Scrambled Negative Control            Product#4390843(5nm) 
Positive Control, GAPDH siRNA           Product#4390849(5nm) 
 
BDH Limited: 
Tween® 20        Product# 66368 
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Bio-Rad, Hercules, CA, USA: 
Ammonium Persulfate      Product#161-0700 
2-mercaptoethanol       Product#161-0710 
10X TGS (Tris/Glycine/SDS)     Product#161-0772 
TEMED        Product#161-0800 
        
DAKO, CA, USA: 
Fluorescent Mounting Media      Product# S3023  
 
Eurofins MWG Operon, Ebersberg, Germany: 
Gene Specific Primers: 
α-Actin  Sense: TTCAATGTCCCAGCCATGTA 
Anti Sense: GAAGGAATAGCCACGCTCAG 
Calponin  Sense: AGGCTCCGTGAA GAAGATCA 
Anti Sense: CCACGTTCACCTTGTTTCCT 
Smoothelin  Sense: TGGAGGAATTGACTGCACTG 
Anti Sense:GAAACCTCTGCCTGCTGTTC 
 FAK  Sense: NA 
Anti Sense: NA 
 FRNK  Sense: NA 
Anti Sense: NA 
GAPDH  Sense: NA 
Anti Sense: NA 
18S  Sense: NA 
Anti Sense: NA 
Exportin 5 Sense: GTTGCCATCGTCAGACATT 
Anti Sense: CCACTACAATTCGAGACAGAG 
Drosha Sense: CTAATAACAGCAGTAGTCCTCATT 
Anti Sense: GCCTGTGGTCATCATAGTG 
Dicer Sense: GACTGTCGTGCCGTATTG 
Anti Sense: GTAGTTCTCTTACCATCATTCCA 
Argonaute 2 Sense: CTAATAACAGCAGTAGTCCTCATT 
Anti Sense: TTCTGCCACTGCTCCTTA 
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Fermentas, York, UK (Thermo Fisher): 
Dream Taq Green Buffer10X      Product# B71 
Gene Ruler 100bp Plus DNA Ladder     Product# SM0321 
Page Ruler Plus- 
Prestained Protein Ladder      Product# SM1811 
Spectra Multicolour High Range Protein Ladder   Product# PN26625 
Taq DNA Ppolymerase      Product# EP0402 
GE-Healthcare, Buckinghamshire, UK:  
Goat monoclonal to Mouse IgG (HRP) secondary antibody 
 
Invitrogen, CA, USA (Life Technologies): 
AlexaFluor® 488 goat anti mouse     Product# A-10667 
DAPI Nuclear Stain       Product# D357 
DEPCTreatedWater 
Pyrogen Free, Certified DNAse/RNAse Free    Product# 46-2224 
DH5α E-coli Max Efficiency Competent Cells   Product# 12034013 
Propidium Iodide       Product# P3566 
Rhodamine Phalloidin      Product#R415   
SYBR® Safe Solution      Product# S33102 
Trizol® Reagent       Product# 15596018 
 
Lennox Laboratory Supplies LTD, Dublin, Ireland: 
100% Industrial  
Methylated Spirits (IMS)                    Product# CRTSI0330716 
 
Medical Supply Company / Pierce (Thermo Scientific): 
BCA Protein Assay Kit      Product# 23227 
Restore™ Western Blot Stripping Buffer    Product# 21059 
Super Signal® West Pico Chemiluminescent Substrate  Product# 34080 
 
Merck Millipore CA, USA: 
Antibodies: 
Activated form of β1  
Integrin                            Product# MAB2079Z 
Argonaute2 (Ago2) 200µg      Product# 07-590 
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Dicer, MSX 5D12.2 100µg      Product# 04-721 
Focal Adhesion Kinase (FAK) Pc 12-305    Product# 06-543 
GAPDH        Product# ABS16 
Smoothelin MSX 100µg      Product# MAB3242 
Goat anti Mouse HRP Secondary     Product#AP308P 
EasyCheck™ Kit for HT Systems     Product# 4500-0025 
Immobilon-P  
(PVDF Transfer Mmenbrane)                         Product# IPVH00010 
Luminata™ Forte  
HRP Substrate 100ml                                    Product# WBLUF0100 
 
Promocell, Heidelberg, Germany: 
Human Aortic Smooth Muscle Cells (HAoSMC); 
-500,000 Cryopreserved Cells    Product# C-12533 
-500,000 Proliferating Cells      Product# C-12532 
Cryo-SFM serum free medium for cryopreservation;    
-30ml        Product# C-29910 
-50ml        Product# C-29912 
HAoSMC Growth Medium2 Kit     Product# C-22162 
HAoSMCCell Growth Medium2 Supplement Mix;   Product# C-39262 
-Fetal Calf Serum 0.05ml/ml 
-Epidermal Growth Factor (recombinant human) 0.5ng/ml 
-Basic Fibroblast Growth Factor (recombinant human) 2ng/ml 
-Insulin (recombinant human) 5µg/ml. 
Detach Kit;         
-30ml        Product# C-41200 
-125ml        Product# C-41210 
 
Qiagen, West Sussex, UK: 
HiSpeed Plasmid Midi-prep kit     Product# 12643 
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R & D Systems 
Quantikine® ELISA Human FGF-2     Product# DFB50 
Duo Set ELISA Thrombomodulin     Product#DY3947
  
Roche Diagnostics, Basal, Switzerland: 
Complete (EDTA – Free), Protease Inhibitor  
Cocktail Tablets      Product# 11873580001 
Fast Start Universal SYBR Green 
Master (ROX)       Product# 04913914001 
 
Sigma Aldrich Chemical Company Ltd, Dorset, UK: 
Acetone       Product# 34850-2.5L   
Agarose (500g)      Product# A5093-500g 
Ammonium Persulfate (100g)    Product# A9164-100g 
Ampicillin       Product# A0166-5g   
Bovine Serum Albumin (BSA)    Product# A2153-50g   
Chloroform       Product# C2432   
Ethanol (for miRNA work)     Product# E7023-500ml 
Glycerol       Product# G6279-1L 
Glycine;          
-500g       Product# G8898-500g 
-1kg       Product# G7126-1KG 
Kanamycin Sulphate (5g)     Product# K4000-5g  
37% Formaldehyde       Product# F8775-500ml  
Phosphate Buffered Sulphate (PBS) Tablets   Product# P4417-100TAB 
Penicillin/Streptomycin 10X (100ml)   Product# P4333-100  
Ponceau S solution      Product# P7170-1L  
Trypsin-EDTA (10X)      Product# T4174-100ml 
Triton X- 100 (500ml)     Product# 9002-93-1  
Sodium Chloride      Product# s3014-5kg   
Sodium Deoxycholate     Product# D6750-100g 
Sodium Dodecyl Sulfate     Product# L3771-500g 
Sodium Orthovanadate (250g)    Product# s-6508 
Sodium Phosphate      Product# S3264-1KG    
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Thermo Fisher Scientific, Leicestershire, UK: 
Methanol        Product#34860-2.5L   
10X PBS Solution       Product# 10649743  
Trizma Base        Product# BP152-2 
Isopropanol        Product# P/7490/15  
Hydrochloric Acid            Product# H/1100/PB17  
Acetic Acid           Product# A/03601/PB17  
 
2.1.2. Instrumentation 
Applied Biosystems, CA, USA: 
Applied Biosystems 7900HT Fast Real Time PCR Machine with Sequence Detection 
Software (SDS) 
  
Bennett Scientific Ltd., Devon, UK: 
Clifton Duo Water Bath 
 
Becton Dickinson 
FACS Aria 
 
Bio-Rad, Hercules, CA, USA: 
MJ-Mini Gradient Thermocycler 
Mini-PROTEAN Tetra Cell System 
-(4-Gel System Includes: Electrode Assembly, Electrophoresis PowerPak® 
Basic, Companion Running Module, Tank, Lid With Power Cables, Mini Cell 
Buffer Dam, Gel Casting Stands, 10 well combs, Gel Casting Frames, 5Short 
Plates,5Spacer Plates and Transfer Electrode Rig) 
 
BioTEK, VT, USA: 
Microplate Reader ELX800 
 
 
 
 
 
 
84 
 
Eppendorf, Cambridge, UK: 
Centrifuge 5702 
Centrifuge 5430R 
Centrifuge 5810R 
Centrifuge 5415D  
 
Flexcell International Corp, NC, USA: 
Flexercell® tension plus™ FX-4000T system 
 
Heraeus Frankfurt, Germany: 
HERA Safe Laminar Air Cabinet 
 
Invitrogen (Life Technologies): 
Neon Transfection System      Product# MPK5000 
 
Labtech (East Sussex, UK): 
ADAM ™ Counter 
Nikon® Eclipse TS100 phase-contrast microscope 
 
Mason tech (Dublin, Ireland): 
Nanodrop 1000 ™ system 
 
Medical Supply Company (Dublin, Ireland): 
Horizontal Agarose Gel Electrophoresis Rig 
Liebherr 4°C Refrigerator 
Liebherr Profiline -20°C Freezer 
 
Memmert (Distributed by Mason Technology): 
Cell Culture Incubator INC 246 
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Merck Millipore CA. USA: 
Guava® Easy Cyte™ 8HT Bench Top Flow Cytometer  Product# 0500-4008 
 
Nalgene, Rochester, NY, USA: 
Cryo-freezing container 
 
Roche/ Acea Diagnostics, Basal, Switzerland: 
RTCA DP Analyzer 
 
Stuart Scientific Ltd, Staffordshire, UK: 
Block Heater                  Product# SBH130D 
Orbital Shakers                  Product#SSL1/SSM1 
Rotator                  Product# SB3 
See-Saw Rocker                 Product# SSL4 
Vortex                   Product# SA8 
 
Syngene, Cambridge, UK: 
G-Box Fluorescence and Chemi-Luminescence Gel Documentation and Analysis 
System 
 
Taylor-Wharton, USA: 
Liquid Nitrogen Cryo-Freezer Unit (VHC-35 ®) 
 
Thermo Fisher Scientific, Leicestershire, UK: 
Holten LaminAir laminar flow cabinet 
-80 Freezer 
HERA Cell 150 Cell Culture Incubator 
 
VWR International Ltd. (West Sussex, UK) 
Nalgene Mr Frosty® Freezing Container 
Haemocytometer
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2.1.3 Consumables / Plastic ware 
 
Applied Biosystems, CA, USA: 
Fast Optical 96 Well Reaction Plate with barcode (0.1ml)  Product # 4346906 
MicroAmp Optical Adhesive Film- 
PCR Compatible, DNA/RNA/RNAse free    Product# 4311971 
 
Dunn Labortechnik GmBH, Asbach, Germany: 
6-well Bioflex plate  
AminoCoated                                      Product#BF-3001A/10 
 
DigitalBio Technology, Boston MA, USA: 
4 channel Accuchip kit with Accustain Solution   Product# AD4K-200 
 
Eppendorf, Cambridge, UK: 
Safelock Tubes 2.0ml PCR Clean     Product# 123.344 
 
GE-Healthcare, Buckinghamshire, UK:  
Whatman Filter Paper       Product# 3001919 
 
Invitrogen, CA, USA: 
Neon Transfection System 100µl Kit (192 Reactions)  Product# 
MPK10096 
 
Pall Life Science, NY, USA: 
Nitrocellulose Transfer Membrane      Product# 66485 
Acrodisc 32 mm Syringe Filter with 0.2 μm Supor Membrane Product# 4651 
 
Roche/ Acea Diagnostics, Basal, Switzerland: 
xCELLigence E-Plate 16     Product#05 469 830 001 
xCELLigence CIM-Plate 16     Product# 05 665 817 001 
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Sarstedt AG & Co Numbrecht, Germany: 
Individually Wrapped and Plugged Sterile Serological Pipettes: 
- 2ml       Product# 86.1252.001 
-  5ml       Product# 86.1253.025 
- 10ml       Product# 86.1254.025 
 - 25ml       Product# 86.1685.001 
Aspiration Blow- Out Pipette     Product# 86.1252.011 
100mm x 20mm Tissue Culture Dishes   Product# 83.1802.002 
 6 Well Tissue Culture Dish      Product# 83.1839 
24 Well Tissue Culture Dish      Product# 83.1836 
96 Well Tissue Culture Dish      Product# 83.1835 
15ml Polypropylene Reagent & Centrifuge Tubes   Product# 62.554.001 
50ml Polypropylene Reagent & Centrifuge Tubes   Product# 62.559 
Cryotubes        Product# 73.380.992 
2ml Safe Lock Tubes       Product# 72.695.500 
 
StarLab, Hamburg, Germany: 
1000 µl Graduated Filter Tips    Product# S1120-8810 200  
200 µl Graduated Filter Tips     Product# S1122-1830 
20 µl Graduated Filter Tips     Product# S1120-1810 
10 µl Graduated Filter Tips     Product# S1121-3810 
 
VWR International Ltd. (West Sussex, UK) 
Cover slips        Product# 631-0124 
Super Frost Glass Slides      Product# 631-0104
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2.1.4 Preparation of stock solutions and buffers. 
2.1.4.1 Immuno-blotting. 
 
RIPA Cell Lysis Buffer Stock (1.28X)500ml 
HEPES, pH7.5    64mM 
NaCl      192mM 
Triton X-100     1.28% (v/v) 
Sodium Deoxycholate  0.64% (v/v) 
SDS     0.128% (w/v) 
dH2O to final volume   500ml 
 
RIPA Cell Lysis Buffer (1X) 
1.28X RIPA Stock    1X 
Sodium Fluoride    10mM 
EDTA, pH8.0     5mM 
Sodium Phosphate    10mM 
Sodium Orthovanadate   1mM 
Protease Inhibitors    1X 
 
Sample Solubilisation Buffer (4X) 
Tris-HCl, pH6.8    250mM 
SDS      8% (w/v) 
Glycerol     40% (v/v) 
β-Mercaptoethanol    4% (v/v) 
Bromophenol Blue    0.008% (w/v) 
 
Transfer Buffer (1X) 
Tris-HCl     25mM 
Glycine     192mM 
SDS      0.1% 
Methanol     20% 
 
 
 
89 
 
TBS wash Buffer 
Tris-HCl, pH7.4    50mM 
NaCl     150mM 
 
Coomassie Stain 
Coomassie Brilliant Blue R250  0.2% 
Methanol    45%  
Glacial Acetic acid    10% 
dH2O      44.8% 
Filter the Coomassie stain using a 0.25μm filter. 
 
Coomassie Destain Solution 
Methanol    20% 
Glacial Acetic acid    10% 
dH2O     70% 
 
2.1.4.2 Molecular Biology Buffers and Medium. 
SOC Media 
Tryptone     2% (w/v) 
Yeast Extract     0.5% (w/v) 
NaCl      10mM 
KCl      2.5mM 
MgCl2     10mM 
MgSO4    10mM 
Glucose     20mM 
 
Luria-Bertani (L.B) Media 
Tryptone     1% (w/v) 
Yeast Extract    0.5% (w/v) 
NaCl      171mM 
 
Luria-Bertani (L.B) Agar (1L) 
Agar      15g 
Made up to 1L with L.B. media 
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Antibiotics 
Ampicillin      100 μg/μl 
Kanamycin     50 μg/μl 
Antibiotics were dissolved with dH2O and subsequently sterilised using a 0.25μm filter. 
Aliquots may be stored at -20C, but must be kept wrapped in tin foil to avoid 
degradation through exposure to natural light. 
 
TE Buffer 
Tris      10mM 
EDTA (pH8.0)     1mM 
 
DNA Loading Buffer 
Sucrose     40% (w/v) 
Bromophenol Blue   0.25% (w/v) 
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2.2 Methods  
 
2.2.1 Cell Culture Technique 
For the entirety of this study, the cell types used were as follows: Human Aortic Smooth 
Muscle Cells (HAoSMC) and Human Aortic Endothelial Cells (HAEC). Both cell types 
were maintained in a 37°C humidified atmosphere containing 5% CO2. (Freshney et al., 
2011). 
2.2.1.1 Human Aortic Smooth Muscle Cell (HAoSMC) Culture. 
 
HAoSMC obtained from Promocell®, Germany. Lot # 1012003.2. Cells were isolated 
from a 19 year old, male, Caucasian, non-smoker with a population doubling time 
estimated at 40.6 h derived from the thoracic region. The cells were maintained in 
HAoSMC specific growth medium, containing basal media, 5% fetal calf serum (FCS), 
human endothelial growth factor (hEGF), human basic fibroblast growth factor (hbFGF) 
and Insulin. Primocin® antibiotic was also added at a final concentration of 100µg/ml 
to protect against fungal and bacterial infection. The cells were primarily cultured and 
sub cultured on 78cm
2 
tissue culture dishes from Starstedt®. For experimental purposes 
cells were typically seeded on 6, 24 and 96 well plates.  For use in cyclic strain 
experiments the cells were seeded onto an amino coated flexible membrane Bioflex® 6 
well plate.  (http://www.promocell.com/fileadmin/promocell/PDF/C-12532.pdf) 
2.2.1.2 Human Aortic Endothelial Cell (HAEC) Culture. 
 
HAECs (Promocell®) were derived from the thoracic aorta of a 21 year old male, non-
smoker. The isolated endothelial cells were maintained in a cell growth medium MV 
supplemented with a separate Supplement Mix ® of growth factors containing; 
endothelial cell growth supplement/ heparin (ECGS/H) 0.4% (v/v), fetal calf serum 
(FCS) 5.0% (v/v), endothelial growth factor (EGF) 10ng/ml and Hydrocortison 1µg/ml. 
The antibiotic/antifungal Primocin was also added to a final concentration of 100µg/ml 
to protect against fungal and bacterial infection. The cells were primarily cultured and 
sub cultured on 78cm
2 
tissue culture dishes from Starstedt®. For experimental purposes 
cells were typically seeded on 6, 24 and 96 well plates. 
(http://www.promocell.com/fileadmin/promocell/PDF/C-12271.pdf)  
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2.2.1.3 Trypsinisation and Sub Culturing of Adherent Cells. 
Adherent cells were lifted from culture dishes using the pancreas derived enzyme 
trypsin in a process known as trypsinisation. This is required for sub culturing or 
seeding cells for experimental purposes.  Cells were grown to a confluence of 70-90%. 
To passage a confluent dish, all required solutions are brought to 37°C including, 
trypsin, PBS and cell culture media. New cell culture dishes were filled with 7mls of 
media and allowed equilibrate in a 37°C humidified incubator with 5% C02 (v/v) for at 
least 30 minutes prior to sub culturing. 
Using a sterile disposable aspiration pipette, growth media from the confluent dish was 
removed. The cells were then gently washed 3 times with 2mls of PBS to remove 
trypsin inhibiting compounds such as α-macroglobuin present in serum. Any solutions 
added to cell culture dishes was done so by allowing them to run down the wall of the 
dish to reduce shear stress on cells and prevent lifting by applying directly to the cell 
layer. Following washing with PBS 2ml of 0.25% (v/v) trypsin was added to a 78cm
2
 
dish or 1ml for a single well of a 6 well plate. The cells were incubated at room 
temperature for approximately 3 minutes then viewed under a microscope at 4X and 
10X magnification. When approximately 50% of cells were lifted the remaining, which 
were rounded in morphology, were dislodged by gently tapping on the side of the dish. 
An equal volume of full culture medium to that of trypsin was then added to neutralise 
and prevent further trypsinisation. Cell suspension was then added to a sterile 15ml tube 
and centrifuged at 700 RPM (50g) for 5 minutes at room temperature. The supernatant 
was carefully aspirated off and the pellet gently re-suspended in 500µl of media by 
careful pipetting up and down. The cells were then counted and seeded as required for 
sub culturing or experimental use. 
(http://www.promocell.com/fileadmin/promocell/PDF/C-12532.pdf) 
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2.2.1.4 Cell Counting. 
To ensure precise seeding densities of cells, for culturing and experimental reasons, 
cells were counted using both a Neubauer chamber haemocytometer and an automated 
ADAM cell counter. (http://scienceservices.eu/media/pdf/User_manual_ADAM-
MC_V3_0.pdf) 
2.2.1.4.1Haemocytometer 
The haemocytometer was covered with a precision ground cover slip. 20µl of trypan 
blue was added to 100µl of cell suspension and the haemocytometer chamber filled by 
capillary action. 
Cells were visualised by phase contrast microscopy under a 10X objective. Viable cells 
excluded the trypan blue stain whereas dead cells stained blue. The outer four corners of 
the haemocytometer are used for counting purposes where cells touching the bottom 
and left lines of the corner were excluded. 
 
Figure 2.1 The Haemocytometer: Four outer squares of 4x4 boxes with a centre grid of 5x5 
boxes. Outer four corners are counted omitting cells touching bottom and left side lines. Image 
taken from (www.microbehunter.com) 
Cell number from each four corners were added then divided by four to give an average 
count per 1mm
2
. The volume under the coverslip is 0.1mm
3
 = (0.0001cm
3
 = 0.0001ml 
or 10
-4
) 
Hence, total viable cell number = average cell number x dilution factor (if any) x 1x 10
-4 
(conversion factor) = viable cells/ml  
(http://www.abcam.com/index.html?pageconfig=resource&rid=11454) 
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2.2.1.4.2 Adam Counter  
 
Digital Bio ADAM (Advanced Detection and Measurement) Counter is an automated 
viable cell counter that uses a laser based fluorescent microscope and CCD detection 
system. Two 20µl aliquots of cell suspension were added, respectively, to a 20µl sample 
of Accustain solution T ® and Accustain solution N ®.  Solution T contains a lysing 
solution and propidium iodide (PI) stain to give a total cell count. Solution N contains 
only PI stain to give a non-viable cell count.  Viability percentage is calculated as 
follows: 
             
     
 
     
The cell/dye suspension is then added to the microfluidic card and read in the ADAM 
counter. Cell counts are given as total cell per ml and viable cells per ml. 
 
   
 
Figure 2.2 ADAM Counter: Left- ADAM Counter unit, Middle – 562nm green laser excitation 
of PI stain, detected using 605nm excitation filter and CCD camera, Right – Microfluidic chip 
on which cell/dye suspension is loaded. Images taken from (http://www.digital-bio.com/). 
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2.2.1.5 Cryo-Preservation of Cells. 
 
For long-term storage, cells were stored at -196°C in a Taylor – Wharton VHC-35 ® 
liquid nitrogen containing dewar. Following trypsinisation the cells were centrifuged at 
700RPM (50g) for 5 minutes. The supernatant was aspirated off and the cells 
resuspended, by gently pipetting up and down, in 1ml of serum free CRYO-SFM™ 
medium from Promocell. The 1ml cell suspension was then aliquotted into sterile 1ml 
cryovials and quickly placed into a Mr-Freeze ® cryo-freezing container. The cryovial 
container was then placed into a -80°C freezer. This freezes the cells at a rate of -1°C 
per minute. The following day the cells were transferred to the liquid nitrogen cryo unit. 
For cell recovery, the cryovials were heated rapidly in a 37°C water bath. The cell 
suspension was added to a 58cm
2
 culture dish containing 7mls of pre equilibrated 
growth medium to dilute the DMSO. Medium was changed 24 hours later. 
(http://www.promocell.com/fileadmin/promocell/PDF/C-29910.pdf) 
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2.2.2 Molecular Biology 
 
2.2.2.1 Reconstituting cDNA. 
DNA plasmids arriving dried on filter paper were reconstituted in the following manner. 
Using flame sterilised scissors and forceps, a 1cm
2
 area of filter paper containing the 
plasmid of interest was cut out and added to a sterile 1.5ml micro-centrifuge tube. 
100µl of endotoxin free TE buffer (10mM TRIS base, 1mM EDTA, pH 8.0) was added 
to the micro-centrifuge tube against the filter paper and the mixture was vortexed 
briefly. The reconstituted DNA was then incubated for 5 minutes at room temperature 
and the vortex was repeated. The tube was then centrifuged at 10,000 RPM for 15 
seconds. 1-2µl was used in the transformation of competent cells. 
2.2.2.2 Transformation of Competent Cells. 
For transformation of FAK and FRNK plasmids, JM109 and DH5α strains of E. Coli 
competent cells were used respectively. 1-2µl of reconstituted plasmid DNA was added 
to a vial of 50 µl competent cells. They were mixed by gentle tapping on the side of the 
tube, and then incubated on ice for 30 minutes. Following this the tube was heat 
shocked for 30 seconds in a 42°C water bath.  This makes the bacterial cell membrane 
porous to allow the transformation of the plasmid DNA. The cells were then 
immediately transferred to ice for 2 minutes, following this 500µl of nutrient SOC 
media was added at room temperature. Cells were then incubated at 150RPM in an 
orbital shaker at 37°C for 30 minutes then placed on ice. Transformants were then 
spread on two L.B. agar plates containing the appropriate selective antibiotic in volumes 
of 40µl and 400µl. They were then incubated for 10 minutes at room temperature and 
placed inverted at 37 °C overnight.  
2.2.2.3 Overnight Culture and Glycerol Stock. 
Single colonies were selected from the inoculated spread plate if possible; otherwise 
colonies were diluted using a streak plate, to inoculate sterilised baffled culture flasks 
containing 150ml of LB broth containing the appropriate antibiotic. These were 
incubated at 150RPM in an orbital shaker at 37°C overnight. Glycerol stocks of the 
overnight culture were made to eliminate the need to go back to the reconstituted DNA 
and transform into competent cells again. These were made by taking 250µl of glycerol, 
250µl of de-ionised water and 500µl of the overnight culture into a 2ml microcentrifuge 
tube. The tube was then stored in a -80°C freezer. 
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2.2.2.4 Midi – Preparation of Plasmid DNA. 
DNA purification was carried out using a Qiagen plasmid midi-prep kit as per the 
manufactures instructions. 
In brief, the bacterial cells were pelleted at 6000 x g for 15 minutes at 4°C in a sterile 
50ml tube. The supernatant was removed by inverting. The pellet was resuspended 
using 6ml of chilled P1 buffer. 6ml of P2 buffer was then added and mixed vigorously 
for 30 seconds to lyse the bacterial cells then incubated at room temperature for 5 
minutes. 6ml of P3 buffer was then added, to neutralise the lysing effect of the P2 
buffer, and solution was mixed vigorously again for 30 seconds. The cell lysate was 
then poured into the barrel of a QIA midi-cartridge and incubated at room temperature 
for 10 minutes to allow cell debris settle. Using the QIA filter the cell lysate was filtered 
into a previously equilibrated hi speed midi-prep tip where the DNA was allowed bind 
to the resin column. Bacterial cell proteins were removed by washing the column with 
20ml of QC buffer and then precipitated with 3.5ml room temperature isopropanol and 
the tube was gently mixed by inversion. The DNA was then allowed precipitate by 
incubation at room temperature for 5 minutes. The isopropanol mixture was then added 
to the QIA-precipitator and filtered through. Plasmid bound to the precipitator was then 
washed with 2ml, 70% (v/v) ethanol, air dried and eluted finally into a 1.5ml micro-
centrifuge tube using 700µl sterile TE buffer. Lastly the eluted DNA was flushed 
through the precipitator once again to remove any unbound DNA and quantified by 
spectrometric analysis. (http://www.qiagen.com/knowledge-and-support/resource-
center/resource-download.aspx?id=0bc0a0fe-480e-4e5e-b6e2-e75a654dd791&lang=en) 
 
2.2.2.5 Spectrometric analysis of Plasmid DNA. 
The concentration and purity of the recovered DNA was measured using an automated 
Nano Drop® system (detailed below). The purity of the DNA was determined by 
measuring the ratio of absorbance at 260nm and 280nm. Pure DNA which has no bound 
protein impurities should have an A260/A280 ratio of 1.8-1.9. 
(http://www.nanodrop.com/library/nd-1000-v3.7-users-manual-8.5x11.pdf) 
 
98 
 
2.2.2.6 Agarose Gel Electrophoresis. 
Agarose gel electrophoresis was used to visualise and quantify size of plasmid DNA 
and bench top PCR products from gene specific oligonucleotides. It was also used, 
along with dissociation curves, to quality control qRT-PCR products post amplification. 
The agarose solution is prepared by adding 2g of ultra-pure agarose to 200ml of TAE 
buffer or 1g to 100ml of TAE for a smaller sized rig; this gives a 1% gel. This solution 
was swirled gently in a conical flask then boiled to dissolve the agarose until clear. It 
was allowed cool briefly then 20µl of Sybr Safe® was added to the 200ml or 10µl for 
the 100ml. This allows for visualization of the DNA. The agarose solution was then 
poured into a sealed gel cassette with the comb set in place and covered with tin foil to 
prevent photo bleaching and allowed to set for approximately 30 minutes. 
The apparatus consists of a horizontal rig which houses the gel cassette and comb; this 
was then filled with TAE buffer and samples loaded into the wells created by the comb. 
(Meyers et al., 1976).  
 
Figure 2.3: DNA Gel rig Shows gel rig containing empty cassetee. Combs (green) for creating 
the wells are inset at the bottom. Image taken from (http://www.thermoscientific.com/) 
The gel was electrophoresised at 80V until the loading dye ran approximately three 
quarters of the way down the rig. The gel was then visualised using a G- Box 
fluorescence gel documentation and analysis system (Syngene, UK).   (http://www.bio-
rad.com/webroot/web/pdf/lsr/literature/M1704400B.PDF) 
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2.2.2.7 Plasmid Sequencing. 
Both FAK and FRNK plasmids were sent for sequencing to Source BioScience - 
AUTOGEN™ & Geneservice™. The plasmids were eluted in 50 µl of ultrapure 
RNAase, DNAase free water at a concentration of 100ng/ µl. 
The sequence was then confirmed using Finch TV software. 
2.2.3 Transfections. 
2.2.3.1 Electroporation. 
Nucleofection by electroporation is a novel transfection technique in which the 
DNA/siRNA is transported directly into the nucleus to yield high transfection efficiency 
and cell viability. The transfection is non-viral based using a unique set of cell specific 
electric parameters and solutions. 
2.2.3.2 Amaxa/Lonza Nucleofector II 
Cells to be transfected were grown to 60% confluence on 58cm
2
 culture dishes prior to 
transfection. All cell culture solutions trypsin, growth medium etc along with HAoSMC 
specific transfection solutions, were pre warmed to 37°C. 2.5ml of full culture medium 
was added to each of well of the six well plate and allowed equilibrate in the 37°C 
incubator. HAoSMC were trypsinised and counted. The required numbers of cells were 
aliquotted and pelleted at 700RPM (50g) for 5 minutes.  
Media was aspirated off the pelleted cells which were then resuspended in 100µl of the 
supplemented Nucleofector solution. For one transfection 18µl of supplement 1 was 
added to 82µl of nucelofector solution to make the supplemented nucleofector solution, 
this included allowance for pipetting error. 3µg of plasmid DNA was then added to the 
cell suspension.  
The DNA/cell suspension was then transferred to the supplied cuvette, ensuring no air 
bubbles were present. The cuvette was then capped and placed in the nucleofector 
device, programme U-025 for HAoSMC was selected and ran. Immediately after, 500µl 
of prewarmed full growth medium containing no antibiotic was added to the cuvette. 
The transfected cell suspension was then carefully transferred to a pre warmed well of 
the 6 well using the supplied soft plastic pipette. This pipette reduced shear force on the 
cells during transfer. The plate was incubated over night at 37°C in a tissue culture 
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incubator and the medium was replaced the following day. 
(http://bio.lonza.com/fileadmin/groups/marketing/Downloads/Protocols/Generated/Opti
mized_Protocol_227.pdf) 
 
Figure 2.4: left- Nucleofector II device, right- cell type specific solution kit with cuvettes. 
Image taken from (www.lonza.com) 
 
 
2.2.3.3 Invitrogen Microporator 
The Microporation device is a unique method of transfection which uses a gold plated 
tip to electroporate plasmid DNA/siRNA into cells. This allows a more uniform electric 
field to be generated with minimal heat generation, metal ion dissolution, pH variation 
and oxide formation, which can present difficulties in alternative electroporation 
methods. Microporation was carried out according to the manufacturer’s instructions. 
In brief, Cells to be transfected were grown to 60% confluence on 58cm
2
 culture dishes 
prior to transfection. Cell culture solutions, trypsin, growth medium etc. were pre 
warmed to 37°C. Transfection solutions, including resuspension R buffer and 
electrolyte E buffer were allowed come to room temperature. Cells were trypsinised and 
counted to give a final density of 7x10
5
 cells/100µl. For each well of a 6 well to be 
used, 2.5ml of full culture medium ,without antibiotics, was added and allowed 
equilibrate in the 37°C incubator. Counted cells were pelleted at 700RPM (50g) for 5 
minutes then resuspended with 110µl of R buffer and transferred to a 1.5ml micro- 
101 
 
centrifuge tube. 3µg or 20-100nM of siRNA was added. Upon the addition of 3mls of E 
buffer the microporation tube was inserted to the microporator device. 100µl of 
cell/DNA suspension was taken up in the gold tip, ensuring no air bubbles formed, and 
placed into the microporation tube gently.  
For HAoSMC, the desired electrical parameters were a pulse voltage of 1350, pulse 
width of 20ms and a pulse number of 2. After transfection the cell suspension was 
transferred to the pre equilibrated growth medium containing 6 well. Cells were allowed 
to recover overnight and medium changed the next day. 
(http://www.lifetechnologies.com/content/dam/LifeTech/migration/en/filelibrary/cell-
culture/neon-protocols.par.11634.file.dat/smooth-muscle-cells-cascade-biologics.pdf) 
 
Figure 2.5: Invitrogen Microporator. Left -  Microporation tube and pipette which holds gold 
tip, Centre- Microporator device for setting electric parameters and delivereing the charge, 
Right – Electrolyte (E) & Resuspension (R) buffers, gold plated tips & microporation tubes 
which hold the E buffer. Image taken from (http://www.lifetechnologies.com/) 
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2.2.3.4 siRNA. 
For gene knock down experiments small interfering RNA (siRNA) were used. These 
were purchased from both Sigma Alrdich ® and Ambion silencer ® select pre-designed 
siRNA from Invitrogen Life Sciences. 
siRNA were designed and purchased for Drosha, Exportin 5, Argonaute 2 and Dicer. A 
positive GAPDH control and negative scrambled were also implemented in gene knock 
down experiments. The sequences of these siRNA are found in table 2.1. 
Table 2.1: List of siRNA used, genes they target and the gene accession number. 
Gene siRNA code Gene 
Drosha SASI_Hs02_00321994 NM_013235  
 SASI_Hs02_00321995 NM_013235  
 SASI_Hs02_00321996 NM_013235  
Dicer SASI-Hs01-00160748 NM_030621 
 SASI-Hs01-00160749 NM_030621 
 SASI-Hs01-00358175 NM_030621 
Argonaute 2 s259321 NM_012154 
 s25932 NM_012154 
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2.2.4 Immuno-Detection Techniques. 
2.2.4.1 Immuno (Western) Blotting. 
2.2.4.1.1 Preparation of whole cell lysate. 
For western blot assays, cells were harvested in the following manner. Cells to be lysed 
were placed on ice or at 4 °C, cell culture media was removed and the cells were 
washed 3 times with PBS. The cells were then lysed with 1X radioimmunoprecipitation 
assay (RIPA) buffer (30 µl per well of a 6 well and 60µl for a 58cm
2
 dish) and collected 
using a cell scraper. The lysate was collected in a sterile 1.5 ml micro-centrifuge tube 
and rotated at 4 °C for 45 minutes to ensure full lysis of cells. The lysate was then 
centrifuged at 10,000g for 20 minutes at 4 °C to ensure the sedimentation of triton 
insoluble material to a compact pellet. The protein containing supernatant was then 
carefully lifted off into 30µl aliquots and frozen at -80 °C. Alternatively the lysate was 
used straight away in a BCA assay and ultimately a western blot. (Tobin et al., 1979) 
2.2.4.1.2 Bicinchoninic Acid Assay B.C.A. Assay. 
To ensure that samples are in the proper range for detection of the assay, and so they 
can be compared on an equivalent basis, it is important to know the concentration of 
total protein in each sample. This was achieved using a BCA or Smith assay. The assay 
depends on two reactions, firstly the ability of peptide bonds to reduce Copper (Cu
2+
) 
ions to Cu1+ and secondly, on the ability of bicinchoninic acid (green) to chelate with 
each Cu
+
 to form a complex (purple) that strongly absorbs light at 562nm.  
The assay consists of each sample being read in triplicate, this includes protein 
standards (0-2mg/ml) along with each lysate sample and the 1XRIPA buffer used to 
lyse the cells, to exclude background measurement. The reagents used were from Pierce 
Biotechnology that comes as two solutions; (A) an alkaline bicarbonate solution and (B) 
a copper sulphate solution. These were mixed in a ratio of 50 parts A to 1 part B. 200µl 
of this mixture was then added to each well to be assayed on the 96 well plate. The plate 
was then covered to protect form light and incubated for 30 minutes at 37 °C, then ran 
on a plate reader at an absorbance of 562nm. (Smith et al., 1985) 
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2.2.4.1.3 Preparing Samples 
Samples were prepared in a solution of 4 X Laemmli, this buffer contains glycerol 
which enables the sample to sink to the bottom of the well and bromophenol blue which 
allows separation to be tracked as it migrates through the gel. SDS and β 
Mercaptoethanol are added to fully reduce and denature the protein and remove any 
higher order structure. Samples are then heated to 95°C for 5 minutes to further aid in 
denaturing. 
2.2.4.1.4 Polyacrylamide Gel Electrophoresis (SDS-PAGE). 
After the samples have been prepared, they are separated by size using sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE). The SDS containing loading 
buffer applied a uniform negative charge to the samples which migrate in an electrical 
field towards the positive electrode. The proteins are separated primarily by size as a 
result of the mass to charge ratio following binding of the SDS. 
10 x 100mm glass plates (one short one long containing 1mm spacers) were cleaned 
with 70% v/v (ethanol) and dried completely. They were assembled and sealed tight 
using the casting frame and stand. Resolving gels of 7.5 and 10% were prepared as 
described in table 2.2 below. 7-8 ml of the resolving gel was poured between the glass 
plates, avoiding air bubbles, this was then topped with a layer of 70% v/v ethanol to 
remove any surface air bubbles and give an even surface to the gel. The gel was allowed 
polymerise for 30-40 minutes at room temperature. Following this the ethanol was 
carefully poured off and the stacking gel was prepared as described in table 2.2. The 
stacking gel was added on top of the polymerized resolving gel and a 1.0mm comb was 
gently inserted to create the loading wells. (Tobin et al., 1979) 
Table 2.2:  Recipe for SDS-PAGE resolving gel. 
Solutions 7.5% 10% 12% 
Distilled Water 4.85ml 4.00ml 3.35ml 
1.5M Tris-HCL,pH 8.8 2.5ml 2.5ml 2.5ml 
Bis Acrylamide (30%) 2.5ml 3.33ml 4.0ml 
10% SDS 100µl 100µl 100µl 
10% Ammonium persulfate 50 µl 50 µl 50 µl 
TEMED 5 µl 5 µl 5 µl 
Total Volume 10ml 10ml 10ml 
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A 4% v/v polyacrylamide stacking gel was used throughout all experiments and was 
prepared according to table 2.3 below. 
Table 2.3: Recipe for SDS-PAGE Stacking gel. 
Solutions 4% 
Disitlled Water 6.1ml 
0.5M Tris –HCL, Ph6.8 2.5ml 
Bis- Acrylamide (30%) 1.3ml 
10% SDS 100µl 
10% Ammonium Persulfate 100µl 
TEMED 5µl 
Total Volume 10ml 
 
Upon polymerization, the comb was carefully removed and the gel was inserted into the 
cassette and loaded into the electrophoresis tank. The chamber between the gel and 
buffer dam is filled with running buffer and any loose acrylamide is flushed from the 
wells using a pipette. The tank was filled to the mark with the remaining running buffer.  
The wells were loaded with 30µl of prepared sample in SSB buffer as well as 5µl of the 
molecular weight marker. The samples and marker then underwent electrophoresis at 
80V for 20 minutes then the voltage was increased to 100V for ~ 80 minutes. 
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2.2.4.1.5 Electroblotting 
Following electrophoresis, the gel containing the separated proteins was transferred to a 
solid support for further analysis. The electric field used for the transfer is orientated 
perpendicular to the surface of the gel causing proteins to move out of the gel and onto 
the blotting membrane. This membrane sits between the gel surface and the positive 
electrode. The blotting membrane used was either nitrocellulose or PVDF 
(polyvinylidene fluoride), the latter had to be activated by soaking in methanol for 5 
minutes prior to use. The gel and blotting membrane are assembled into a sandwich 
along with several sheets of filter paper which protect the gel and membrane and ensure 
close contact between their surfaces.  The sandwich was then pressed with a roller 
wetted in transfer buffer to eliminate any possible air bubbles. It is imperative that the 
membrane is placed between the gel and the positive electrode so that the negatively 
charged proteins migrate from the gel to the membrane. The transfer buffer used for 
electroblotting is similar to that used for running the gel with the addition of methanol 
which helps proteins bind to the membrane. 
Electrophoretic transfer can be accomplished under wet or semi-dry conditions. In a wet 
transfer the gel/membrane sandwich is placed inside a cassette and then submersed in a 
tank filled with transfer buffer and subjected to an electrical field. In semi-dry the 
gel/sandwich is assembled on large electrode plates which generate the electrical field 
and transfer buffer is confined to the stack of wet filter papers.  
Wet tank transfers were typically performed overnight at 4°C. Transfer buffer was 
agitated using a magnetic stirring bar and voltage set to 50V or at room temperature for 
2 hours at 100V. (Tobin et al., 1979) 
2.2.4.1.6 PVDF versus Nitrocellulose 
Nitrocellulose was preferred for its protein binding capabilities. However, it is brittle 
and can be difficult to reuse. For blots that needed to be re-probed PVDF was used due 
to its higher strength however care needed to be taken with washing as it can produce 
higher background signal. It also needs to be activated prior to use with methanol and 
not allowed to dry out. 
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2.2.4.1.7 Blocking 
To reduce non-specific binding of the antibody, the membrane was blocked  by 
incubating with either 5% non-fat dried milk in 0.05 % Tween PBS or 5% BSA in 
0.05% Tween PBS at room temperature for 40 minutes on a see-saw rocker.  Following 
blocking the membrane was washed for 5 minutes on a see-saw rocker with 0.05% PBS 
Tween. (http://www.abcam.com/ps/pdf/protocols/wb-beginner.pdf) 
 
2.2.4.1.8 Antibody Incubation 
After blocking and washing, the blot was incubated, usually overnight at 4°C and gentle 
rocking, with the appropriate primary antibody. The antibody was made up in a solution 
of 1-5% BSA 0.05% PBS Tween or TBS Tween. See table below for specific antibody 
solutions and dilution factor.  
Bernette et al., 2009. (http://www.abcam.com/ps/pdf/protocols/wb-beginner.pdf) 
Table 2.4: List of antibodies used for Immunodetection including: species, dilution factor 
(primary and secondary) and diluent make up. 
Antibody 
PBS/TBS 
BSA/Milk 
Tween % Species Dilution Factor 2° Antibody 
Smooth muscle α-actin PBS/BSA 0.05 Rabbit 1:600 1:3000 
Calponin PBS/BSA 0.05 Rabbit 1:1000 1:3000 
Smoothelin PBS/BSA 0.05 Mouse 1:250 1:3000 
FAK PBS/BSA 0.05 Rabbit 1:200 1:3000 
Phospho FAK TBS/BSA 0.05 Rabbit 1:200 1:3000 
Phospho FRNK TBS/BSA 0.05 Rabbit 1:200 1:3000 
Argonaute2 PBS/BSA 0.05 Rabbit 2µg/ml 1:3000 
Dicer PBS/BSA 0.05 Mouse 1:200 1:3000 
FGF-2 PBS/BSA 0.05 Rabbit 2µg/ml 1:3000 
VWF PBS/Milk 0.1 Rabbit 1:500 1:3000 
β-actin PBS/BSA 0.05 Rabbit 1:3000 1:5000 
GAPDH PBS/BSA 0.05 Rabbit 1:3000 1:5000 
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After incubation with the primary antibody the blot was washed 3 times with 0.05% 
TBS/PBS tween for 5 minutes with gentle rocking. Following this the blot was 
incubated with the appropriate species of secondary antibody conjugated with HRP 
(horse radish peroxidase) in 1-5% BSA 0.05% TBS/PBS Tween for 2 hours at room 
temperature. HRP is a small stable enzyme with high specificity and rapid turnover. See 
table 2.5 for appropriate secondary species and the dilution factor for each protein. 
Finally, the membrane was washed 3 times in TBS/PBS Tween 0.05% for 5 minutes 
each time with gentle rocking. 
 
2.2.4.1.9 Detection with Substrate  
Detection of target proteins was possible once they were specifically tagged with the 
appropriately labeled antibody. This was achieved through use of either Millipore; 
Luminata ® Enhanced Chemiluminescent (ECL) substrate or Thermo Scientific 
SuperSignal® West Pico Chemiluminescent Substrate. When probing for an abundant 
cellular protein with a reliable antibody, the less sensitive SuperSignal® West Pico 
Chemiluminescent Substrate was used. The peroxide solution and luminal enhancer 
solution were mixed in equal parts and approximately 1ml of this mixture was added for 
an entire 10 well blot. When probing for minimally expressed proteins or using weak 
antibodies the Millipore, Luminata ® was used, capable of detecting (pg) amounts.  
Approximately 500µl was added to a full 10 well membrane. In both cases detection 
imaging was carried out immediately. The light emission was captured using either X-
Ray film or a Syngene G-Box, CCD camera. Exposure times ranged from 30 seconds to 
10 minutes depending on the signal strength. Image J software was used for 
densitometry and relative band comparison. 
(http://www.abcam.com/ps/pdf/protocols/wb-beginner.pdf) 
2.2.4.1.10 Coomassie Gel Staining 
Coomassie gel staining was used to visualise proteins on the SDS-PAGE gel, which was 
useful to ensure an efficient transfer by showing protein left behind. In brief, the SDS-
PAGE gel was covered with filtered coomassie solution and agitated by gentle rocking 
for up to 4 hours. The solution was then poured off and the gel de-stained using a 
mixture of methanol and acetic acid (50:50) until the protein bands appeared clear with 
no background. (http://www.abcam.com/ps/pdf/protocols/wb-beginner.pdf) 
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2.2.4.1.11 Ponceau-S Membrane Staining 
Ponceau S is a red stain applied in an acidic solution which reversibly stains all protein 
present on the membrane prior to any immuno blotting. This was used to confirm the 
transfer and help to show equal transfer of protein from the gel. The stain was 
subsequently removed by washing in distilled water. 
(http://www.abcam.com/ps/pdf/protocols/wb-beginner.pdf) 
2.2.4.1.12 Membrane Stripping 
To allow for re-probing of the membrane with different antibodies or to optimize 
antibody concentration, the membrane was stripped with RESTORE® stripping buffer. 
This was used as per the manufacturer’s instruction. In brief, the blot was washed in 
wash buffer to remove any previous ECL substrate then covered with stripping buffer 
and agitated by rocking gently for 15 minute. Removal of both primary and secondary 
antibody was confirmed by first incubating the membrane with the appropriate 
secondary and subsequent detection with ECL substrate. If no bands were detected the 
blot had been successfully stripped. It was then washed again to remove ECL substrate 
and re probed with alternative antibodies as previously described. (Zhang et al., 2003)  
2.2.4.2. Immunocytochemistry (ICC) 
ICC was performed to show the presence and location of specific proteins within the 
cell. This was carried out on glass coverslips. Coverslips were immersed in 70% v/v 
ethanol and flame sterilised before being placed in the well of a sterile 6 well plate.  
Cells were lifted using EDTA, counted and seeded onto the coverslips overnight. The 
following day cells were washed with PBS and fixed using 3.7% formaldehyde pH 7.4 
at room temperature for 20minutes. The cells were then washed twice with PBS and 
permeabilised with 0.2% Triton X-100 solution in PBS for 5 minutes at room 
temperature. Cells were again washed with PBS and then blocked for 1 hour with 5% 
BSA in TBS 0.05% Tween while being gently rocked. Cells were then incubated with 
primary antibody over night at 4°C. Following incubation the primary antibody was 
taken off.  Cells were then washed with PBS and incubated with the appropriate 
secondary fluorophore antibody for 2 hours at room temperature.  
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Following this, cells were washed and incubated with a 1:40 dilution of Rhodamine 
Phalloidin (Invitrogen) for 20 minutes at room temperature to visualise actin. Cells were 
washed one final time then inverted and mounted on a flame sterilised microscope 
slides using DAKO mounting medium. The slides were allowed to set for two hours and 
then placed in the fridge and protected from light. 
(http://www.invitrogen.com/site/us/en/home/brands/Molecular-Probes.html) 
2.2.4.3 Enzyme Linked Immuno Sorbent Assay (ELISA) 
 
2.2.4.3.1 Quantikine® ELISA 
The Quantikine Human Fibroblast Growth Factor-2 (FGF-2) immunoassay kit is a solid 
phase ELISA designed to measure (FGF-2) in cell media and lysate. It contains E. Coli 
expressed recombinant human FGF-2 and antibodies raised against the recombinant 
factor. 
Principle of the Assay 
This assay employs the quantitative sandwich enzyme immunoassay technique. A 
monoclonal antibody specific for FGF-2 is pre coated on a 96 well plate.  Standards and 
samples are pipetted into the wells and any FGF-2 present is bound by the immobilized 
antibody. 
After washing away any unbound substances, a horse radish peroxidase linked 
monoclonal antibody specific for FGF-2 is added to the wells. Following a wash to 
remove any unbound antibody-enzyme reagent, a substrate solution is added. A colour 
then develops the intensity of which is proportional to the amount of FGF-2 present. 
The colour development is stopped and the intensity measured using a plate reader. 
The protocol was followed as per the manufacturers’ guideline;  
In brief, 20 ml of wash buffer (0.05% Tween in PBS) was diluted in distilled water to 
prepare 500ml of wash buffer. Substrate solution was made 15 minutes prior to use by 
mixing equal volumes of reagents A (H2O2) and B (tetramethylbenzidine) protected 
from light. The FGF-2 standard was reconstituted with calibrator diluents (1% BSA in 
PBS) to give a 640 pg/ml stock. This stock was serial diluted 1:2 down to 10pg/ml to 
give 7 standards. 
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100µl of assay diluent (1% BSA in PBS with blue dye) was added to each well using a 
multichannel pipette. Following this 100µl of standard or sample were added to each 
well and the plate was sealed and incubated at room temperature for 2 hours. After 
incubation the wells were aspirated and the plate was washed 4 times by submerging it 
in wash buffer ensuring complete removal of wash buffer from each well by blotting 
against paper towels at each stage. 
200µl of FGF-2 conjugate (HRP Ab) was then added to each well and the plate was 
sealed and incubated at room temperature for 2 hours once more. Following this, the 
plate was washed as previously described. 200µl of substrate solution was then added 
and the plate was protected from light and incubated for 30 minutes. The colour reaction 
was stopped by adding 50µl of stop solution (2N H2SO4) to each well, changing the 
colour from blue to yellow. If the colour was green the plate was gently tapped to 
ensure proper mixing. The optical density (OD) of each well using a plate reader set to 
450nm. Wavelength correction was calculated by removing readings at 540nm. This 
removed optical inaccuracies within the plate itself. 
The results were calculated on a spreadsheet using equation of the line incorporating 
readings from the standards. (Wide et al 1966) 
2.2.4.3.2 DuoSet ELISA 
The DuoSet ELISA for human Thrombomodulin from R&D systems is a sandwich 
ELISA similar to that described previously for human FGF-2. The principle of the assay 
is identical. The DuoSet differs from the Quantikine® ELISA in that the capture 
antibody is added to the 96 well plate by the user.  In brief, Wash buffer was made with 
0.05% Tween in PBS. The capture antibody was reconstituted in 1ml of PBS to a stock 
concentration of 360 µg/ml. This was further diluted in PBS to a working concentration 
of 2µg/ml. 100µl of this working concentration was added to each well and the plate 
was incubated overnight. The plate was then washed as previously described. The plate 
was then blocked for 1 hour by adding 300µl of reagent diluent (1%BSA in PBS) to 
each well. Following this the plate was washed. 100µl of sample or standard was then 
added to the plate and incubated for 2 hours. The plate was subsquently 
aspirated/washed. The protocol after sample addition is identical to that of the 
Quantikine® ELISA kit following sample addition stage. (Wide et al 1966) 
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2.2.5 Ribonucleic Acid (RNA) Work 
As RNA is easily damaged and degraded by ubiquitous ribonuclease (RNase), all RNA 
work was carried out according to the protocol outlined in Sambrook, Fritsch and 
Maniatis’ “Molecular Cloning, A Laboratory Manual”.  To prevent genomic DNA 
contamination, prior to any RNA work, surfaces and equipment were cleaned down 
with DNA Zap (Invitrogen). This consists of two solutions that are innocuous when 
used alone, but become a potent nucleic acid degrading solution when mixed. This 
mixture is able to instantaneously degrade high levels of contaminating DNA and RNA 
from surfaces. Gloves were also used and changed frequently. (Chomczynski et al., 
2006). 
  
2.2.5.1 RNA Isolation 
Two methods were used for isolation and purification of total RNA from cell culture 
samples. The miRVANA® RNA extraction kit and isolation by Trizol® reagent. RNA 
isolation was developed by (Chomczynski & Sacchi et al., 1987). 
2.2.5.1.1 miRVANA Kit 
The miRVANA® kit uses an organic extraction method followed by immobilisation of 
RNA on glass-fibre filters to purify total RNA. 
For (1-2x10
6
) HAoSMC the culture medium was aspirated off and the cells washed 
twice with PBS. 600µl of total lysis binding solution was added to the cells (in the case 
of a 6 well plate 100µl into each well). The cells were then scraped and collected, using 
a rubber cell scraper, into a 1.5ml RNase free micro centrifuge tube. The sample was 
vortexed for 30-60 seconds to obtain a homogenous lysate. The volume of the lysate 
was recorded and 1/10 of this volume of miRNA homogenate additive was added to the 
lysate. This solution was well mixed by vortexing for 30-60 seconds. The solution was 
then incubated on ice for ten minutes after which the volume prior to addition of the 
miRNA homogenate additive was the volume added of acid-phenol chloroform and 
ensured it was taken from the bottom phase of the acid phenol chloroform. The lysate 
solution was again vortexed for 30-60 seconds before being centrifuged for 5 minutes at 
10,000g at room temperature to separate the aqueous and organic phases. 
Following centrifugation, the lysate solution was checked for a compact interphase and 
if this was not evident the centrifugation step was repeated. The upper aqueous phase 
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was transferred to a fresh tube taking care not to disturb or carryover any of the bottom 
organic phase. The volume of upper aqueous phase recovered was noted and 1.25X of 
this volume of room temperature 100% high grade ethanol was added to the fresh tube. 
A maximum of 700 µl of this lysate/ethanol mixture was pipetted onto a glass-fibre 
filter cartridge, which was placed in a fresh tube. This was centrifuged at 10,000g for 15 
second to pass the mixture through the filter. This step was repeated until all of the 
lysate/ethanol had been passed through the filter and the flow through was discarded 
each time. 700µl of wash buffer 1 was then added to the filter column and passed 
through by centrifugation at 10,000g for 15 second. This was repeated using 500µl of 
wash buffer 2/3 again with the flow through being discarded each time. After the third 
wash the filter column was centrifuged at 10,000g for 1 minute to dry off the filter 
column and prevent ethanol carry over to the new tube in which filter column was 
placed. The total RNA was then eluted into a fresh collection tube by centrifugation at 
10,000g for 30 seconds using 100µl of elution buffer which was pre-heated to 95°C. 
The RNA was quantified and qualified on a NanoDrop® Spectrophotometer. The 
sample was then stored at -80°C. 
(http://tools.lifetechnologies.com/content/sfs/manuals/cms_055423.pdf) 
2.2.5.1.2 RNA Extraction and Isolation using Trizol® 
Trizol® is a ready to use reagent for the isolation of total RNA, DNA and/or protein 
from cultured cells and tissue. Trizol® reagent maintains integrity of total RNA while 
disrupting cell membranes and dissolving cellular components. 
Media was aspirated from cultured cells and they were washed 3 times with PBS. Cells 
were then lysed by addition of 1ml chilled Trizol® reagent. The final volume of 
Trizol® per sample was always made to1ml, for example if 3 wells of a 6 well are of 
the same sample 333µl was used in each and pooled. The plate was then left on ice for 
10 minutes to allow complete dissociation of nucleoprotein complexes. The cell lysate 
was scraped from culture dishes and collected in a sterile RNase free micro-centrifuge 
tube.  20% volume of Chloroform was added (i.e. 0.2ml of Chloroform for each 1ml of 
Trizol® used.) The sample was then vortexed for 20 seconds and incubated at room 
temperature for 15 minutes. The lysate was then centrifuged at 13,000g for 20 minutes 
at 4°C. Following this the upper aqueous phase was transferred to a new micro-
centrifuge tube taking care not disturb or carry over any of the lower organic phase or 
interphase. To precipitate the RNA out of solution, 0.5 ml of isopropanol per 1ml of 
Trizol® used was added to the aqueous phase and the new tube was mixed by inverting 
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several times. The solution was then placed at -20 °C overnight. The next day the 
sample was taken from the -20 °C and incubated at room temperature for 15 minutes. 
The tube was then centrifuged at 13,000g for 15 minutes at 4°C. The supernatant was 
removed taking care not to disturb the small opaque pellet of RNA. The pellet was 
washed by gently knocking it off the wall of the tube with 75% v/v room temperature 
ethanol. The re-suspended pellet was then centrifuged at 13,000g for 10 minutes at 4 °C. 
The ethanol was then aspirated off, again being careful not to disturb the small opaque 
pellet of RNA. The pellet was air dried in a laminar air cabinet. Finally the Pellet was 
then re-suspended in 50µl nuclease free water and incubated at 55°C for 10 minutes to 
homogenise the sample prior to quantification. The RNA was quantified and qualified 
on a NanoDrop® Spectrophotometer. The sample was then stored at -80°C. 
(http://tools.lifetechnologies.com/content/sfs/manuals/trizol_reagent.pdf) 
 
2.2.5.2 RNA/DNA Quantification Using NanoDrop® ND-1000 Spectrophotometer 
The NanoDrop® ND-1000 Spectrophotometer was used to determine nucleic acid 
sample concentrations and integrity. An undiluted 1.2 μl sample was pipetted onto the 
end of a fiber optic cable (the receiving fiber). A second fiber optic cable (the source 
fiber) was then brought into contact with the liquid sample causing the liquid to bridge 
the gap between the fiber optic ends. A pulsed xenon flash lamp provides the light 
source and a spectrometer is used to analyse the light after passing through the sample. 
The instrument is controlled through use of specific PC based software. 
The NanoDrop® automatically calculates the purity of the nucleic acid samples by 
reading the absorbance at 260 nm and the absorbance at 280 nm and then determining 
the ratio between the two (Abs.260/Abs.280) . Pure DNA which has no protein 
impurities has a ratio of 1.8 whereas pure RNA has a ratio of 2.0. Lower ratios indicate 
the presence of protein; higher ratios imply the presence of organic reagents. (Sambrook 
et al., 2001) 
2.2.5.3 RNA Purification. 
RNA for use in Reverse Transcription-PCR (RT-PCR) was pre treated with 
amplification grade DNase1 to remove any RNase activity and DNA from sample RNA.  
In brief, 8µl of RNA suspended in water along with 1µl of 10X reaction buffer and 1µl 
of DNase1(1unit/µl) were added to a PCR tube. The solution was mixed gently and 
incubated for 15 minutes at room temperature. Following this 1µl of stop solution was 
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added and the tube was heated at 70°C for 10 minutes. This heating step also removed 
any hair pin structures within the RNA. RNA was then chilled on ice ready to be 
synthesized into cDNA. (Sambrook et al., 2001) 
2.2.5.4 Polymerase Chain Reaction (PCR) 
PCR is a process used to amplify specific sequences of DNA at an exponential rate for 
use in a variety of applications. Standard PCR, coined bench top PCR, was used for 
making of cDNA and as a cost effective method to analyse and optimise newly 
synthesized primers before committing them to quantitative real time PCR (QRT-PCR). 
(Bartlett, J. M. S.; Stirling, D. et al 2003).  
2.2.5.5 Reverse Transcription (RT-PCR) 
RT-PCR is a variant on PCR, used to reverse transcribe the RNA strand into its DNA 
complement. This is achieved by utilising an enzyme called reverse transcriptase as 
outlined in (Roth et al., 1985;Sambrook et al., 1989). This was accomplished by using a 
high capacity cDNA reverse transcription kit (Applied Biosystems, CA, USA) In brief,  
20µl reactions were made up as shown in table 2.4. 
 
Table 2.5: Recipe for single sample reverse transcription Master Mix. 
 
RT Buffer 2ul 
Random Primer 2ul 
dNTP 0.8ul 
Multiscribe 1ul 
Pure H20 4.2ul 
Master Mix 
Final Volume 
10ul 
 
RNA was made up to 1000ng in 10µl of nuclease free water and added to an RNase free 
0.2ml PCR tube, to this 10µl of master mix was added for each RNA sample. The tubes 
were spun down briefly and placed in aMiniJ bench top PCR thermocycler (BioRad).  
The programme included 25°C for 10 minutes, 37°C 120 minutes and finally 85°C for 5 
minutes. cDNA products were then quantified on the NanoDrop® spectrophotometer as 
previously described. 
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2.2.5.6 PCR Primer Design 
For PCR, DNA primers were designed using the online website 
http://frodo.wi.mit.edu/primer3/ in accordance with the standard rules of primer design. 
Each primer was designed to anneal to exon-exon border regions so as to only amplify 
reverse transcribed cDNA and not genomic DNA. The generated primers were then run 
through BLAST to verify their sequence homology and ensure there would be no primer 
dimer formation or risk of the primer folding on itself. All primers and optimum 
temperatures used can be found in table 2.7. For all mRNA QRT-PCR endogenous 
controls used were 18s and GAPDH. 
2.2.6 Quantitative Real Time Polymerase Chain Reaction (QRT-PCR) 
Quantitative real time polymerase chain reaction follows the standardized principles of 
PCR. It is used to amplify target DNA with the addition of simultaneously quantifying 
the targeted DNA sequence as it accumulates during the reaction. Two types of 
chemistries were used in this project for detection of PCR products.  For mRNA work 
SYBR® Green was incorporated. This dye does not inhibit PCR and increases 
fluorescence upon binding to doubled stranded DNA.As the reaction progresses more 
PCR product is created. SYBR® Green binds to all double stranded DNA, so the result 
is an increase in fluorescence proportional to the amount of PCR product produced. 
Endogenous controls 18S or GAPDH were monitored in tandem with the target gene to 
correct for loading bias. 
For miRNA profiling a Taqman® probe was used. This chemistry, also known as 
“fluorogenic 5’” nuclease chemistry uses a fluorgenic labeled 5’ probe. This relies on 
the nuclease activity of Taq DNA polymerase. 
 An oligonucleotide probe contains a reporter fluorescent dye on the 5' end and a 
quencher dye on the 3' end. While the probe is intact, the proximity of the quencher dye 
greatly reduces the fluorescence emitted by the reporter dye by fluorescence resonance 
energy transfer (FRET). 
If the target sequence is present, the probe anneals downstream from one of the primer 
sites and is cleaved by the 5' nuclease activity of Taq DNA polymerase as this primer is 
extended. 
This cleavage of the probe:  
-- Separates the reporter dye from the quencher dye, increasing the reporter dye signal. 
-- Removes the probe from the target strand, allowing primer extension to continue to 
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the end of the template strand. Thus, inclusion of the probe does not inhibit the overall 
PCR process. 
Additional reporter dye molecules are cleaved from their respective probes with each 
cycle, resulting in an increase in fluorescence intensity proportional to the amount of 
PCR product produced. 
The QRT-PCR was carried out using an Applied Biosystems 7900 HT real time thermo 
cycler.  
When using SYBR® Green for mRNA gene amalysis a master mix containing enough 
volume for sample triplicates and pipetting error was made up as shown in table 2.5. 
 
Table 2.5: Recipe for single sample triplicate in qRT-PCR. 
Component Volume (µl) 
SYBR Green MM 39.13 
Forward Primer 3.2 
Reverse Primer 3.2 
cDNA (500ng/µl) 6.5 
Nuclease Free H20 29.42 
Total Volume 81.45 
 
Samples were loaded on to a 96 well optical PCR plate sealed and centrifuged to 
eliminate any air bubbles and ensure the entire sample was pulled to the bottom of each 
well. 
ΔΔCT programme was used for comparative analysis and the samples were subjected to 
an initial denaturing step of 95°C for 10 minutes followed by 40 cycles of 95° for 15 
seconds and 50°C for 1 minute and 72 ° for 30 seconds before a final extension step of 
72°C for 5 minutes.  
Following amplification dissociation /melt curve analysis was carried out. This was to 
ensure single product production and rule out possible contaminant from foreign DNA 
and possible primer dimerisation.  
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2.2.7 miRNA Isolation and Amplification. 
miRNA profiling was carried out using the Applied Biosytems® Taqman® Low 
Density Array (TLDA) Human miRNA Cards Set (v2.0)  
2.2.7.1 Isolation 
For analysis on the TLDA cards, total RNA was extracted from HAoSMC using the 
Ambion™ mirVANA miRNA® isolation kit as previously described.  
2.2.7.2 Reverse Transcription of RNA for Taqman® Array Analysis. 
Single stranded cDNA was synthesised from the total RNA using the Applied 
Biosystems TaqMan® micoRNA Reverse Transcription (RT) Kit. For a full miRNA 
profile two RT reactions were needed incorporating primers for both pool A and B 
miRNA panels. This kit creates cDNA from only mature miRNA and not precursors.  
The RT reaction has a final volume of 7.5µl and contains: 
 3µl (1-350ng) total RNA 
 4.5µl of RT master mix 
The master mix was made up as shown in table 2.6 in a 2ml RNAse free tube. 
Table 2.6: Recipe for reverse transcription of miRNA to cDNA (pool A and B).  
RT Reaction Mix 
Components 
Volume for one 
samples (µl) 
 
Volume for ten 
samples (µl)* 
Megaplex RT Primers 
(Pool A & B) 10x 
.8 9.00 
dNTPs (100mM) 0.2 2.25 
Multiscribe Reverse 
Transcriptase (50 U / µL) 
1.5 16.88 
10 X RT Buffer .8 9.00 
MgCl .9 10.12 
RNase Inhibitor (20 U / 
µL) 
0.1 1.12 
Nuclease Free Water 0.2 2.25 
Total 4.5 50.62 
* includes 12.5% excess for volume loss from pippetting. 
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The samples are mixed by gentle pippetting and incubated on ice for 5 minutes. The 
samples are then run on the bench top PCR thermo cycler under the conditions found in 
table 2.7. 
Table 2.7: Thermocycler conditions for miRNA specific reverse transcription. 
Stage Temp °C Time 
Cycle 
(40 cycles) 
16 2 min 
42 1 min 
50 1 min 
Hold 85 5 min 
Hold 4 ∞ 
  
2.2.7.3 Preamplification of cDNA 
If total RNA from sample is less than 350ng a preamplification step is carried out prior 
to committing the cDNA to the TaqMan microRNA arrays. This uniformly pre 
amplifies desired cDNA prior to quantification with the TLDA cards. The 
preamplification reaction has a final volume of 25 µl containing: 
 2.5 µl RT product 
 22.5 µl Preamp reaction mix 
The master mix is made up as shown in table 2.8 in a 2ml RNAse free tube. 
Tabel 2.8: Recipe for Pre-Amplification master mix. 
PreAmp Reaction Mix 
Components 
Volume for one 
sample (µl) 
Volume for ten 
samples (µl) 
TaqMan PreAmp Master 
Mix (2X) 
 
12.5 140.62 
Megaplex PreAmp Primers 
(10X) 
 
2.5 28.13 
Nuclease Free Water 7.5 84.37 
Total 22.5 253.12 
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The sample is then mixed by gentle pippetting and run on a bench top PCR 
thermocycler under the conditions found in table 2.9. 
Table 2.9: Thermocycler conditions for miRNA cDNA Pre-Amplification. 
Stage Temp °C Time 
Hold 95 10 min 
Hold 55 2 min 
Hold 72 2 min 
Cycle (12 cycles) 95 15 sec 
60 4 min 
Hold (for enzyme 
inactivation) 
99.9 10  min 
Hold 4 ∞ 
 
Following PCR the sample is diluted with 75 µl of 0.1x TE buffer (pH8) and used for 
array analysis immediately or stored for up to one week at -20°C. 
2.2.7.4 Running the Taqman® microRNA Array 
DNA polymerase from the TaqMan® Universal PCR Master Mix amplifies the target 
cDNA using sequence specific primers and a probe on the TaqMan microRNA array. 
The presence of the target is detected in real time through cleavage of the TaqMan 
probe by the polymerase 5’-3’ activity. 
The master mix for the cards is made up as shown in table 2.10 for preamplified cDNA. 
Table 2.10: Recipe for miRNA array sample when using a Pre-Amplified product. 
Component Volume for One Array (µl) 
TaqMan Universal PCR MasterMix 
 
450 
Diluted PreAmp Product 
 
9 
Nuclease-Free Water 
 
441 
Total 900 
 
For non preamplified cDNA the master mix changes are as shown in table 2.11. 
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Table 2.11:  Recipe for miRNA array sample which has not been Pre-Amplified. 
Component Volume for one array (µl) 
TaqMan Universal PCR MasterMix 
 
450 
Diluted PreAmp Product 
 
6 
Nuclease-Free Water 
 
444 
Total 900 
 
The sample is mixed by gentle pipetting and centrifuged briefly. The arrays are allowed 
to come to room temperature then 100µl of the mix is dispensed into each chamber of 
the array and the card is centrifuged twice for 1 minute at 1000 RPM to fill each of the 
384 wells of the card. The card is then sealed and the loading chambers are cut off.  
The card is then run on the Applied Biosystems® 7900 HT thermo cycler using the 
parameters contained within the SDS setup file on the supplied CD as shown in table 
2.12. 
Table 2.12: Real time thermocycler parameters for miRNA array. 
Temperature(°C) Time (min) Cycles 
50 2 40 
94.5 10 40 
97 30(seconds) 40 
59.7 1 40 
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2.2.8 miRNA Data Analysis 
2.2.8.1 Data Formatting 
Following qRT-PCR, the SDS files were opened in RQ manager and a manual threshold 
of 0.1 was set to ensure CT determination consistency across each miRNA target. The 
amplification data was then exported as TXT.files. The files were finally imported into 
R statistical analysis software for initial bioninformatics including generation of P 
values and establishing a short list of the most differentially expressed miRNA. 
Data from the temporal study and biological replicates was processed as follows: 
0-48 hour Temporal Study  
 All endogenous controls were removed to allow for mean normalisation (Pieter 
Mestdagh et al 2009). 
 Calculation of Pearson Correlation Coefficient (PCC). 
  P-values generated for PCC. 
 Only miRNA with strong correlation were retained ≥ 0.9 or ≤ -0.9 with a P 
value of ≤ 0.05. 
 Hierarchical Cluster Analysis was performed to validate the experiment. 
 Two way heat map plotted of priority miRNA. 
 dCT was multiplied by -1 to correlate increasing value with increasing 
expression when plotted. 
Biological Replicates of 24hour time point 
 All endogenous controls were removed to allow for mean normalization (Pieter 
Mestdagh 2009). 
 Priority miRNA short lists were made up of miRNA whose adjusted P value was 
≤0.05 using the Benjimani Hochberg approach. 
 Hierarchical Cluster Analysis was performed to validate the experiment. 
 Venn diagrams generated for a 3 way comparison of Static Vs 3%, Static Vs 
10% and 3% Vs 10% to elucidate commonality of miRNA across the strains.  
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2.2.8.2 Target Prediction  
To determine which genes may be affected by the priority miRNA the putative targets 
were downloaded using the on line database TargetScan (version 6.2).  
TargetScan predicts biological targets of miRNAs by searching for the presence of 
conserved 8mer and 7mer sites that match the seed region of each miRNA (Lewis et al., 
2005). As an option, nonconserved sites are also predicted. Also identified are sites with 
mismatches in the seed region that are compensated by conserved 3' pairing (Friedman 
et al., 2009). In mammals, predictions are ranked based on the predicted efficacy of 
targeting as calculated using the context and scores of the sites (Grimson et al., 2007).  
2.2.8.3 Biological Processes and Pathway Analysis 
The gene list generated from Target Scan, for a miRNA of interest, was entered into the 
online bioinformatics database DAVID (Database for Annotation, Visualisation and 
Integrated Discovery) (version 6.7)  
DAVID tools were used to determine enrichment for biological themes such as GO  
(Gene Ontology) biological processes. They were also used to visualise genes on KEGG 
(Kyoto Encyclopedia of Genes and Genomes) pathway maps for analysis. (Huang et al., 
2009; Sherman et al., 2009) 
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2.2.9 Pathophysiological Assays 
 
2.2.9.1 Cyclic Strain 
In order to assess the impact of haemodynamic force on the cell it was necessary to 
replicate it. This was achieved using a Flexcell® FX-4000T™ Tension Plus™ system 
which utilises a micro-processor controlled vacumn (Banes et al 1985). This allows for 
cyclic deformation of cells cultured on flexible-bottomed culture plates. The Flexcell® 
system can reproduce several waveforms found in the body. These include those found 
in an electrocardiogram (ECM), a heart P wave which mimics the pressure experienced 
by vessels from the heart beat, a static wave for constant pressure and a sine, triangle 
and square wave which show increasing rates from minimum elongation to maximum 
respectively. For the purpose of this project the heart P wave form was used. 
HAoSMC were seeded to an amino, Poly- D – Lysine, coated 6 well Bioflex® plate at a 
density of 3 x10
5
 per well. Once the cells had completely adhered (~ 7 hours) they were 
exposed to either a physiological (5%) or pathological (10%) strain from 2 – 72 hours. 
Following the experiment cells were harvested for total RNA for miRNA/mRNA 
analysis, lysed for protein quantification by western blot or used in cell function assays 
including, migration, adhesion, apoptosis and cell cycle/ proliferation.   
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Figure 2.6: Top: Image of Flexcell® FX-4000T™ Tension Plus™ system. Includes vacuum 
base plate on far left, to the right is the Flex Link® housing the valves and to the far right is the 
Flex Central® PC containing the software to run the system. Bottom: Schematic diagram 
showing a side view (left) of cells under strain from the applied vacuum as they are pulled over 
the loading post. Right: top view of cells on BioFlex® plate highlighting the equibiaxial strain 
when under vacuum. Image taken from (http://www.flexcellint.com/) 
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2.2.10 Cell Function Assays 
2.2.10.1 xCELLigence Real Time Cell Analysis 
The xCELLigence system monitors cellular events in real time without the 
incorporation of labels. The system measures electrical impedance across integrated 
micro-electrodes on the bottom of tissue culture E and CIM plates. The impedance 
measurement provides quantitative information about the biological status of the cells, 
including cell number, viability and morphology. The system was used to measure cell 
adhesion and migration using the E-plate and CIM plate respectively. Presence of cells 
on the electrodes alters the local ionic environment at the electrode/solution interface 
leading to increased electrode impedance. The more cells attached or the stronger the 
attachment the higher the impedance. 
The impedance is measured using a dimensionless parameter termed Cell Index (CI) 
which is derived from the relative change in electrical impedance.  
Characteristics of this parameter include: 
 When cells are not present or are not well-adhered on the electrodes, the CI is zero. 
 Under the same physiological conditions, when more cells are attached on the 
electrodes, the CI values are larger. Thus, CI is a quantitative measure of cell number 
present in a well. 
 Additionally, change in a cell status, such as cell morphology, cell adhesion, or cell 
viability will lead to a change in CI. Ke N et al., (2011). 
(http://www.aceabio.com/UserFiles/doc/literature/20131108_xCELLigence_Publication
_List.pdf) 
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Figure 2.7: Schematic diagram explaining Cell Index (CI). Diagaram taken from (www.roche-
applied-science.com) 
 
 
 
Figure 2.8: Image of E-Plate (left) and cover (right) 
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Figure 2.9: Image of assembly plate for CIM migration plates. 
 
 
Figure 2.10: Image of CIM migration plate. Left: Lower chamber plate containing the 
chemoattractant. Middle: Upper, electrode containing, chamber plate to which the cell 
suspension is added. Right: Cover. 
 
 
Figure 2.11: Typical xCelligence graph depicting CI values (y axis) Vs time in hours (x axis). 
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2.2.10.1.1Cell Adhesion/Proliferation Assay 
E-Plates are single-use, disposable devices used for performing cell-based assays on the 
xCELLigence system. Each individual well on an E-Plate incorporates a sensor 
electrode array that allows cells in the well to be monitored and assayed. 
1) Using a multi-channel pipette, 100 µl of full culture media was added to each 
well of the E-Plate 16. It was important to ensure no air bubbles were introduced 
and also be careful not to touch the electrodes on the bottom of the well with the 
tips. Approximately 300 µl of de-ionized water was then added to the trophs 
surrounding the wells. This helped humidify the plate. The plate was then left to 
equilibrate in the laminar for 30 minutes. 
2) While the plate was incubating experimental parameters were set up on the 
RTCA software as follows. 
 Exp Notes tab: Experimental information, purpose, name etc. were 
entered.  
 Layout tab: Here, wells are highlighted to enter information on the cell 
number, type, treatment etc. within that well. This is what will decide 
whether you are doing duplicates or individual well analysis. It is best 
to set up for a minimum of duplicates. 
 Schedule tab: This is what determines the length of the experiment and 
timing of intervals between sweeps. Right click on page and choose add 
step for initial back ground reading. Next right click and add a second 
step, for a typical adhesion/proliferation experiment 48 sweeps at 15min 
intervals were selected. This gives monitoring of adhesion over a 12 
hour period. A sub step was then added which runs automatically after 
step 2. In this sub step reading intervals were set at 30 minutes and 192 
sweeps giving proliferation monitoring over a 4 day period. 
3) The equilibrated E-Plate is then inserted into the dock cradle ensuring it was 
aligned correctly. The background reading was taken by starting step 1. 
4) The plate was removed and a 100µl of cell suspension was added or a 100µl of 
media for the no cell controls. The plate was left for 30 minutes in the laminar 
for cells to settle, with the plate gently tapped to help with even distribution of 
the cells. 
5) Following incubation the plate was reinserted to the cradle for a final time and 
step 2 was started. 
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2.2.10.1 .2 Cell Migration/Proliferation Assay 
 
CIM-Plates are single use, disposable devices used for performing cell invasion and cell 
migration assays on the instrument.  The CIM-Plate 16 comprises a plate cover (lid), an 
upper chamber and a lower chamber.  The upper chamber has 16 wells that are sealed at 
the bottom with a microporous polyethylene terephthalate (PET) membrane containing 
microfabricated gold electrode arrays on the bottom side of the membrane.  The median 
pore size of this membrane is 8 μm.  The lower chamber has 16 wells, each of which 
serves as a reservoir for media and any chemo attractant for the cells in corresponding 
upper chamber wells. 
1) The metal plate holder was placed in the laminar with the blue alignment dots 
facing away. The lower chamber of the CIM-Plate was then placed on to the 
holder. Using a multichannel pipette 160 µl of full serum media was added to 
the sample wells. For a negative control 160 µl of serum free medium was used 
in 2 of the 16 wells. No air bubbles were allowed to form. 
2) The upper (electrode containing) chamber was then clicked in place on top of 
the lower chamber. 
3) 50 µl of serum free media was added to each well of the upper chamber; again 
ensuring no bubbles formed. 
4) The completed CIM-Plate was then loaded into the xCELLigence system cradle 
and allowed to equilibrate for one hour. 
5) During the incubation time the experiment was set up on the RTCA software as 
described for the cell adhesion/proliferation experiment. 
6) Following one hour equilibration the one minute background check was 
conducted. 
7) 100µl of cell suspension was then added to each well and 100 µl of media for 
the no cell control. The plate was left for 30 minutes in the laminar cabinet 
following addition of cells. After the 30 minute incubation the plate was again 
loaded into the cradle and step 2 was started. 
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2.2.10.2 Flow Cytometry 
Flow cytometry is a sensitive technology which can give a quantitative and qualitative 
measurement on the size, complexity and condition of a cell. As the name suggests, it 
involves flowing single cells through a capillary past a point of detection. Detection is 
typically achieved through use of lasers and detectors. The technology enables studies 
of a multitude of cell functions such as proliferation, cell cycle and apoptosis. Forward 
scatter is a measure of the size of the cell, whereas side scatter denotes the granularity of 
the cell. Fluorescence is the property of a molecule to absorb light and re-emit it at a 
different wavelength. (Fulwyler et al,. 1965; van Engeland et al., 1996).  
2.2.10.2.1 Apoptosis Study 
Apoptosis is a carefully regulated process of cell death that occurs as part of normal 
development. In normal live cells, phosphatidylserine (PS) is located on the cytoplasmic 
surface of the cell membrane. However in apoptotic cells, PS is translocated from the 
inner to the outer leaflet of the plasma membrane, thus exposing PS to the external 
cellular environment. The human anticoagulant, annexin V, is a 35-36kDa Ca
2+
 
dependent phospholipid-binding protein that has a high affinity for PS. Thus annexin V 
labelled with a flurophore can identify apoptotic cells by binding to the exposed PS on 
the outer membrane. In conjunction, red-fluorescent propidium iodide (PI) nucleic acid 
binding dye is incorporated to the cell population. PI is impermeable to live or apoptotic 
cells. Thus, after staining a cell population with Alexafluor®488 annexin V and PI, 
dead cells will show red and green fluorescence, apoptotic cells will show green only 
and live healthy cells should show little or no fluorescence.  
Cells were trypsinised and counted to give a final concentration of 1 x 10
6 
/ml. As a 
positive control apoptosis was introduced by incubating cells with 3.7% para-
formaldehyde at room temperature for 15 minutes. PI was used at a concentration of 
100µg/ml. 
Cells were pelleted at 700RPM for 5 minutes, washed with PBS and re-suspended in 1 x 
annexin V binding buffer, 100µl per assay. Samples were then incubated with 5µl of 
Alex Fluor 488 and 1µl of 100µg/ml PI for 15 minutes at room temperature. Following 
incubation 400µl of 1x annexin V binding buffer was added and samples analysed on a 
BD FACS Aria. 
(http://tools.lifetechnologies.com/content/sfs/manuals/mp13199.pdf) 
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For initial experiments to set gates and flow parameters 5 samples were prepared, 4 of 
which were controls, as shown in table 2.13. 
 
Table 2.13: Staining parameters of samples for optimization. 
Live Cells Dead Cells 
Unstained Stained with PI and Alexa Fluor 488 
Stained with PI and Alexa Fluor 488 Stained with PI only 
---------------- Stained with Alexa Fluor 488 only 
 
 
2.2.10.2.2 Proliferation Study 
Measuring a cell’s ability to proliferate is a fundamental method for assessing cell 
health and investigating diseases such as atherosclerosis. The most accurate way is to 
measure newly synthesised DNA.  
 
Clik-iT® EdU 
The Clik-iT EdU flow cytometry assay kit is a novel alternative to BrdU incorporation. 
It uses a 5-ethynyl-2’ – deoxyuridine nucleoside analog tothymidine. This is 
incorporated into the DNA during active DNA synthesis. Detection is based on a click 
reaction, a copper catalyzed covalent reaction between an azide and an alkyne. In this 
assay the alkyne is found in the ethynyl moiety of EdU, while the azide is coupled to 
Alexa Fluor 488 dye.  
(http://tools.lifetechnologies.com/content/sfs/manuals/mp10338.pdf) 
Cells were trypsinised and counted then placed in suspension with 4ml of full growth 
medium. A final concentration of 10 µM EdU was added to the cell suspensions which 
were then incubated for two hours at 37°C, 5%CO
2
. Cells were then pelleted and 
washed with 1% BSA PBS. Pellet was re-suspended in 100µl Clik-iT fixative, 4% 
formaldehyde, at room temperature protected from the light for 15 minutes. Cells were 
again pelleted and washed with 1% BSA PBS. The pellet was then re-suspended in 
133 
 
100µl 1x saponin based permeabilisation and wash reagent and incubated at room 
temperature for 15 minutes.  
 
During this incubation the “Click-iT® reaction cocktail” was prepared as shown in table 
2.14. 
Table 2.14: Recipe for Click-iT® reaction cocktail 
Reaction Component Number of reactions 
1 
PBS 438µl 
CuSo4 10 µl 
Fluorescent Dye Azide 488 2.5 µl 
Reaction Buffer 50 µl 
Total Reaction Volume 500 µl 
 
0.5ml of this reaction cocktail was added per sample and protected from the light. The 
sample was incubated at room temperature for 30 minutes. Cells were then pelleted and 
washed with 3mls of 1% BSA PBS and the supernatant was removed. Cells were 
pelleted one last time and re-suspended in 600 µl of 1x saponin based permeabilisation 
and wash reagent. The samples were then analysed on the BD FACS Aria. 
 
2.2.11Statistical analysis  
Results are expressed as mean ±sem. Experimental points were performed in triplicate 
with a minimum of three independent experiments (n=3). Statistical comparisons 
between controls versus treated groups were performed using One-way Anova and by 
Student’s unpaired t-test. A value of *P≤0.05 or δP≤0.05 was considered significant. 
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CHAPTER THREE: Characterisation of the impact of cyclic strain on 
HAoSMCs 
3.1 Introduction 
 
Vessels, particularly arterial vessels, experience mechanical or haemodynamic force as 
a direct result of the pulsatile nature of blood flow in vivo. Physiological intraluminal 
pressure is essential to ensure homeostasis within the vessel (Lehoux et al., 2006; 
Birukov et al., 1998).  
Change in any parameter of haemodynamic force can have a pathological consequence 
for the blood vessel. For example, persons suffering from prolonged hypertension are at 
greater risk of developing atherosclerotic plaques resulting from migrating smooth 
muscle cells (Timmins et al., 2011). Atherosclerosis results from the development and 
progression of atherosclerotic plaques. These plaques can be classified as either stable 
or unstable, depending on their composition. Stable plaques are predominantly 
composed of synthetic migrating SMCs which have transcended through the 
endothelium into the luminal space.  
Vascular smooth muscle cells (VSMCs) are primarily responsible for regulating 
vascular tone and blood pressure. They possess a unique plasticity which allows them to 
reversibly differentiate between a synthetic and contractile phenotype. This is known as 
phenotypic modulation. The synthetic form is characterised by a proliferating migratory 
phenotype, while cells in the contractile state are predominantly quiescent. This 
phenomenon appears to be as a result of both environmental cues, such as 
haemodynamic pressure and innate genetic pathways (Owens et al., 1995). Expression 
of specific contractile cell markers such as SM α-actin, Smoothelin, Calponin and 
myosin heavy chain (MHC) can be used to determine SMC phenotype. 
Ironically, the procedures used to reopen occluded atherosclerotic vessels such as 
stenting or balloon angioplasty, often result in damaging surrounding vascular cells and 
an increase in the pressure on the vessel wall. This heightened force on the VSMCs can 
result in a synthetic migratory phenotype ultimately leading to restenosis (Taylor et al., 
2000).  
135 
 
As a result, a myriad of in vitro investigations into the mechanical sensitivity of VSMCs 
has been performed using deformable substrates (Brown et al., 2000). These have 
attempted to elucidate both the molecular mechanisms in which SMCs convert 
mechanical stimulation into a cell response and also the direct impact of cyclic strain on 
SMC phenotype (Haga et al., 2006).  The results have demonstrated that cyclic strain 
undoubtedly regulates SMC growth, however, to what extent and direction remains 
ambiguous. This is due to conflicting data, exemplified by both an increase and 
decrease in VSMC proliferation following exposure to cyclic strain (Hipper et al., 2000; 
Birukov et al., 1995).   
Coincidentally, a definitive extent of mechanical parameters which elicit a specific 
reproducible cell response and function remains to be fully elucidated.  Therefore, work 
carried out in this chapter was designed to assess the specific impact of cyclic strain and 
deformation on VSMC injury and phenotype. 
3.1.1 Chapter Hypothesis  
Mechanical cyclic strain regulates VSMC health as well as expression of VSMC 
contractile genes, specifically SM α-actin, Smoothelin and Calponin in human aortic 
smooth muscle cells (HAoSMCs).  
3.1.2 Specific aims and Experimental Approach: 
To test this hypothesis, experiments included in this chapter were designed to:  
 Characterise and confirm the HAoSMC lineage through use of cell specific 
markers. 
 Determine which extracellular matrix (ECM) facilitated the longest adhesion of 
HAoSMCs on the silicone membrane flex plates which are required for 
application of cyclic strain. 
 Explore the impact of cyclic strain on HAoMSC phenotype and assess its 
pathophysiological properties on the cell by quantifying expression of injury and 
contractile markers. 
Cyclic strain was applied by adhering cells to a flexible silicone membrane to which a 
vacuum iss applied stretching the membrane over a fixed loading post. Injury markers 
quantified were Fibroblast Growth Factor-2 (FGF-2) and Thrombomodulin (TM). 
HAoSMC phenotype was determined by quantification of expression of the contractile 
markers SM α-actin, Smoothelin and Calponin at both mRNA and protein level. 
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3.2 Results  
3.2.1 Characterisation of Human Aortic Smooth Muscle Cells (HAoSMCs) 
3.2.1.1 Investigation of SMC lineage through use of cell specific markers 
 
     
 
 
 
 
 
Figure 3.1: Western Blot for Cell Specific Markers. Top: shows presence of Von Willebrand 
Factor (VWF) in Human Aortic Endothelial Cells (HAEC) and absence in Human Aortic 
Smooth Muscle Cells (HAoSMC). Centre: shows presence of smooth muscle specific α-actin 
in HAoSMC and absence in HAEC. Bottom: Shows GAPDH positive control. 
 
 
Figure 3.2: Immunohistochemistry of α- actin (10X Magnification). HAoSMC were fixed to 
a glass slide using 3.7% paraformaldehyde. Cells were then incubated with AlexFluor 488 
conjugate secondary Ab to bind to the smooth muscle specific α-actin Ab. The nucleus was also 
imaged using nuclear stain DAPI (blue). 
VWF      (250kD) 
 
 
HAoSMC      HAEC 
GAPDH     (38kD) 
 
α-actin    (42kD) 
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3.2.1.2 Adhesion profiles of HAoSMCs 
 
In order to subject the HAoSMCs to cyclic strain, they were seeded on to the flexible 
silicone membrane of the Flexcell® plates. The silicone membrane, however, has a 
hydrophobic property making prolonged adhesion (>24hr) of HAoSMCs difficult. To 
overcome this, adhesion profiles were created on the xCELLigence real time impedance 
system for a range of extracellular matrices (ECMs) and coating factors. This enabled 
an ECM or coating factor, which would provide optimal adhesion and attachment to be 
selected.  
 
 
 
 
Figure 3.3: xCELLigence plot of HAoSMC adhesion. Adhesion profile of HAoSMC on 
several ECM and coating factors. Experiment was conducted over a 12 hour time point. Red - 
No Coating, Blue – Fibronectin (50µg/ml), Light Blue – Collagen Type I (15 µg/ml), Purple - 
Laminin (20 µg/ml) n=3.  
 
 
 
 
 
No coating 
Fibronectin (50ug/ml) 
Collagen type 1 (15ug/ml) 
Laminin (20ug/ml) 
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Figure 3.4: xCELLigence plot of HAoSMC adhesion. Adhesion profile of HAoSMC on 
several ECM and coating factors. Experiment was conducted over a 12 hour time point. Red – 
No Coating, Blue – Poly – D – Lysine (50µg/ml), Light Blue -1:100 dilution of Max Gel, Purple 
– 1:200 dilution of Max Gel, Pink – Laminin (20 µg/ml), Green Vitronectin (5 µg/ml) n=3.  
  
No coating 
Poly-D-Lysine (50ug/ml) 
Max Gel (1:100) 
Max gel (1:200) 
Laminin (20ug/ml) 
Vitronectin (5ug/ml) 
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3.2.1.3 The effect of ECMs and coating factors on contractile gene expression  
To assess if the ECMs and coating factors had an impact on HAoSMC phenotype, 
transcript expressions of SM α-actin, Smoothelin and Calponin were quantified in total 
RNA extracted from the cells.   
 
 
 
 
A
. 
B
. 
* 
* 
* 
* * 
* * 
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Figure 3.5: mRNA Expression of Contractile Genes. A – Alpha Actin mRNA expression 
from HAoSMC coated on various extra cellular matrices. n=3, *P≤0.05 vs. no coating; one-way 
Anova. B - Calponin mRNA expression from HAoSMC coated on various extra cellular 
matrices. n=3 *P≤0.05 vs. no coating; one-way Anova. C - Smoothelin mRNA expression from 
HAoSMC coated on various extra cellular matrices. n=3, data just outside statistical 
significance. D – Comparative analysis of contractile genes expression on several ECM and 
coating factors. n=3.  
C. 
D. 
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3.2.2 Injury Marker Expression 
Expression of in vitro SMC injury markers Fibroblast Growth Factor -2 (FGF-2) and 
Thrombomodulin were quantified to assess any HAoSMC injury resulting from cyclic 
deformation at 5% and 10% amplification. Expression levels of these proteins were 
quantified in both culture medium and cell lysate using ELISA and western blot. 
3.2.2.1 Secreted Fibroblast Growth Factor -2 (FGF-2) 
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Figure 3.6: ELISA analysis of secreted Fibroblast Growth Factor- 2 (FGF-2). A – FGF-2 
levels quantified in HAoSMC media, cells were exposed to 10% cyclic strain over a time course 
of 72 hours. n=3, *P≤0.05 vs. static adhesion; one-way Anova B - FGF-2 levels quantified in 
HAoSMC media, cells were exposed to 5% cyclic strain over a time course of 72hours. n=3, 
*P≤0.05 vs. static adhesion; one-way Anova C – Comparative analysis of levels of FGF-2 in 
HAoSMC media, cells were exposed to 5% and 10% cyclic strain over 72 hours. n=3, δ P≤0.05 
pairwise; t-test.  
C. 
δ 
δ 
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3.2.2.2 Cellular Lysate Fibroblast Growth Factor -2 (FGF-2) 
 
 
 
 
 
 
 
 
 
 
Figure 3.7: Western Blot of HAoSMC Lysate. Blots are for SMC injury marker Fibroblast 
Growth Factor -2 (FGF-2) and endogenous loading control GAPDH. HAoSMC were exposed to 
10% cyclic strain over a time course of 72 hours. FGF-2 was quantified from cell lysate. Values 
are normalized for loading bias using GAPDH endogenous control and calibrated against 0hr. 
n=3, δP≤0.05; pairwise t-test. 
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Figure 3.8: Western Blot of HAoSMC Lysate. Blots are for SMC injury marker Fibroblast 
Growth Factor -2 (FGF-2) and endogenous loading control GAPDH. HAoSMC were exposed to 
5% cyclic strain over a time course of 72 hours. FGF-2 was quantified from cell lysate. Values 
are normalized for loading bias using GAPDH endogenous control and calibrated against 0hr. 
n=3, *P≤0.05 vs. static adhesion; One-way Anova.  
FGF-2 18kD 
 GAPDH 38kD 
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Figure 3.9: Grouped data from figures 3.7 & 3.8. Comparative analysis of FGF-2 expression 
in lysate from HAoSMCs exposed to 5% and 10% cyclic strain over 72 hours. n=3, δP≤0.05; 
pairwise t-test.   
  
δ 
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3.2.2.3 Secretred Thrombomodulin (TM) 
The second injury marker utilised was Thrombomodulin (TM), a robust endothelial cell 
marker which is also known to be expressed by SMC in culture. Levels of TM in 
HAoSMC lysate and media was quantified using a sandwich ELISA. 
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Figure 3.10: ELISA analysis of secreted Thrombomodulin (TM). Levels of 
Thrombomodulin were quantified in media from HAoSMCs exposed to strain. A – HAoSMC 
exposed to 10% cyclic strain over a time course of 72 hours.n=3, *P≤0.05 vs. static adhesion; 
one-way Anova B - HAoSMC exposed to 5% cyclic strain over a time course of 72 hours. n=3, 
*P≤0.05 vs. static adhesion; one-way Anova.  
A. 
B. 
* 
* 
* 
* 
* 
147 
 
3.2.2.4 Cellular Lysate Thrombomodulin (TM) 
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Figure 3.11: ELISA analysis of total cellular Thrombomodulin (TM).  Levels of total 
cellular Thrombomodulin were quantified in lysates of HAoSMCs exposed to strain. A –
HAoSMC exposed to 10% cyclic strain over a time course of 72hours. n=3, *P≤0.05 vs. static 
adhesion; one-way Anova.  B - HAoSMC exposed to 5% cyclic strain over a time course of 72 
hours. n=3, δP≤0.05; pairwise t-test.    
A. 
B. 
* 
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Figure 3.12: A – Comparative analysis of TM expression in culture media of HAoSMCs 
exposed to 5% and 10% cyclic strain. n=3, δP≤0.05; pairwise t-test. B – Comparative analysis 
of TM expression in total cell lysate of HAoSMCs exposed to 5% and 10% cyclic strain. 
A. 
B. 
δ 
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Figure 3.13 A - Comparative analysis of TM expression in HAoSMC media and cell lysate of 
cells exposed to10% strain over 72 hours. B - Comparative analysis of TM expression in 
HAoSMC media and cell lysate of cells exposed to5% strain over 72 hours. 
 
B. 
A. 
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3.2.3 Investigation of phenotype modulation of HAoSMCs  
To assess the effect of cyclic strain on HAoSMC phenotype, the expression of three 
contractile markers was quantified. These were; Smooth Muscle Alpha Actin, Calponin 
and Smoothelin. Following strain, both gene and protein expression were quantified 
through the use of specific primers and antibodies for SM α-actin and calponin, while 
only gene expression was quantified for smoothelin as the protein detection in cell 
lysate was unreliable.  
3.2.3.1Gene expression of contractile markers 
 
 
A. 
B. 
* 
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* 
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Figure 3.14: Expression of contractile genes in total HAoSMC RNA.  A, B &C Alpha Actin, 
Calponin and Smoothelin mRNA expression from HAoSMC exposed to 10% cyclic strain over 
a 72 hour time course, respectively. n=3, *P≤0.05 vs. static adhesion ; one-way Anova. 
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3.2.3.2Protein expression of contractile markers 
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Figure 3.15: Western Blot of HAoSMC Lysate. Blots for SMC contractile marker Alpha 
Actin and endogenous loading control GAPDH. HAoSMC were exposed to 10% cyclic strain 
over a time course of 72 hours. Values are normalized for loading bias using GAPDH 
endogenous control and calibrated against 0hr. n=3, δP≤0.05; pairwise t-test.  
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Figure 3.16: Western Blot of HAoSMC Lysate. Blots for SMC contractile marker Alpha 
Actin and endogenous loading control GAPDH. HAoSMC were exposed to 5% cyclic strain 
over a time course of 72 hours. Values are normalized for loading bias using GAPDH 
endogenous control and calibrated against 0hr. n=3, *P≤0.05 vs. static adhesion; one-way 
Anova. 
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Figure 3.17: Western Blot of HAoSMC Lysate. Blots for SMC contractile marker Calponin 
and endogenous loading control GAPDH. HAoSMC were exposed to 10% cyclic strain over a 
time course of 72 hours Values are normalized for loading bias using GAPDH endogenous 
control and calibrated against 0hr. n=3, δP≤0.05; pairwise t-test.  
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Figure 3.18: Western Blot of HAoSMC Lysate. Blots for SMC contractile marker Calponin 
and endogenous loading control GAPDH. HAoSMC were exposed to 5% cyclic strain over a 
time course of 72 hours. Values are normalized for loading bias using GAPDH endogenous 
control and calibrated against 0hr. n=3, *P≤0.05 vs. static adhesion; one-way Anova. 
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Figure 3.19: Effect of strain amplitude on Calponin expression. HAoSMC were exposed to 
both 5% and 10% cyclic strain over a time course of 72 hours. Expression of Alpha Actin (A) 
and Calponin (B) were quantified for both strains and each time point using densitometry 
analysis of western blots. 
A. 
B. 
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Figure 3.20: Correlation between gene and protein expression. A - Alpha Actin mRNA and 
protein levels were quantified from total RNA and cell lysate, respectively, from HAoSMC 
exposed to 5% cyclic strain over 72 hours. Calponin mRNA and protein levels were quantified 
from total RNA and cell lysate, respectively, from HAoSMC exposed to 10% cyclic strain over 
72 hours. 
A. 
B. 
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3.3 Discussion 
 
As previously stated, haemodynamic stresses are innate to the in vivo environment of 
the vascular smooth muscle cell. One of these mechanical forces is cyclic strain, this has 
been characterised as a tensile stress which is perpendicular to the lumen and cyclic due 
to the pulsatile nature of blood flow (Cevallos et al., 2006; Lehoux and Tedgui et al., 
2003). In vivo, each cardiac cycle causes an arterial stretch of anything between 5 and 
10%. During some physiological conditions a stretch of up to 25% is possible (Gotlieb 
et al., 1996; Osol et al., 1995). Vascular smooth muscle cells exposed to this 
deformation experience higher local strains in the actin rich pseudopods than in the cell 
body (Barbee KA et al 1994). The strain experienced by the cell may also depend on its 
particular cytoskeletal arrangement and focal adhesion organization and distribution.  
Chronic changes to this mechanical force in vivo, particularly in the setting of 
hypertension, is often accompanied by vessel remodeling such as a thickened arterial 
wall and decreased luminal diameter (Geng & Libby et al., 2002; Hahn & Schwartz et 
al., 2009). Hypertension also increases the risk of pathological disease states such as 
atherosclerosis. Typically, the underlying driving force of vessel remodeling and 
progression of atherosclerosis is synthetic, pro proliferative and pro migratory SMCs. 
The altered luminal pressure can modulate VSMC phenotype between a contractile and 
synthetic phenotype (Rensen et al., 2007). However, the exact properties of the 
mechanical force and its associated biological consequence remain to be fully detailed. 
As such investigations into the significance of amplitude of strain, frequency of cardiac 
cycle and duration of the force in modulating cellular dynamics and selecting for a 
particular SMC phenotype over another is at the centre of much debate amongst groups. 
Work carried out in this chapter aims to address some of these questions. 
Experiments were designed to elucidate the impact of cyclic strain on HAoSMCs in 
culture, in particular its effect on cell injury and phenotype. To achieve this, the 
expression of both injury and contractile markers, found within the cell and secreted 
into the growth media, were quantified. The injury markers investigated were FGF-2 
and Thrombomodulin while the contractile markers were SM α-actin, Calponin and 
Smoothelin. 
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The HAoSMCs used throughout experiments were routinely characterised for cell 
specific markers to ensure genuine lineage. Qualitative western blot analysis was carried 
out for the presence of smooth muscle specific α–actin (figure 3.1), and as a negative 
control Human Aortic Endothelial Cell (HAEC) lysate was used. Von Willebrand 
Factor was also probed for, as a follow up negative control showing presence in HAEC 
lysate and absence in HAoSMC, (figure 3.1). 
Immunohistochemistry of smooth muscle specific α–actin was also carried out on 
HAoSMCs. The SM α–actin specific Ab was bound with a secondary antibody, 
conjugated with AlexaFluor 488. This decorated SM α–actin in green; the nuclei of the 
cells were also stained blue using DAPI (figure 3.2, 10X magnification). 
In order to subject the SMC to cyclic strain, they were seeded on to the flexible silicone 
membrane of the Flexcell® plates as described in chapter 2.2. The silicone membrane, 
however, is slightly hydrophobic making prolonged adhesion (>24hr) of HAoSMC 
difficult. To overcome this, adhesion profiles were created on the xCELLigence real 
time impedance system for a range of extracellular matrices (ECMs) and coating 
factors. This enabled an ECM or coating factor, which would provide optimal adhesion 
and attachment to be selected. It should also be noted that VSMCs will deposit their 
own ECM over the duration of the experiment particularly when mechanically 
stimulated with strain (O’Callaghan et al., 2000).  
Figure 3.4 and 3.5 show adhesion plots of SMCs on several different ECMs and coating 
factors. The data shown is for 12 hours and rate of adhesion is given as the 
dimensionless figure CI or cell index. This denotes the amount of resistance created by 
the cells for that particular sample, the full adhesion time course plots (~ 60-72 hours) 
can be found in the appendix.  Resistance can be directly correlated for ~ the first five 
hours, to the strength of adhesion.   
In figure 3.4, cells seeded on un-coated wells (red plot) show a basal adhesion of ~ 2.2. 
Fibronectin 50µg/ml (blue plot) shows the highest adhesion at ~ 3.3 CI followed by 
Collagen type I 15µg/ml (blue plot) ~2.6 CI. Finally a decrease in adhesion was seen in 
the well coated with 20µg/ml of Laminin (pink plot) with a CI of 2.0. 
Figure 3.5 also shows a plot of adhesion profiles of HAoSMCs on additional ECM as 
well as various coating factors. Cells seeded onto un-coated wells showed a CI of 1.5 
(red plot). The highest adhering sample was Poly-D-Lysine 50µg/ml (blue plot) ~ 2.9 
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CI. This was followed by 1:100 (light blue) and 1:200 (purple) dilutions of MaxGel® 
CIs of 1.6 and 1.5 respectively. MaxGel® ECM is a commercial coating factor 
containing extracellular matrix components including collagens, laminin, fibronectin, 
tenascin, elastin, a number of proteoglycans and glycosaminoglycans. It is designed to 
aid in adhesion and proliferation of many cell types. The two remaining ECMs, Laminin 
20 µg/ml (pink) and Vitronectin 15µg/ml (green), showed decreased adhesion at 1.1 and 
1.2 CI respectively. 
From this experiment it was concluded that the amino acid Poly-D-Lysine showed 
strongest adhesion over the first 5 hours with minimal effect on cell growth over the 
following 72 hours. Poly-lysine is a polycation which binds negatively charged ions of 
the cell membrane and the culture surface. When adsorbed to the culture surface, poly-
lysine increases the number of positively charged sites available for cell binding. Both 
the D- and L- form of the poly-lysine can be used as a coating substrate since poly-
lysine is a nonspecific attachment factor for cells; however, certain cells can digest 
poly-L-lysine. For this reason, poly-D-lysine was used so that the HAoSMCs were not 
disrupted by excessive uptake of L-lysine (Jacobson et al., 1977; Bottenstein et al., 
1977).  
Although cells coated on Fibronectin showed strong adhesion for the first 5 hours, an 
increase in cell death was observed over the remaining 72 hours of the experiment, see 
appendix figure A2. The strong adhesion can be attributed to the fact integrins αVβ3 
and α5β1, which are abundant on the smooth muscle cell surface, are receptors for 
fibronectin. The increased cell death was possibly due to an inflammatory response by 
the cells to this ECM as fibronectin is known to be involved in wound repair. Following 
injury plasma fibronectin along with fibrin are deposited at the damaged site to form an 
initial clot, here macrophages and fibroblasts are recruited to further aid in repair 
(Grinnel et al., 1984). For this reason Poly-D-Lysine (PDL) was preferable to 
fibronectin as it has not known to evoke an inflammatory response in HAoSMCs. As 
PDL are synthetic molecules, they do not stimulate biological activity in the cells 
cultured on them, and they do not introduce impurities carried by natural polymers. 
 The lower adhesion of cells coated on laminin was possibly due to the fact the integrins 
αVβ3 and α5β1, do not find ligands with this ECM. Interestingly though cells seeded 
onto vitronectin also demonstrated lower adhesion despite the fact αVβ3 is a receptor 
for this ECM. An explanation may be found in the fact the 2D environment of cell 
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culture will not necessarily stimulate activation of the same integrins as are present in 
vivo (Haga et al., 2007). Asecond theory is that the HAoSMCs may have adhered, 
spread and then retracted so strongly as to pull the Vitronectin ECM back off the E-
plate. This would rationalize the low CI value and yet the cells may have been tightly 
bound in solution to the ECM. 
The fact Max Gel® coated plates did not provide the strongest adhesion despite having 
a combination of most ECMs would highlight how certain ECM proteins provide 
stronger adhesion than others. When they are pooled together competition between each 
ECM for the receptors may reduce cell binding to a high adhesion substrate, such as 
fibronectin. Collagen type I has shown to promote a synthetic phenotype within SMCs 
(Orr et al., 2009). To allow motility in this synthetic state, cells must release adhesions 
to the substrate to facilitate traction, this could explain the lower adhesion of HAoSMCs 
coated on Collagen type I. Variation in CI values across both experiments for the 
uncoated wells can be attributed to a difference in cell number.     
Results from this experiment encouraged the choice of the amino coated plates from 
Flexcell®. Using these plates it was possible to achieve strong adhesion from the 
HAoSMC and an extended experimental time course using the strain unit. 
Seeding any cell on a specific ECM will evoke, to a lesser or greater extent, a biological 
response. To investigate the HAoSMC response, at molecular level, to being seeded 
onto the ECMs and coating factors used in figure 3.3 & 3.4, expression of mRNA of 
three contractile genes was quantified. These were smooth muscle α-actin, calponin and 
smoothelin, figure 3.5 A, B & C respectively. There was a marked decrease in each of 
the transcripts of these genes when cells were seeded onto the different matrices. This 
highlights a change towards a more synthetic SMC. In particular, the coating factor 
chosen, Poly-D-Lysine, showed a significant reduction in gene expression for these 
markers. α-actin showed the most significant drop, down to 0.5 fold that of the uncoated 
control. Although these are significant findings, the core investigation of this chapter 
was to elucidate the impact cyclic strain has on SMC dynamics. Predisposing the SMCs 
to a synthetic state should not alter this work. In addition, extracellular matrix is 
synthesized and released by the cell during culture, which will ultimately negate the 
effect of the chosen coating factor as the experiment extends. On top of this the static 
adhesion of the culture itself promotes an unhealthy phenotype, giving confidence that 
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cells used in the experiments of this thesis were predominantly in a synthetic state at the 
start of each study. 
3.3.1 Cell Injury Caused by Cyclic Strain 
 
With the HAoSMCs now strongly adhered and able to undergo deformation for up to 72 
hours, it was subsequently important to discern if cyclic strain was exerting either a 
pathological or physiological effect. This was achieved through quantification of two 
injury markers, Fibroblast Growth Factor–2 (FGF-2) and Thrombomodulin. 
The initial injury marker looked at was FGF-2, this growth factor participates in the 
response to vascular injury. FGF-2 is ubiquitously found throughout most vascular cells. 
It has been well documented that FGF-2 is released from vascular cell cytoplasm 
following cellular injury, particularly in SMCs (Reidy et al., 1992; Linder et al., 1993; 
Crowley et al., 1995; George et al., 1997). FGF-2 contributes to growth responses of 
SMC by exerting an auto or paracrine mitogenic effect on the cell (Mason et al., 1994; 
Clowes et al., 1983). It occurs in many forms and is distributed differentially in 
subcellular compartments in the cytoplasm and nucleus (Renko et al., 1990). FGF-2 has 
also been shown to be released from cells in vitro by cytosolic leakage through an 
injured membrane (S.T. Crowley et al., 1995). For this study FGF-2 released into cell 
media was quantified using a Quantikine® human FGF basic immunoassay (ELISA) by 
R&D Systems®.  
Figure 3.6 (A) shows quantified levels of FGF-2 released from HAoSMC that have 
been subjected to 10% cyclic strain at 1Hz. Samples were taken over a time course of 
72 hours at 0hr, 6hr, 12hr, 24hr, 48hr and 72hr.The time course reveals that during the 
first 6 hours of strain there is an increase of ~ 30 pg/ml of FGF-2 compared with the 
static control, from ~300pg/ml to ~330pg/ml. This may be viewed as an initial adaptive 
response of the cells to the acute strain. As the strain becomes more chronic, a 
significant reduction in secreted FGF-2 is seen throughout the remaining time points 
down to ~ 20pg/ml at 24 hr. The reduced levels of injury marker would suggest a 
physiological response of the cells is evoked by the 10% strain after the initial 12 hours. 
The modest peak at 48 hr to ~ 90pg/ml may be indicative of some cell detachment or 
cell injury caused by the extended culture time, whereas another theory is that the 
intracellular pool of FGF-2 is regenerated and a further release is seen. At 72 hours, 
levels of FGF-2 in the media are down to ~ 30pg/ml.  
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To establish the relevance of strain amplitude on FGF-2 release, SMCs were also 
subjected to a lower 5% strain for the same time course (figure 3.6 B). Some literature 
suggests this may be a more physiological representation of in vivo haemodynamics (Qi 
et al., 2010). 
The increase of  FGF-2 secretion at both the 6 and 12 hours to ~ 370 and 460pg/ml 
respectively compared with 300pg/ml of the static control would suggest the acute 
response of the cells to the lower amplitude strain is extended compared to that of the 
higher strain which dropped after 6 hours to below that of the static control. However, 
similar to the 10% experiment, as the strain becomes more chronic the level of FGF-2 in 
the media is significantly reduced, and by 72 hr it has dropped to ~ 20pg/ml.   
The grouped graph in figure 3.6 (C) shows a clearer comparison of FGF-2 release by 
HAoSMCs subjected to 5% and 10% strain. The higher release of the protein over the 
first 24 hours by cells subjected to 5% cyclic deformation would suggest the cells are 
being understrained and in a more pathological state. At the longer chronic time points 
of 48 and 72 hours, the higher 10% strain conversely shows a greater expression of 
FGF-2 in the media compared to cells strained at 5%, yet this is still markedly lower 
than the static adhesion control. Although distinct profiles are evident the trend in both 
experiments is comparable, that is the initial hours of strain cause a large release of 
FGF-2 into the culture media. By 24 hours, however, levels of secreted FGF-2 in both 
experiments are significantly less than that of the static adhesion control and remain 
lower for the duration of the experiment. First observations would conclude cyclic strain 
at both 5% and 10% has an acute effect on the cells signalling vascular injury and 
therefore stimulating FGF-2 release but as the strain becomes more chronic an adaptive 
response is seen where the cells are secreting far less amounts of FGF-2 and have 
entered into a more physiological phenotype. The protein that is initially released over 
the acute time points may be sequestered back into the ECM or broken down by matrix 
enzymes such as MMPs (Pintucci et al., 2003).   
To strengthen this theory and observe a more global expression change of the protein in 
the cell, levels of FGF-2 from total cell lysate was also quantified (Figures 3.7 & 3.8). 
The comparative graph of both strain amplitudes in figure 3.9 shows the expression of 
the protein seems to peak in both strain conditions at 12hours to ~ 1.5 fold that of the 
static culture and then gradually drops back to basal level over the remaining time 
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points. It should be noted, however, that levels of the protein remain higher in cells 
exposed to 5% compared to 10% strain.  
This expression profile was surprising following quantification of the secreted protein in 
the culture media. The high level of FGF-2 found in the media at the earlier time points 
would have suggested a lower level quantified in the cellular lysate due to a depletion of 
the cellular pools instead of the peak in expression which was actually observed. 
Similarly low levels of secreted FGF-2 did not correspond to a higher cellular content. 
One possible interpretation is down to the way FGF-2 is compartmentalised in the cells. 
The FGF-2 secreted into the cell media may not have originated from cytoplasmic 
reservoirs but instead pools of FGF-2 located in extracellular matrices. These reservoirs 
have shown to be released rapidly and easily requiring neither cell death nor injury 
(Presta et al., 1989).  The lower amounts of secreted protein in the longer time points 
may also be consequence to the fact unbound FGF-2 which was secreted over the time 
course was potentially sequestered by extracellular low affinity receptors such as 
heparin sulphate proteoglycans and other pericellular matrix components (Aviezer et al., 
1994; Bashkin et al., 1989). Taking this into account and the fact cellular levels are not 
replenished at the later time points when such low levels of FGF-2 are secreted in the 
culture media would suggest a finite resource of the protein within the cell. 
Similarly, work carried out by G. C. Cheng et al., (1997) showed FGF-2 release from 
SMCs was tightly regulated by mechanical strain and is amplitude, frequency and 
duration dependent. However, past 90 cycles of strain there was no further release even 
when tested up to 90,000 cycles. Their interpretation was that the rapid and limited 
nature of FGF-2 release in response to cellular strain was consistent with a cell injury-
mediated mechanism. They also highlighted that under long term oscillatory strain the 
cell synthesizes and maintains a cellular pool of FGF-2.  This is only released following 
cell deformation which exceeds an amplitude threshold, as found in cases such as 
balloon angioplasty. Below that, release may be from a sub population of injured cells. 
This would give reasoning to the relatively low amounts released during the longer 
strain time points as seen in figure 3.6 (A-C). It has been shown that healthy cells under 
little or no mechanical stimulus may also release FGF-2. This is also the case for cells 
undergoing normal physiological activities such as migration and contraction (Clarke et 
al., 1993; Clarke et al., 1995). 
  
165 
 
This said, it appears that both extensive trauma and mild mechanical stimulation may 
induce FGF-2 release suggesting it plays a role both pathologically and physiologically. 
Consequently, it is impossible to say for certain that results shown in figures 3.6 – 3.9 
are as a result of strain alone. For this reason a second injury marker, Thrombomodulin, 
was also investigated. This was hoped to show a more stable secretion and therefore be 
a better representative model for cellular injury resulting from strain.  
Thrombomodulin (TM) is an integral membrane bound glycoprotein, which binds 
thrombin, the final enzyme in the coagulant pathway (Sadler et al., 1997). It is primarily 
used as an injury marker for endothelial cells in vitro (Wolfgang et al., 2003). However, 
it has also shown to be expressed in SMC in culture (Soff et al., 1991; Grinnel et al., 
1991). Work by Feng et al., (1999) show it is also mechanically regulated by cyclic 
strain within SMCs. To assay this protein a Duo Set® ELISA from R&D Systems® was 
used. The samples quantified were the same as those used for the FGF-2 ELISA 
assaying both total cellular TM and secreted TM at the same time points and strain 
regimes. 
In figure 3.10 (A) HAoSMCs subjected to 10% strain at 1Hz for 6 hours showed a 
marked reduction in the levels of secreted TM in the cell culture media compared with 
the static adhesion control. Here, a drop from ~730 pg/ml to ~ 160pg/ml was seen. The 
level goes back to ~ 630 pg/ml at 12 hr, but still remains below that of the static past 24 
hours. It is not until the 48hr time point that the level goes over that of the control, with 
a marked increase seen at 72 hours, 877 pg/ml & 1400 pg/ml respectively. The 72 hour 
strain time point is up nearly two fold that of the static control. To correlate secreted 
TM expression with total cell expression of the protein cell lysates were also analysed 
from the same samples. 
 Figure 3.11 (A) shows an increased level of total cellular TM over the first 12 hours 
from ~ 700pg/ml for the static culture to ~ 1200pg/ml at 12 hours of 10% strain. By 24 
hours of strain the cellular level of TM drops by~ 400pg/ml to ~ 800pg/ml. Levels of 
the protein decrease further at the longer time points of 48hr and 72hr to ~640pg/ml and 
~600pg/ml respectively, dropping just below that of the static adhesion control. 
The higher expression in cellular TM at the 6hr and 12hr time points, matched by a 
reduced level in the culture media, would suggest the cells are switching to a healthier 
phenotype in comparison to cells in static culture. As the strain continues into longer 
time points this expression drops off and levels of TM in the culture media also 
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increase. Chronic exposure of HAoSMCs to 10% strain seems to transition the cell back 
to an unhealthy phenotype as cellular levels of TM are depleted. HAoSMCs strained at 
the lower amplitude of 5%, showed a similar expression profile of TM over the 72 
hours. Secreted levels of TM, figure 3.10 (B), were lower in the first 24 hours than the 
static adhesion control, with the lowest expression again shown following 6 hours 
strain. It is only at the chronic strain time points of 48 and 72 hours that secreted levels 
of TM are higher than those in the static adhesion control. Again TM expression in cell 
lystes had a corresponding profile, with cell reserves of the protein increasing by ~ 
750pg/ml over the first 24 hours to that of the static control. The later chronic strain 
time points show a drop of TM to ~600pg/ml for the 48hr and 620pg/ml for the 72hr. 
This is still an increase on the static sample of ~ 150pg/ml. 
The comparative graphs of 5% and 10%, (figure 3.12 A&B) show an extended 
physiological response is evident in cells subjected to 5% strain, with total cellular 
levels of TM remaining high up until the 24hr time point, after which a drop back to 
static level is seen. The higher levels of cellular TM at 24hr for the 5% strain when 
compared with those of the 10% may suggest the lower strain being closer to the 
physiological pressure found in the arterial system. This is reinforced by the lower 
levels of secreted TM at the 72 hour time point. Correlation between the increases in 
TM secreted into the media and the drop in cellular lysate levels are outlined in figure 
3.13 A&B. 
Thrombomodulin was useful as a secondary injury marker as it is not as readily secreted 
in resting or static cells as compared with FGF-2 which provided a more accurate 
analysis of SMC response to strain. It has also been proven to be a marker of both late 
and early stages of cell injury and necrosis induced by neutrophil derived proteases and 
oxygen radicals (Boehme et al., 2002). What should be noted is the experiment was run 
without a media change. Therefore as the cells are cultured and strained, there is a 
buildup of metabolites in a confined culture well which may have adverse/potent effects 
on the cells themselves, and their response to this may potentiate the effect seen by the 
strain.  
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3.3.2 Impact of Cyclic Strain on SMC Phenotype. 
To investigate if cyclic strain altered VSMC phenotype, three SMC contractile markers 
were selected for analysis of expression. These included smooth muscle α-actin, 
smoothelin and calponin. Both gene and protein expression were assayed for α-actin and 
calponin, only the gene transcript was assayed for smoothelin. The reason for this is that 
smoothelin is almost solely expressed in contractile SMCs and therefore protein 
detection was difficult and unreliable in a cell culture of mixed phenotype. 
As detailed in the introduction, smooth muscle α-actin is ubiquitously expressed in 
SMCs, making up over 40 % of the total cellular protein and is an integral part of the 
SMC cytoskeleton (Fatigati et al., 1984). As the cell moves towards a contractile state, 
expression of this protein increases. SM α-actin is responsible in providing the cell with 
its force generating capabilities. Smoothelin, another constituent of the smooth muscle 
cell cytoskeleton is exclusively expressed in fully differentiated SMC. Smoothelin co-
loacalises with actin stress fibers and is detected at two isoforms on a western blot 
including 59kD and 100 kD. The third contractile protein used in this study, Calponin, 
is a thin filament-associated protein, also implicated in the regulation and modulation of 
smooth muscle contraction. It is capable of binding to actin, calmodulin, troponin C and 
tropomyosin. The interaction of calponin with actin inhibits the actomyosin Mg-ATPase 
activity.  
As before with the injury markers HAoSMCs were exposed to 5% and 10% cyclic 
strain over a time course of 72 hours. Both total RNA and cell lysate for protein were 
extracted from samples at each time point for analysis. Each time point was compared 
relative to control. Initial quantification of mRNA expression of Calponin and α-actin 
show a steady increase with time when exposed to 10% cyclic strain as shown in figure 
3.14 A&B. The Smoothelin transcript shows an increase up to ~24 hours after which 
point a drop in mRNA of this gene is seen, figure 3.14 C. The drop in expression may 
be consequence of this gene’s selective association in only the contractile phenotype. As 
shown with the injury marker, TM, 10% strain at chronic time points appears to cause 
cell injury, therefore this may also revert the cells back to the synthetic phenotype.  
 
 
168 
 
To get a better representation of the cells’ phenotype protein expression of SM α-actin 
and Calponin was also quantified. The protein expression of α-actin shows to be 
increased with both 5% and 10% strain over 72 hours, figures 3.25 & 3.16. However, 
the expression is higher throughout nearly all the time points in HAoSMC exposed to 
5% clearly shown in the comparative graph, figure 3.19 A. Expression of the Calponin 
protein follows a similar profile under the same conditions when exposed to 5% and 
10% strain, figures 3.17 & 3.18. When the effect of 5% and 10% strains are compared, 
figure 3.19 B, the levels of Calponin at 5% strain increase rapidly within 6 hours and 
remain relatively constant throughout the experiment. In comparison, the 10% strain 
shows a more gradual increase in expression of the protein up to 48 hours and then a 
drop at 72 hours. 
It is evident from these contractile markers that cyclic strain at either strain amplitude 
induces a more contractile phenotype within HAoSMCs. At mRNA level both α-actin 
and calponin are increased throughout all the time points with 10% strain compared to 
the static. Smoothelin shows increasing expression up to 12 hours at which point it 
begins to drop back, importantly though even at 72 hours it still remains above the static 
control. As stated the protein expression of α-actin and calponin are also increased at 
both 5% and 10%. However cells exposed to 5% show both a higher and longer 
expression of SM α- actin when compared with the 10% counterpart, figure 3.19A. The 
poor correlation between the mRNA expression and protein expression of α-actin and 
calponin in figure 3.20 (A&B) is not surprising as there are many processes between 
transcription and translation. An excellent review by Vogel and Marcotte et al., (2012) 
highlights the causes of this and also shows as little as 40% correlation can be observed 
in some genes. Factors include; protein stability, the half-life of different proteins can 
vary from minutes to days - whereas the degradation rate of mRNA would be far tighter 
regulated, 2-7hrs for mammalian mRNAs, lower rate of mRNA transcription compared 
to protein translation in mammalian cells, alternative splicing and post translational 
modification. What is important is that the correlation of increased expression in both 
mRNA and protein of the contractile markers, when exposed to strain, is evident. 
Many stimulants such as vasoconstrictors, polypeptide growth factors and extracellular 
matrix have been shown to regulate expression of contractile markers, specifically SM 
α-actin. (Tock et al., 2003). Results in this chapter, however, demonstrate that cyclic 
mechanical strain is a critical regulator of HAoSMC contractile expression. 
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The mechanism by which the contractile protein expression is regulated has been 
associated with numerous pathways including the mitogen activated kinases (MAPK) 
such as c-Jun NH2-terminal kinase (JNK), p38 (Tock et al., 2003) and the extracellular 
signal-regulated kinase (ERK) (Wang et al., 2003). 
 
3.4 Summary and Conclusion 
To summarise this chapter, HAoSMC lineage was confirmed through the use of cell 
specific markers. ECM and coating factor experiments on the xCELLigence revealed 
that the use of poly-d-lysine amino flex plates allowed a strong cell adhesion which 
enabled prolonged cyclic strain time points. However, coating on this amino acid results 
in a push towards the synthetic state of the HAoSMCs as assayed by mRNA expression 
of the contractile markers. As the experiment was to characterise the impact of cyclic 
strain on SMC injury and phenotype, having the cells in a uniform synthetic state at the 
beginning of the study did not bias the results. After quantifying the mRNA and protein 
expression levels, it is clear cyclic strain increases the abundance of these contractile 
phenotype markers. This holds for both 5% and 10% levels of amplitude. However, the 
higher strain, although encouraging a more physiological state initially, appears to 
create a higher degree of cell injury. This is evidenced through the use of injury markers 
FGF-2 and TM. Expression of α-actin is also higher in SMCs exposed to 5% compared 
with 10%.  
Works carried out in this chapter show HAoSMC phenotype may be modulated by 
cyclic strain as assayed by contractile markers. It is also evident that the mechanical 
properties of the strain as well as duration play a pivotal role in cell adaption and 
response to this stimulus. Studies in this chapter looked at amplitude and duration of 
strain only whereas frequency is certainly a key contributor. Greater strain amplitude 
than 10% is also most likely needed to represent a pathological hypertensive model as 
although cell injury was evident through use of TM, the contractile markers still 
remained elevated in cells exposed to 10%. A higher, more pathological 15% was 
attempted using the in vitro model discussed here but resulted in cell rounding and 
detachment. To conclude, haemodynamic force by way of cyclic strain is essential to 
maintain homeostasis within the vasculature yet variation in parameter of this force can 
have pathophysiological consequences. 
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CHAPTER FOUR: Impact of Cyclic Strain on the miRNA Profile of 
HAoSMCs 
4.1 Introduction 
 
Experimental results outlined and discussed in chapter 3 have demonstrated that cyclic 
strain has a direct impact on cultured SMC phenotype and health. This was revealed 
through quantification of injury markers and changes in expression of both contractile 
marker mRNA and protein. To further understand the significance of 
mechanotransduction in the regulation of SMC fate and function, and the molecular 
mechanisms which underpin and ‘fine-tune’ the phenotypic switching phenomena, we 
hypothesised that micro RNA (miRNA) are haemodynamicaly regulated and are 
responsible for cell fate decisions and function.  
In brief, miRNA are canonically generated into short (18-24) nucleotide long non 
coding RNA molecules. They regulate gene expression by hybridising to the 3’ UTR of 
mRNA. This results in either mRNA degradation or translational inhibition depending 
on the complementarity between the strands (V. Ambros et al., 2001).  
There exists a miRNA profile or “miRNome” characteristic or specific for individual 
cell types.  To determine if the miRNome for HAoSMC is altered by cyclic strain, we 
extracted highly pure total RNA from strained lysates and determined the miRNA 
profile with qRT-PCR using Applied Biosystems
®
 Taqman LowDensty Array
©
 cards. 
For a complete profile of miRNA, two microfluidic cards containing a total of 384 
TaqMan® MicroRNA Assays per card were used. In total, this allows accurate 
quantification of 754 human microRNAs. These are deemed the A and B card. The A 
card contains miRNA which have been well documented tending to be functionally 
defined, and are broadly and/or highly expressed. The miRNAs in card B are narrowly 
expressed and/or expressed at low levels and are usually not as well functionally 
defined. 
The data was analysed using both SDS and R statistical analysis software. 
Bioinformatics was carried out on the shortlisted miRNA of greatest differential 
expression. This included putative target prediction involvement of these predicted 
targets in biological processes and finally, pathway analysis. 
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4.1.1 Chapter Hypothesis: 
MicroRNA (miRNA) expression is haemodynamicaly regulated by cyclic strain and as 
a result can influence and modulate cell fate decisions and biological functions.  
4.1.2 Specific aims and Experimental approach: 
The specific aims of this chapter are to show that the miRNA profile in HAoSMCs is 
altered with cyclic strain at a specific time point. In addition, this study aims to 
demonstrate that the haemodynamicaly sensitive miRNA signature plays a role in cell 
motility.  The experimental approach for this chapter was as follows: 
 Temporal study of HAoSMC miRNA profile as the cells were exposed to 10% 
cyclic strain at1Hz over a time course of48hours. 
This experiment had a two-fold output:  
1) Elucidate at what time over the 48 hours of cyclic strain the HAoSMC 
miRNA profile had a significant change. 
2) A priority list was also created containing miRNA which showed a 
linear correaltaion in expression with respect to time during 10% strain. 
 Selection of a time point from the temporal study where a significant shift of the 
miRNA profile was evident and perform biological replicates of strains at 5%, 
10% and static conditions. 
 
 Establish a shortlist from the biological replicates study of the most 
differentially expressed miRNA with an adjusted P value ≤0.005. 
 
 Target determination of shortlisted miRNA. 
 
 Enrichment of Gene Ontology (GO) biological processes using putative 
conserved targets. 
 
 KEGG Pathway analysis of putative targets. 
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4.2 Results 
4.2.1 Temporal 10% strain study on HAoSMC miRNA profile 
4.2.1.1 Hierarchial Cluster Analysis (HCA) 
To determine the effect of cyclic strain on the HAoSMC “miRnome”, cells were 
exposed to 10% cyclic strain over a 48 hour time course. Initial experimental validation 
was to ensure there was significant separation of samples. This was achieved by 
hierarchical cluster analysis (HCA) visualised by the use of dendrograms generated 
from the bioinformatics software as shown in figure 4.1.  A dendrogram is a branching 
diagram used to illustrate the arrangement of clusters produced by hierarchal clustering 
based on degrees of similarity/number of shared characteristics among samples. 
 
 
 
 
 
 
 
A. 
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Figure 4.1 A&B: Dendograms of miRNA profiles following temporal strain study. Hierarchical 
cluster analysis (HCA) of miRNA profiles from HAoSMC. Each cluster represents SMCs 
exposed to 10% cyclic strain at different time points. A) Human miRNA panel A.  B) Human 
miRNA panel B. All data is mean normalised with a PCC ≤ ±0.9 and P≤ 0.05.
B. 
174 
 
4.2.1.2  Two-way heat map miRNA from priority list 
 A two-way heat map comprised of the priority list of miRNA was then constructed for 
the A and B panel of miRNA. This allowed visualization of the global miRNA 
expression profiles across the strain time course, as shown in figure 4.2 A & B. A shift 
in colour from red to green indicates a down regulation of that miRNA detector. Each 
miRNA detector comprising the heat map is listed on the right hand side. Colour key on 
the bottom right shows CT value and corresponding colour. 
 
.     
Static 2 hr  6 hr  12 hr 48 hr 24 hr 
A. 
Color Key 
(Ct) 
) 
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Figure 4.2 A&B: Two-way heat maps of human miRNA panels A&B providing a visual 
representation of miRNA profile of HAoSMCs exposed to 10% cyclic strain. Samples were 
taken were over a time course of 48 hours of cyclic strain and included a static sample and 
samples at 2hr, 6hr, 12hr, 24hr, and 48hr of strain. Heat-maps were comprised of the priority list 
of miRNA elucidated following bioinformatics on the HAoSMC miRNA profiles. All data is 
mean normalized, PCC ≤ ±0.9, P≤ 0.05. 
48 hr 24 hr 12 hr 6 hr  2 hr  Static 
Color Key 
B. 
(Ct) 
) 
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3.2.1.3 Correlated miRNA  
To deduce if any miRNA showed a linear relationship of expression between time and 
10% cyclic strain, a Pearson Correlation Coefficient (PCC) was generated for each 
miRNA. From this a priority list, made up solely of miRNA which had a PCC of ≤ -0.9 
and a P value of ≤ 0.05, was created. miRNA with the strongest correlation were 
graphically represented. Figure 4.3 (A-C) shows miRNA from the A panel which had a 
PCC of ≤ -0.9 and a P≤ 0.05. 
 
   
 
 
Figure 4.3 A, B & C: miRNA Down Regulated with 10% cyclic strain. Shows plotted 
miRNA from A card panel which showed the strongest linear relationship of expression 
between time and 10% strain. CT values were multiplied by -1 to ensure decreasing value 
indicated decreasing expression. PCC ≥ 0.9 or ≤ -0.9, P≤ 0.05.  
A. B. 
C. 
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miRNA from the B card panel which also made the priority list and showed the 
strongest PCC (PCC of ≤ -0.9 and a P value of ≤ 0.05) are graphically shown in figure 
4.4 A & B.  
 
 
 
Figure 4.4 A & B: miRNA Down Regulated with 10% cyclic strain. Shows miRNA from B 
card panel which showed the strongest linear relationship of expression between time and 10% 
strain. CT values were multiplied by -1 to ensure decreasing value indicated decreasing 
expression. PCC ≥ 0.9 or ≤ -0.9, P≤ 0.05. 
 
 
 
 
B. 
A. 
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Of all the published miRNA which have been cited to be involved in regulating SMC 
biology only miR-1 showed a PCC ≥ 0.9 or ≤ -0.9, P Value ≤ 0.05 as shown in figure 
4.5 A. However the expression of miRNA clusters miR-143/miR-145 and miR-
221/miR-222, which are known to influence SMC differentiation, are also shown in 
figure 4.5 B & C. These fell outside the criteria for the priority list but as their 
expression reflects SMC phenotype they have been graphed to evaluate the impact of 
cyclic strain on phenotypic modulation in the discussion.  
 
 
 
 
 
Figure 4.5 A, B & C: Expression of Published miRNA involved in SMC biology with 10% 
cyclic strain. A. Expression plot of miR-1 part of the priority list incorporating a PCC of ≥ 0.9 
or ≤ -0.9, P Value ≤ 0.05. B. Expression of VSMC phenotype marker miR-143/145 cluster C. 
Expression of miR-221/222 cluster with 10% cyclic strain.  
B. 
A. 
C. 
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4.2.1.4 Bioinformatic analysis on priority miRNA from temporal 10% strain study 
To extrapolate biological meaning from the priority list, bioinformatics was performed 
on miRNA which showed the strongest PCC. These miRNA were from both the A and 
B card panel. This involved determination of putative targets using Targetscan. 
Following this, involvement of these targets in gene ontology (GO) biological processes 
and pathways of interest from the Kyoto Encyclopedia of Genes and Genomes (KEGG) 
were analysed using DAVID bioinformatics database. To help visualise the regulatory 
potential of each short listed miRNA a table was constructed; this illustrates the number 
of potential genes the miRNA could target, the number of GO biological processes 
these potential targets were involved in and finally the number of KEGG pathways the 
predicted targets were part of. 
Table 4.1: Bioinformatics of strain regulated miRNA. Table composed of miRNA regulated 
by 10% cyclic strain from A and B panel which have the strongest PCC (≥ 0.9 or ≤ -0.9) with a 
P value ≤ 0.05. Table shows the number of in silico predicted Conserved Targets of each 
miRNA along with the number of GO Biological processes and KEGG Pathways these targets 
are involved in. 
  
Detector 
Conserved 
Targets 
Biological Processes Pathways 
Published miRNA involved in  VSMC biology 
miR-1 860 333 34 
A Card miRNA 
miR-125a 222 102 16 
miR-211 669 309 22 
miR-328 207 73 6 
miR-409 142 59 2 
miR-431 166 24 4 
miR-452 338 163 14 
miR-518d 35 35 1 
miR-518f 35 35 1 
miR-520b 844 296 29 
B Card miRNA 
miR-7 444 182 22 
miR-497 1273 454 46 
miR-628-3p 112 25 5 
miR-641 535 227 18 
miR-656 726 341 30 
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Table 4.2: Bioinformatics of strain regulated miRNA. This table shows KEGG pathways 
which are involved in cell motility and migration. Strain regulated miRNA from the priority list 
which had in silico predicted conserved targets within these pathways are also shown. All 
miRNA involved hold a PCC of  (≥ 0.9 or ≤ -0.9) with a P Value ≤0.05. 
 
 
 
 
 
 
 
MAPK Signalling Pathway Focal Adhesion Regulation of Actin Cyto Skeleton 
Down Regulated miRNA Down Regulated miRNA Published VSMC miRNA 
miR-1 miR-1 miR-1 
miR-211 miR-211 miR-520b 
miR-328 miR-7 miR-7 
miR-520b miR-497 miR-497 
miR- miR-656  
miR-497   
miR-641   
miR-656   
Cell Cycle Wnt Signalling Adherens Junction 
Down Regulated miRNA Down Regulated miRNA DownRegulated miRNA 
miR-497 miR-1 miR—1 
 miR-211 miR-211 
 miR-328 miR-328 
 miR-520b miR-431 
 miR-641 miR-497 
 miR-656 miR-641 
VEGF p53 Signalling Pathway miR-656 
Down Regulated miRNA Down Regulated miRNA  
miR-497 miR-497  
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4.2.2 Investigation of strain amplitude on miRNA profile (biological replicates) 
4.2.2.1 Hierarchial Cluster Analysis (HCA) 
To assess if strain amplitude had any effect on the HAoSMC miRNA profile, cells 
exposed to 10% and 5% cyclic strain for 24 hours were compared against each other 
and to the profile of SMCs under static adhesion conditions. Biological triplicates were 
performed for each of these conditions. Only miRNA which had an adjusted P value of 
≤ 0.05 were retained to make up the priority lists for each strain comparison. In total 
there were three priority lists generated for each strain comparison namely 10% vs. 5%, 
10% vs. static and 5% vs. static at the 24 hour time point.  Initial experiment validation 
consisted of HCA of the biological replicates and strain conditions schematically shown 
in figure 4.6. 
 
Figure 4.6: Dendogram of miRNA profiles from biological replicates. HCA of biological 
replicates of SMCs exposed to static, 5% and 10% cyclic strain at a 24 hour time point. 
Biological replicates are shown to cluster with the highest separation seen between 10% strain 
and 5% or static adhesion, thus validating the experiment. n=3, all data has been mean 
normalized, adjusted P≤ 0.05. 
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4.2.2.2 Venn Diagram of commonly expressed miRNA across strain parameters 
The number of miRNA which make up the priority list for each strain comparrison 
(10% vs 5%, 10% vs static and 5% vs static), for both the A and B cards were illustrated 
using venn diagrams. This allowed visualisation of the numbers of miRNA unique to a 
certain strain comparison as well as those common between strain comparisons. Total 
numbers of miRNA from the A panel across all strain comparisons are shown in Figure 
4.7(A), these are irrespective of direction of expression. While direction of expression 
of miRNA from the A panel are shown in figure 4.7 (B).  
            
 
Figure 4.7: Venn Diagrams of strain sensitive miRNA from A panel. (A)- Number of unique 
and common miRNA between strain comparisons with no direction of expression from A card. 
(B)- Shows the number of up (red) and down regulated (green) miRNA expression in each 
strain comparison priority list as well as showing where they are common across comparisons.  
A. 
B. 
183 
 
Similarly, figure 4.8 (A & B) show miRNA from the B panel across all strain 
comparisons without and with direction of expression respectively. 
 
 
           
 
 
 
Figure 4.8: Venn Diagrams of strain sensitive miRNA from B panel. (A)- Number of unique 
and common miRNA between strain comparisons with no direction of expression from B card. 
(B)- Shows the number of up (red) and down regulated (green) miRNA expression in each 
strain comparison priority list as well as showing where they are common across comparisons.  
A. 
B. 
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4.2.2.3 Bioinformatic analysis on priority miRNA from strain amplitude investigations 
 
The next stage of bioinformatics consisted of determining the putative targets of each of 
the top most differentially expressed miRNA making up the priority lists. As before 
with the temporal study, these were downloaded using TargetScan. The gene lists 
generated from TargetScan were then inputted into DAVID online bioinformatics 
database. From here a full profile of gene ontology (GO) biological processes was 
retrieved for each gene list. As well as this the involvement of the gene list in cellular 
pathways was determined using KEGG pathways. A bioinformatics profile for each 
miRNA was then constructed. This included adjusted P values, fold change, number of 
conserved targets as well as the number of GO biological processes and the number of 
KEGG pathways in which the generated gene lists were involved. These were then 
tabulated for each priority list and separated into miRNA from the A and B panel as 
well as miRNA which have been published to be involved in SMC biology. These are 
shown in tables 4.3- 4.5.  The priority list generated from this study was used for the 
reminder of the work in this chapter. 
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Table 4.3: - Short list of most regulated VSMC miRNA in the priority list from the 10% vs. 5% strain 
comparison. The table is segmented into three sections: Top- miRNA present on A card both up and 
down regulated, Middle- miRNA present on B card both up and down regulated, Bottom- published 
VSMC miRNA regulated by strain present on either A or B card. Table shows fold change, adjusted P 
value and the number of in silico predicted Conserved Targets, GO Biological processes and KEGG 
pathways (n=3, Adjusted P≤ 0.05).  
  
miRNA 
Adjusted P 
Value 
(≤0.05) 
Fold 
Change 
Conserved 
Targets 
(GO) 
Biological 
Processes 
(KEGG) 
Pathways 
10% vs. 5% miRNA from A Card 
hsa-miR-618 5.60E-06 185159.4936 189 122 3 
hsa-miR-888 9.50E-07 8756.723011 381 107 15 
hsa-miR-375 0.000497404 2834.577507 229 130 3 
ath-miR159a 0.000209385 826.0306185 —— —— —— 
hsa-miR-10a 0.014714407 5.124942484 271 124 9 
hsa-miR-520e 0.009835236 4.572522715 844 296 29 
hsa-miR-210 0.008659358 0.101373098 32 5 0 
hsa-miR-148a 0.014714407 0.092054363 698 323 25 
hsa-miR-18b 0.01326892 0.091878459 275 145 4 
hsa-miR-331-5p 0.026675902 0.087811808 125 39 5 
hsa-miR-654-5p 0.009363792 0.047257528 172 21 1 
hsa-miR-496 0.008558878 0.02884925 128 60 1 
hsa-miR-485-5p 0.031370758 0.016991582 376 82 8 
hsa-miR-887 0.014714407 0.015578802 10 0 0 
hsa-miR-302a 0.027646841 0.013014899 844 296 29 
hsa-miR-501-3p 0.006821052 0.007958486 223 118 17 
hsa-miR-518f 0.000209385 1.66E-05 35 35 1 
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miRNA 
Adjusted P 
Value 
(≤0.05) Fold Change 
Conserved 
Targets 
(GO) Biological 
Processes 
(KEGG) 
Pathways 
10% vs. 5% miRNA from B Card 
hsa-miR-520c-3p 5.09E-05 150.2434709 844 296 29 
hsa-miR-610 0.006143201 121.0558387 265 35 3 
hsa-miR-564 0.011041923 118.5591669 25 31 7 
hsa-miR-513-3p 0.016115292 45.80254895 —— —— —— 
hsa-let-7f-2* 0.018066858 40.78959924 —— —— —— 
hsa-miR-661 0.011917494 39.21246247 319 71 5 
hsa-miR-509-3p 0.011917494 31.53671093 143 87 3 
hsa-miR-939 0.011917494 26.29849576 178 84 2 
hsa-miR-516a-3p 0.011917494 24.26700534 384 175 19 
hsa-miR-144* 0.018353118 20.4691761 —— —— —— 
miRNA 
Adjusted P 
Value 
(≤0.05) Fold Change 
Conserved 
Targets 
(GO) Biological 
Processes 
(KEGG) 
Pathways 
10% vs. 5% Published miRNA known to be involved in SMC biology 
hsa-miR-29b 0.035749209 0.343665259 1078 207 27 
hsa-miR-221 0.046262844 0.296324793 446 243 24 
hsa-miR-21 0.023204853 0.270429603 307 230 14 
hsa-miR-222 0.032855765 0.259303271 446 243 24 
hsa-miR-24 0.042161061 0.243385449 631 127 20 
hsa-miR-29a 0.011962396 0.186311116 1078 207 27 
hsa-miR-143 0.023204853 0.178962246 404 211 29 
hsa-miR-145 0.010960162 0.151332141 731 265 21 
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Table 4.4: Shortlist of most regulated VSMC miRNA in the priority list from the 10% vs. static 
strain comparison. The table is segmented into three sections: Top- miRNA present on A card 
both up and down regulated, Middle- miRNA present on B card both up and down regulated, 
Bottom- published VSMC miRNA regulated by strain present on either A or B card. Table 
shows fold change, adjusted P value and the number of in silico predicted Conserved Targets, 
GO Biological processes and KEGG pathways (n=3, Adjusted P≤ 0.05).  
 
 
 
 
 
 
10% vs. Static 
 
miRNA 
Adjusted P 
Value 
(≤0.05) 
Fold 
Change 
Conserved 
Targets 
(GO) 
Biological 
Processes 
(KEGG) 
Pathways 
10% vs. Static miRNA from A Card 
hsa-miR-618 2.68E-05 20297.03377 189 122 3 
hsa-miR-375 0.000238093 8387.503833 229 130 3 
hsa-miR-888 1.22E-05 703.0431092 381 107 15 
hsa-miR-150 0.043245376 140.5210172 275 139 18 
ath-miR159a 0.008146783 42.92528172 —— —— —— 
hsa-miR-520e 0.028916724 3.214904647 844 296 29 
hsa-miR-331-5p 0.02176625 0.047716335 125 39 5 
hsa-miR-373 0.019658174 0.043471724 844 296 29 
hsa-miR-496 0.008761138 0.031264892 128 60 1 
hsa-miR-302a 0.043322822 0.021076178 844 296 29 
hsa-miR-518b 0.018002544 0.017848513 35 35 1 
hsa-miR-198 0.022961614 0.01748052 301 59 5 
hsa-miR-520g 0.00097034 0.016112709 579 226 20 
10% vs. Static miRNA from B Card 
hsa-miR-23b* 0.014374153 136.408586 —— —— —— 
hsa-miR-744* 0.024862359 99.59164036 —— —— —— 
hsa-miR-520c-3p 0.014374153 9.449622002 844 296 —— 
10% vs. Static Published miRNA known to be involved in SMC biology  
hsa-miR-21 0.033745284 0.313905747 307 230 14 
hsa-miR-145 0.037765728 0.273919236 731 265 21 
hsa-miR-29b 0.022764928 0.237994414 1078 207 27 
hsa-miR-29a 0.022764928 0.213721706 1078 207 27 
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Table 4.5: Shortlist of most regulated VSMC miRNA in the priority list from the 5% vs. static 
strain comparison. The table is segmented into three sections: Top- miRNA present on A card 
both up and down regulated, Middle- miRNA present on B card both up and down regulated, 
Bottom- published VSMC miRNA regulated by strain present on either A or B card. Table 
shows fold change, adjusted P value and the number of in silico predicted Conserved Targets, 
GO Biological processes and KEGG pathways (Adjusted P. value ≤ 0.05).  
 
5% vs. Static 
 
 
 
 
 
 
 
 
 
 
 
 
 
miRNA 
Adjusted P 
Value 
(≤0.05) 
Fold 
Change 
Conserved 
Targets 
(GO) 
Biological 
Processes 
(KEGG) 
Pathways 
hsa-miR-888 0.008414117 0.080286097 381 107 15 
hsa-miR-520g 0.004300767 0.015052375 579 226 20 
Strain  Regulated miRNA (5% vs. Static B Card) 
hsa-miR-23b* 0.023049829 97.83123344 —— —— —— 
hsa-miR-596 0.035618543 0.142214688 129 60 5 
hsa-miR-520c-3p 0.003873384 0.062895392 844 296 29 
hsa-miR-610 0.035618543 0.03407928 165 35 3 
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4.2.2.4 Cellular pathways analysis 
In table 4.6, the miRNA were categorised on the basis of their potential involvement in 
key cellular pathways involved in cell motility the direction of change in their 
expression (up regulation or down regulation) is indicated by the arrow. 
Table 4.6: Table of KEGG pathways of interest which contain in silico predicted conserved 
targets of strain regulated miRNA. Table shows pathway name with the strain conditon that 
regulated the specific miRNA , 10% Vs 3%, 3% Vs Static or 10% Vs static. Arrows show 
expression change of miRNA with strain, up or down regulated. 
 
 
 
 
 
Focal Adhesion 
Regulation of Actin 
Cytoskeleton 
Vascular Smooth Muscle 
Contraction 
10% vs. 5% 10% vs. 5% 10% vs. 5% 
hsa-miR-520e ↑ hsa-miR-520e ↑ hsa-miR-610↑ 
hsa-miR-148a ↓ hsa-miR-485-5p ↓ has-miR-661↑ 
hsa-miR-520c-3p ↑ hsa-miR-520c-3p ↑ 10% vs. Static 
10% vs. Static hsa-miR-610 ↑ hsa-miR-96 ↓ 
hsa-miR-373 ↓ 10% vs. Static 5% vs. Static 
hsa-miR-522 ↓ hsa-miR-373 ↓ hsa-miR-610↓ 
hsa-miR-96 ↓ hsa-miR-96 ↓  
hsa-miR-520c-3p ↑ hsa-miR-520e ↑  
hsa-miR-520e ↑ hsa-miR-520c-3p ↑  
5% vs. Static 5% vs. Static  
hsa-miR-520c-3p ↓ hsa-miR-610 ↓  
 hsa-miR-520c-3p ↓  
Cell cycle Adherens Junction ECM Receptor Interaction 
10% vs. 5% 10% vs. 5% 10% vs. 5% 
hsa-miR-520e ↑ hsa-miR-10a ↑ hsa-miR-148a ↓ 
hsa-miR-18b ↓ hsa-miR-485-5p ↓  
hsa-miR-520c-3p ↑ hsa-miR-501-3p ↓  
10% vs. Static hsa-miR-96 ↓  
hsa-miR-373 ↓ hsa-miR-509-3p ↑  
hsa-miR-520e ↑   
hsa-miR-520c-3p ↑   
5% vs. Static   
hsa-miR-520c-3p ↓   
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Maps of key pathways involved in cell motility and migration, figure 4.9 – 4.14, were 
downloaded from the KEGG database using DAVID. Genes within the pathways which 
were predicted targets for the short listed miRNA were circled. Gene which were 
potential targets for multiple miRNA were circled in blue, genes which were targets for 
a single miRNA were circled in red and genes which were predicted targets for miRNA 
known to be involved in SMC biology were circled in yellow. 
4.2.2.4.1 Focal Adhesion 
 
Figure 4.9: KEGG map of Focal Adhesion signaling pathway. Genes circled in red are 
predicted targets for an individual miRNA. Genes circled in blue are predicted targets of 
multiple miRNA. Genes circled in yellow are predicted targets of published and verified 
miRNA involved in VSMC function. These may also be predicted targets of multiple novel 
miRNA along with published miRNA data. 
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The predicted targets for an individual miRNA, taken from the priority list, involved in 
each of the key pathways in cell motility were tabulated in tables 4.7-4.12. 
Table 4.7: Mechano-sensitive miRNA involved in the Focal Adhesion signaling pathway and 
their predicted targets. 
. 
 
 
miR-520e miR-373 miR-96 miR-522  
miR-
148 
miR-520c-
3P miR-221/222 miR-24 
ECM ECM ECM Sos ECM ECM ECM ECM 
ITGB ITGB PI3K Cyc D ITGB ITGB ITGA ITGA 
PI3K PI3K Sos MLCP PI3K PI3K ITGB PKC 
GF GF Crk PDK1 GF GF PI3K PI3K 
Sos Sos Cyc D c-Jun Sos Sos CrK Vav 
Crk Crk PAK RTK MLCP Crk PAK PAK 
Akt/PKB Akt/PKB MLCP Shc ITGA Akt/PKB JNK GSK/3β 
MLCK MLCK Vinculin Grb2 Caveolin Cyc D GF mDial  
Cyc D Cyc D RAC Bcl-2 PTEN PAK RTK  
PAK PAK Fyn  Vav    
  DOCK1      
  RTK      
  Shc      
  Grb2      
  MEK1      
  Ciaps      
  Bcl-2      
miR-143 miR-145 miR-29 
ECM ITGB ECM 
ITGA Caveolin ITGA 
ITGB RhoGAP ITGB 
RTK Filamin Vinculin 
Bcl-2 Talin Akt/PKB 
ERK1/2 Paxillin GSK/3β 
 Parvin Caveolin 
 ROCK PI3K 
  CycD 
  JNK 
  GF 
  RTK 
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4.2.2.4.2 Regulation of Actin Cytoskeleton 
 
 
Figure 4.10: KEGG map of the Regulation of Actin Cytoskeleton pathway. Genes circled in red 
are predicted targets for an individual miRNA. Genes circled in blue are predicted targets of 
multiple miRNA. Genes circled in yellow are predicted targets of published and verified 
miRNA involved in VSMC function. These may also be predicted targets of multiple novel 
miRNA along with published miRNA data. 
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Table 4.8: Mechano-sensitive miRNA involved in the Regulation of Actin Cytoskeleton 
pathway and their predicted targets. 
 
 
 
 
miR-520e miR-373 
miR-485-
5p 
miR- 520c-
3p miR-96 miR-610 
miR-
143 miR-222 
GF GF ITG GF GF GF GF GF 
ITG ITG IRSp53 ITG RTK Gα 12, 13 RTK ITG 
Sos GBγ F-Actin Sos Sos WAVE2 ITG CrkII 
GBγ Crk II PAK GBγ RAS PFN Ras PI3K 
Crk II PI3K PFN Crk II Gα 12, 13 MLCK ERK PIX 
PI3K Vav/Tiam2 SSH PI3K PI3K  RhoGEF PAK 
Vav/Tiam1 APC  Vav/Tiam1 Vav/Tiam2  LIMK WAVE2 
APC PIX  APC Dock 180  SSH  
PIX Abi2  PIX Crk II    
Abi2 PFN  PAK GBγ    
PFN PAK  PFN MEK    
PAK ERM  Abi2 Rho GEF    
ERM MLCK  ERM Rac    
MLCK PI4P5K  MLCK PIX    
PI4P5K CFN  PI4P5K PAK    
CFN   PFN Abi2    
   CFN PFN    
    WAVE2    
mIR-21 miR-24 
GF GF 
ITG ITG 
GBγ IQGAP 
PI3K PI3K 
Vav/Tiam2 LIMK 
RhoGEF GIT1 
PI4P5K RTK 
VCL c-Src 
 Vav/Tiam2 
 PAK 
 mDia 
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4.2.2.4.3 Vascular Smooth Muscle Contraction 
 
Figure 4.11: KEGG map of Vascular Smooth Muscle Cell Contraction pathway. Genes circled 
in red are predicted targets for an individual miRNA. Genes circled in blue are predicted targets 
of multiple miRNA.  
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Table 4.9: Mechano-sensitive miRNA involved in the Vascular Smooth Muscle Cell 
Contraction pathway and their predicted targets. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
miR-610 miR-661 miR-96 
IP3R CaM VOC 
Gα12/13 pla EDNRA 
IRAG IRAG IP3R 
MLCK AC Gαq/11 
  PLC 
  PKC 
  MEK 
  MLCP 
  AC 
  Gα12/13 
  RhoGEF 
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4.2.2.4.4 Cell Cycle 
 
 
Figure 4.12: KEGG map of Cell Cycle pathway. Genes circled in red are predicted targets for 
an individual miRNA. Genes circled in blue are predicted targets of multiple miRNA. Genes 
circled in yellow are predicted targets of published and verified miRNA involved in VSMC 
function. These may also be predicted targets of multiple novel miRNA along with published 
miRNA data. 
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Table 4.10: Mechano-sensitive miRNA involved in the Cell Cycle pathway and their predicted 
targets. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
miR-520e miR-18b miR-373 miR-520c-3p 
p107 Smad 2,3 p107 p107 
E2F4,5 ATI MATR E2F4,5 E2F4,5 
Smad 2,3 14, 3-3 
Smad 
2,3 Smacl2,3 
APC/C Cyc-D APC/C APC/C 
Cdc25A CDK2 Cdc25A Cdc25A 
CDK2  CycD CycD 
CycD  p107,130 CDK2 
P107/130  MCM p107/130 
E2F 1,2,3  Wee MCM 
MCM  CDK2 Wee 
Wee   E2F4,5 
   E2F1,2,3 
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4.2.2.4.5 Adherens Junction 
 
Figure 4.13: KEGG map of adherens junction pathway. Genes circled in red are predicted targets 
for an individual miRNA. Genes circled in blue are predicted targets of multiple miRNA. Genes 
circled in yellow are predicted targets of published and verified miRNA involved in VSMC 
function. These may also be predicted targets of multiple novel miRNA along with published 
miRNA data. 
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Table 4.11: Mechano-sensitive miRNA involved in the Adherens Junction pathway and their 
predicted targets. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
miR-509-3p miR-501-3p miR-485-5p miR-96 miR-10a 
Rac/cdc42 Nectin Ponsin Nectin Actin 
Rac α-actinin CKII Pl20ctn ADIP 
TCF/LEF LAR Actin Rac/cdc42 Smad3 
Smad3  TCF/LEF Vinculin  
  IRSp53 Wave  
   Rac  
   TCF/LEF  
   IGF-1R  
   Yes  
   Fyn  
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4.2.2.4.6 ECM-Receptor Interaction 
 
Figure 4.14: KEGG map of Extracellular Matrix Receptor Interaction pathway. Genes circled 
in red are predicted targets for an individual miRNA. Genes circled in blue are predicted targets 
of multiple miRNA. Genes circled in yellow are predicted targets of published and verified 
miRNA involved in VSMC function. These may also be predicted targets of multiple novel 
miRNA along with published miRNA data. 
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Table 4.12: Mechano-sensitive miRNA involved in the ECM-Receptor Interaction signaling 
pathway and their predicted targets. 
 
 
 
 
 
 
 
  
miR-143 miR-221/222 miR-29 miR-148a 
Collagen β8 Collagen Collagen 
α6 β3 Laminin Laminin 
β8 CD47 β1 Tenascin 
CD44 THBS Perlecan α5 
Syndecam  α6 α9 
SV2  α11 α11 
   β8 
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4.3 Discussion 
Since their discovery (R.C. Lee et al., 1993; B Wightman et al., 1993), miRNA have 
become recognised as one of the key regulators of gene expression during both normal 
physiological conditions and in disease states. They are short ~22nt non-coding RNA 
which cause post transcriptional modification by binding to the 3’UTR of their target 
mRNA. Here, the mRNA either undergoes degradation or translational suppression 
depending on complementarity between the bases of the miRNA and the gene.  
With ~ 30,000 estimated genes encoded by the human genome and only ~ 1,000 
miRNA to regulate them, it is clear that one miRNA may regulate hundreds of mRNA. 
For this reason, miRNA expression signatures can be rich in biological information, 
especially pertaining to either pathological or disease states. The hundreds of mRNA 
involved in the fate of cells may only be regulated by a handful of miRNA. These non-
coding RNA can also be quantified and qualified with a much greater sensitivity than 
proteins.  
To date, miRNA profiling has been used in developmental biology whereby comparing 
miRNA profiles at different tissue development stages in organisms can highlight which 
miRNA are involved in tissue development and cell differentiation (E. Wienholds et al., 
2005 Alvarez-Garcia et al., 2005). Their most prevalent use, however, is as biomarkers 
or bio-indicators for disease. Comparative profiling of miRNA in disease and healthy 
states can yield certain expression profiles that may be characteristic of disease states 
and as a result, coined terms such as “angiomiRs” in angiogensis (S. Wang et al., 2009) 
and “metastamiRs” for miRNA involved in metastasis (D.R. Hurst., et al 2009) have 
been developed. 
The current existing and accepted biological paradigm is that there exists a “miRnome” 
within a cell, a group of miRNA characteristic to that cell type.  The SMC, and in 
particular the VSMC miRnome has been well characterised. For example, miR- 143 and 
miR-145 exist as a cluster with their expression being directly related to the phenotype 
of VSMC by targeting Krupel Like factor 4 (KLF4). Increased expression of this cluster 
corresponds with a more contractile phenotype, while the opposite is representative of a 
synthetic SMC (W. Sessa et al., 2010). miR-26a has also shown to be a moderator of 
VSMC phenotype (N. J. Leeper et al., 2010). The cluster of miR- 221 and miR- 222 has 
also been implemented in SMC functions such as proliferation (X. Lin et al., 2010) and 
even SMC calcification (N. Mackenzie et al., 2013). 
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However, work into the effect of mechanical stimulus such as shear stress or cyclic 
strain on miRNA is very novel and only a handful have been identified, such as miR-
365 (Y.J. Guan et al., 2011) or miR-26a (J. Shaik et al., 2010). Work in this chapter was 
carried out to identify a panel of mechanically (bio-mechanotransduction) regulated 
miRNA. 
4.3.1 Temporal 10% strain study on HAoSMC miRNA profile 
The initial experiment was to try and establish at what time point the miRNA profile of 
HAoSMC changed most significantly as a result of cyclic strain. Firstly, cells were 
exposed to a 10% strain at 1Hz over a 48 hour time course. Total RNA was extracted as 
described in methods chapter2 section 2.2.5 at time points of 0, 2, 6, 12, 24 and 48 
hours. The total RNA was reverse transcribed to cDNA using the miRNA specific 
primers as described in section 2.2.7. For a full miRNA profile of the cells both A and B 
human miRNA panels were used for each time point of strain, these utilised qRT- PCR 
(section. 2.2.7.4).  
4.3.1.1 Data Analysis and Normalisation  
Initial raw data analysis consisted of extrapolating average delta (∆ CT values from the 
profiling and entering them into R statistical analysis software. The data was then mean 
normalised, which involved removal of all endogenous controls, such as small nuclear 
RNA. The global measure of miRNA expression was then used as the normalising 
factor. This method of normalisation is based on the assumption that although specific 
miRNA may alter expression across samples as a result of experimental condition or 
stimulus, the overall expression pattern of miRNA is invariable and thus can be used as 
a normalising factor. This method has been shown to outperform other methods such as 
use of endogenous small nuclear RNA, in terms of better reduction of technical variance 
and more accurate appreciation of biological changes (P. Mestdagh et al., 2009; D. 
Risso et al., 2009; D. Wylie et al., 2011). 
The temporal study had a twofold purpose, firstly to establish at what time, if any, the 
miRNA profile of HAoSMC changed when exposed to 10% cyclic strain at 1Hz, and 
secondly to see if any miRNA showed a linear relationship between expression and time 
with 10% strain. 
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The first stage of experiment validation was to determine if there was a significant 
separation of the time point samples and this was demonstrated using hierarchical 
cluster analysis (HCA) on a dendogram, figure 4.1. This revealed a high degree of 
similarity between the profiles of static, 2 hour and 6 hour strain samples. A noticeable 
difference in the miRNA profile expression was not evident until the 12 hour strain time 
point. However, the later time points of 24 and 48 hours proved to have the highest 
degree of separation indicating HAoSMCs strained at 10% for these time points had a 
very different miRNA profile than cells in static culture or cells strained for short 
periods of time.  
Next, the linear expression of miRNA exposed to strain in respect to time was deduced 
by calculating the pearson correlation coefficient (PCC). It was also possible to generate 
a P value for each miRNA using this correlation coefficient. This allowed a priority list 
to be created made up of miRNA with a strong correlation (≥ 0.9 or ≤ -0.9) and a P. 
value of ≤ 0.05. 
This priority list was then used to formulate two way heat maps for miRNA from the A 
and B panel (figure 4.2 A and B). This enabled visualisation of the miRNA profile over 
the time course. A decrease in miRNA expression was represented by a change in color 
from red to green while similarly an up regulated miRNA is represented by a change 
from green to red. Similar to the HCA in figure 4.1, the heat map demonstrated that 
within the first 6 hours of cyclic strain at 10%, the miRNA expression was mostly 
similar. However, after 12 hours of strain the miRNA expression begins to diverge and 
by 24 and 48 hours an extensive profile change was observed with the majority of 
miRNA being down regulated. 
As stated in the introduction miRNA have been shown to be heavily involved in 
supplying robustness to many diverse biological pathways via feed forward and 
feedback loop mechanisms (M.S. Ebert et al., 2012). It is this level of robustness which 
allows cells to maintain normal cellular activity during an acute phase of distress or 
stimulus. This is examplified by the largely unchanged miRNA profile of HAoSMCs 
during the initial 12 hours of cyclic strain in this study. Similarly following chronic 
changes to the cellular environment it is imperative a molecular response is initated 
such as the significant miRNA profile expression change seen at the 24 hour stage of 
cyclic strain.  
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 A selection of correlated miRNA from the heat map which had the strongest PCC was 
graphed in figures 4.3-4.5. Most of these miRNA are quite novel and only a limited 
number have been previously characterised and published with even less being 
associated with vascular biology.  
However, one of the novel miRNA, miR-409, was shown to inhibit cell proliferation 
and vascularization by targeting angiogenin, an angiogenic factor, in a fibrosarcoma 
HT1080 cell line (C. Weng et al., 2012). Another group showed caveolin-3, a protein 
responsible for regulating ion channels in the heart, to be a target of miR-328. They 
found that low expression of this protein coincided with high expression of the miRNA 
in rat and human tissues with atrial fibrillation, the most common cardiac arrhythmia 
(Y. J. Lu et al., 2008).  
Figure 4.4 A and B show miRNA which had the greatest PCC from the B panel, and 
again these miRNA are largely unpublished. miR-7 was shown to be differentially 
expressed in embryonic  stem cell differentiation (H. Chen et al., 2010). miR-628 has 
been associated with both leukemic and normal hematopoiesis (A.J. Favreau et al., 
2011). The most published microRNA from the down regulated B panel was miR-497. 
Down regulation of this miRNA was shown to promote tumor growth and angiogenesis 
in small lung cancer (W. Zhao et al., 2013). 
Figure 4.5 A illustrates miR-1, which is the only microRNA in the priority list known to 
be involved in VSMCs. Increasing expression of miR-1 was shown in differentiation of 
embryonic stem cells (ESC) to SMC. A down-regulation of this miRNA in SMCs was 
also shown to coincide with a reduction in SMC lineage markers (C Xie et al., 2011). 
Contradictory to this work, however, Y. Jiang et al., (2010) demonstrated myocardin 
induces miR-1 expression, which represses the expression of contractile proteins and 
thereby inhibits the contractility of SMCs. This suggested miR-1 plays a role in the 
negative feedback loop in the regulation of contractility induced by myocardin. 
Studies by Jiang et al., (2010) would suggest that the decreased expression of miR-1 
found in figure 4.5 (A) dictates a more contractile phenotype in the cells. This correlates 
to findings in chapter 3 which show that cyclic strain can shift VSMC phenotype to a 
more contractile state as represented by the increase in expression of the contractile 
marker mRNA and protein.  This has been attributed to myocardin induced expression 
of miR-1 which in turn inhibits expression of contractile proteins working as a negative 
feedback loop.  
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Figures 4.5 (B and C) show graphed expression of two miRNA clusters, namely miR-
143/miR-145 and miR-221/miR-222 which both failed to meet the criteria for the 
priority list. However, their expression was graphed as both of these clusters have been 
associated with VSMC differentiation. miR-143/miR-145 originate from the same 
transcriptional unit and are renowned for their crucial role in SMC differentiation and 
vascular pathogenesis (Elia et al., 2009, W. Sessa et al., 2010). 
Both miR-221 and miR-222 are clustered in close proximity on the Xp11.3 
chromosome (Altuvia et al., 2005; Calin et al., 2004).  In VSMCs, miR-221/222 
mediated down-regulation of c-kit reduces the expression level of myocardin which in 
turn suppresses smooth muscle cell differentiation by inhibition of smooth muscle 
specific contractile marker gene transcription (Davis et al., 2009). The fact that the 
expression of this cluster is down regulated over the time course of strain again 
heightens the fact cyclic strain induces a more contractile state within the cells.  
In contrast, the miR- 143/miR-145 cluster was also down regulated with strain which 
would suggest that the cells were in a more synthetic state. However, due to the 
limitations in this study, namely the lack of biological replicates, it is impossible to 
comment with confidence on the expression of any individual miRNA.  
To determine which genes may be affected by the down regulated miRNA shown in 
figures 4.3-4.5, their putative targets were downloaded from Target Scan (Table 4.1). 
The involvement of these in silico predicted genes in cellular processes was then 
assessed by determining enrichment against Gene Ontology (GO) biological processes. 
In addition, DAVID bioinformatics software was used to highlight the involvement of 
predicted targets in pathways of interest from the Kyoto Encyclopedia of Genes and 
Genomes (KEGG) (Table 4.2). 
It is important to note the reason for selecting miRNA which maintained a strong PCC 
was that the temporal study did not contain replicates. As such, although their 
expression profile were interesting, it was impossible to have confidence and justify 
further bioinformatics on miRNA candidates which showed strong expression changes 
at earlier time points. The primary focus of this temporal study was to elucidate a time 
point in which the global miRNA expression signature was altered with strain. 
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4.3.2Investigation of strain amplitude on miRNA profile (biological replicates) 
To ascertain if the strain amplitude had any effect on the SMC miRnome, a second 
study involving biological replicates was designed. The strain amplitudes chosen were 
5%, 10% and static control and these were applied over a time point of 24 hours. They 
were selected on the basis that in the previous temporal study at 10% cyclic strain, there 
was minimal change in the miRNA profile over the first 6 hours of strain followed by a 
slight shift towards global down-regulation of miRNA after 12 hours, while after 24 
hours of cyclic strain the profile was significantly altered. Although a greater change 
was observed after 48 hours, it is possible that some of these changes may be as a result 
of cross-talk between activation molecules of downstream signaling pathways (e.g. 
negative and positive feedback loops) and not entirely due to the strain alone.  
The average delta CT values were entered into R statistical software where they were 
mean normalized, as previously described. New priority lists were then created (10% vs. 
5%, 5% vs. static and 10% vs. static) comprising of miRNA which had an adjusted P. 
Value of ≤ 0.05, using the Benjamini-Hochberg approach. 
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4.3.2.1 Adjusted P Value 
The adjusted P value method allows for controlling the rate of false positives. To begin 
an acceptable false discovery rate is selected, for example 10%. This means 10% of the 
significant miRNA would be false positives. This is acceptable in a large scale 
screening experiment, as presented in this chapter, as any false positives would be found 
in follow-up experiments on short listed miRNA.  Next P values of miRNA are placed 
in order from smallest to largest. The smallest P value has a rank of i=1, the next has 
i=2, etc. Each individual P value is then compared to:  
       
   
Where m is the total number being tested and Q is the chosen false discovery rate. The 
miRNA which has the largest P value but is         is significant and all P values 
smaller than this are also significant (Y. Benjamini., Y. Hochberg et al., 1995).  
Using HCA, (figure 4.6) the first stage of experimental validation was to determine if 
the biological replicates clustered and if there was a reasonable degree of separation 
between the strain conditions. This validation was shown using a dendogram (figure 
4.6). A substantial difference in the miRNA profile was evident between 10% and 5% 
cyclic strain, with a more modest change observed between 5% strain and static 
adhesion.  
The Venn diagrams in figures 4.7 and 4.8 have a twofold purpose; to show the numbers 
of miRNA in the priority lists and to demonstrate whether these miRNA are up-
regulated or down-regulated with strain. Figures 4.7 (A) and 4.8 (A) illustrate the 
number of miRNA, from the A and B panel respectively, which are unique to each 
strain comparison. In addition to this, they show the numbers of miRNA which are 
common across strain comparisons. Figures 4.7 (B) and 4.8 (B) show the direction of 
expression of miRNA in the priority list for each strain comparison. For example in 
figure 4.7 (A) there are a total of 75 miRNA in the priority list of 10% strain vs. 5%. 
From the venn diagram we can see 36 of these are unique to 10% vs. 5%, 38 are 
common between 10% vs. 5% and 10% vs. static and 1 miRNA is common to all three 
strain comparisons. Figure 4.7 (B) shows the direction of expression of these miRNA. 
Of the 36 miRNA in 10% vs. 5% 35 are down regulated and 1 is up-regulated. The one 
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miRNA common to all three strain comparisons is no longer in the centre as its 
direction of expression is only common in 10% vs. 5% and 10% vs. static. 
The majority of miRNA on the A card between the 10% vs 5% and 10% vs. static 
conditions were down-regulated with strain. The low number of differentially expressed 
miRNA within the priority list between 5% and static would suggest that the miRnome 
of HAoSMCs strained at this amplitude is not significantly different to cells in static 
culture.  Interestingly, and in contrast to the A card, the majority of the miRNA on the B 
card between 10% vs 5% and 10% vs static conditions were up-regulated, this may be 
explained by the fact the B panel contains many star or passenger strand miRNA which 
have been shown to be differentially regulated to the leading strand (Kuchenbauer et al., 
2011). As with the previous temporal study, putative targets for the priority miRNA 
were downloaded from Target scan. The involvement of these targets in cellular activity 
was shown by determining enrichment against GO biological processes. The 
involvement of the in silico predicted targets in pathways of interest were evaluated by 
downloading KEGG pathway maps from DAVID bioinformatics software. miRNA with 
the lowest adjusted P value and highest fold change were tabulated in tables 4.3 -4.5, 
listing miRNA from the 10% vs. 5%, 10% vs. static and 5% vs. static conditions. The 
adjusted P value, fold change, number of conserved targets, number of biological 
processes these targets are involved in, and number of pathways the predicted genes are 
linked to are included in these tables for each miRNA.  
Table 4.6 displays the miRNA potentially involved in each of the pathways of interest 
and whether these specific miRNA were up-regulated or down-regulated with the three 
strain conditions. Work presented in the literature highlights the involvement of many 
of these shortlisted miRNA in cell migration, particularly in cancer metastasis. In a 
study by Zhang et al., (2010), miR-520e was shown to be a novel tumor suppressor, as 
expression levels in clinical hepatocellular carcinoma tissues were shown to be 
dramatically decreased. The miR-520e gene is located in 19q13.42 and is reported to be 
in chromosome 19 miRNA cluster (C19MC), the largest human miRNA gene cluster 
discovered so far (Bo-an Li et al., 2012). This miRNA is thought to inhibit cell 
migration through suppression of NIK/p-ERK1/2/NF-κB signaling pathway. In our 
study, its expression was shown to be increased under conditions of 10% cyclic strain vs 
5% strain, and based on the literature, this may represent reduced migration in 
HAoSMC.  
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This theory is further strengthened by looking at the expression of miR-373: This 
miRNA was shown to promote tumour cell invasion and metastasis in vitro and in vivo. 
Increased expression was found in human breast cancer samples in which the miRNA 
was predicted to target CD44 (Q Huang et al., 2008). In our study, expression of miR-
373 was shown to be down-regulated under conditions of 10% strain vs static adhesion.  
In the same study by Huang et al., (2008), expression of miR-520c-3p showed to be 
also increased in carcinoma tissues. However, unlike miR-373, in this work its 
expression was increased between 10% and 5% strain and 10% and static adhesion. 
Interestingly though expression was decreased between 5% and static adhesion, this 
would highlight the impact of strain amplitude on the patho-physiological effect of 
cyclic strain and miRNA expression.  
Importance of strain amplitude can also be seen by looking at the expression levels of 
another novel miRNA, miR-610, which made the priority shortlist. miR-610 has been 
shown to inhibit the migration and invasion of gastric cancer cells by suppressing the 
expression of vasodilator-stimulated phosphoprotein (VASP) (Wang et al., 2012). In 
our study, this miRNA was shown to be increased by greater than 100-fold in the 10% 
strain vs 5% strain, but is decreased in cells at 5% vs static adhesion. However, as it is 
possible that a single miRNA can potentially modulate the expression of hundreds of 
genes and associated pathways, it is probable that miR-610 working as a tumor 
suppressor in gastric cancer cells may not impact on VSMC migration. With this in 
mind miRNA specific to VSMC were also investigated. 
Levels of the miR-143/miR-145 cluster as discussed previously were shown to be 
decreased with 10% strain when compared to static adhesion and 5% strain at 24 hours. 
However, although this cluster fell short of the P value required for the short list in the 
5% strain vs static conditions, the expression levels were shown to be increased. This 
shows a more physiological response of the cells to the lower amplitude strain. The 
study also yielded potential new miRNA highly involved in VSMC biology these were, 
miR-610, miR-661 and miR-96. These miRNA were predicted to target several genes in 
the vascular smooth muscle contraction pathway, as determined by using DAVID 
software analysis.  
The pathway maps downloaded using DAVID from KEGG were used to show the role 
of predicted targets in pathways of interest. These pathways are shown in figures 4.9 - 
4.14 and a list of their associated target genes are shown in tables 4.7 - 4.14. Pathways 
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were chosen based on their involvement in cell migration and motility. Genes within the 
pathways of interest targeted by a single miRNA are circled in red, while those 
potentially targeted by 2 or more miRNA are circled in blue. In addition, genes that 
were targets of verified and published miRNA involved in VSMC biology are circled in 
yellow. Selected pathways were based on VSMC functions of interest and included 
migration, focal adhesion, ECM receptor interaction, VSMC contraction, regulation of 
actin cytoskeleton and adherens junction and cell cycle. 
Cell signaling pathways which also had numerous mechano-sensitive miRNA involved 
included MAPK (which was shown to be activated by cyclic strain, Wnt and mTOR 
signalling, p53, VEGF and Calcium signaling pathways. These are highlighted in the 
appendix. All of these pathways contained copious predicted targets of the mechano-
sensitive miRNA which were shortlisted. 
4.4 Summary and Conclusion 
Characterisation of an individual cell’s “miRnome” is a valuable asset when assessing 
the patho-physiological impact of a condition, such as cyclic strain. The initial temporal 
study of the miRNA profile had a two-fold significance. Firstly, it revealed a change in 
the HAoSMC miRNA profile that was only evident after 12 to 24 hours of strain. This 
would suggest HAoSMC are not as sensitive to cyclic strain as initially thought. 
Evidence for this is further shown by the fact that there was such a low number of 
strain-regulated miRNA differentially expressed between 5% strain and static cells, 
when compared to the higher strain. Secondly it presented a list of mechanically-
sensitive miRNA with expression levels that were linearly correlated with time.  
As sample replicates were not performed in this preliminary study reliability of 
individual miRNA expression is limited, the study was only designed to reveal what 
time point during strain a global miRNA expression change was evident. A second, 
more detailed study containing biological triplicates of samples was conducted to look 
at individual miRNA. This also focused on how strain amplitude was implemented in 
HAoSMC response to mechanical stimulus. Cells were exposed to 24 hour strain at 
10% and 5% and also static conditions. 
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The priority list of miRNA was generated by retaining only those with an adjusted P 
value of equal to or less than 0.05 using the Benjamini Hochberg method. This 
produced a substantial list of miRNA from each of the strain conditions. miRNA with 
the highest differential expression, either increased or decreased, were presented in 
tables 4.4-4.5 along with bioinformatic analysis carried out. This included in silico 
prediction of putative targets followed up by assessment of the potential involvement of 
these targets in cellular process’ and pathways. 
Of these novel miRNA, some show predicted involvement in SMC biology such as the 
vascular smooth muscle cell contraction pathway, namely miR-610 and miR-661. Other 
miRNA selected for bioinformatics, miR-520e, miR- 520c-3p and miR-373, showed 
promising target predictions involved in pathways concerning cell motility. These 
included focal adhesion, regulation of actin cytoskeleton, VSMC contraction pathway, 
cell cycle, adherens junction and ECM receptor interaction pathway. These miRNA are 
novel and largely unpublished, providing a promising avenue for further investigation. 
Follow up experiments are also essential as the in silico target predictions are just that, 
predictions. They need to be validated before further research is carried out. Validation 
can be performed through use of loss and gain of function experiments and luciferase 
reporter assays. 
To conclude, it appears that the use of miRNA expression to identify either VSMC 
phenotype is ambiguous. For example, miR-1(figure 4.5) was shown to induce both a 
contractile and a synthetic phenotype by two different groups. In this thesis, the 
expressions of both the miR-143/miR-145 and miR-221/miR-222 clusters were 
decreased compared to that of the static control, at 24 hour 10% strain. In case of the 
miR-143/miR-145 cluster this would suggest a more synthetic phenotype (Elia et al., 
2009; Sessa et al., 2010). Yet reduction in miR-221/miR-222 cluster expression 
suggests the opposite, a more contractile cell (Altuvia et al., 2005; Calin et al., 2004). In 
the 5% vs. static condition, however, the miR-143/miR-145 cluster is increased 
compared with the static control, yet the P value for these two miRNA in this condition 
did not meet the criteria for the priority list used. 
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It is obvious from our studies and findings that looking at individual miRNA expression 
data in isolation, may not give the full biological explanation and rational to certain 
events studied and observed, but rather the various permutations and combinations of 
miRNA expression must be considered. To become fixated with what miRNA 
expression corresponds to what SMC phenotype is all too easy given the amount of 
literature. To truly characterise the phenotype of a certain population of SMCs a 
combination of cell functions, contractile marker expression, cell morphology and the 
cell miRnome should be utilised. However, work carried out in this chapter was 
primarily done to establish a shortlisted panel of mechano-sensitive miRNA and not to 
directly implement these with a specific HAoSMC phenotype.  
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CHAPTER FIVE: Functional Studies on HAoSMCs Exposed to Cyclic 
Strain 
5.1 Introduction  
The primary function of SMCs is to maintain vascular tone and provide vessel 
resistance to changes in the mechanical environment (Moiseeva et al., 2001). They are 
able to achieve this through their unique phenotype plasticity. In a healthy vessel, the 
SMCs are mostly quiescent showing reduced cell functions such as proliferation and 
migration. All vessels within the body are an environment of constant mechanical strain 
and stress. This is attributed to the haemodynamic force of blood flow, which is 
experienced in two forms; shear stress which is a result of the longitudinal force of the 
blood flow across the endothelial layer and cyclic strain which is produced as a result of 
the pulsatile nature of blood flow. This is felt by all cells making up the vessel and is 
perpendicular to the lumen. 
Cells within the vessel resist these forces by adhering to the ECM, and by forming cell-
cell contacts (Moiseeva et al., 2001). This is achieved through adhesion receptors such 
as syndecans, cadherins, dystrophin-glycoprotein complex (DGPC) and integrins. 
Alteration of the normal magnitude of this force (under straining or overstraining) or the 
initiation and prolonged maintenance of perturbed pathogenic forms (e.g. oscillatory 
flow) can lead to serious cardiovascular disease such as atherosclerosis. These 
pathological changes in haemodynamics can be induced in a disease state such as 
hypertension or following surgical procedures like, balloon angioplasty or coronary 
artery bypass grafting or stenting (Taylor et al., 2000; Moiseeva et al., 2001).  The high 
levels of cyclic strain as a consequence of these sates can result in a pro-migratory, 
synthetic SMC (Li and Chaikof et al., 2002). Pro-migratory and proliferative SMCs can 
lead to an array of vascular disorders, including restenosis after stenting and 
atherosclerosis. In the case of atherosclerosis, the migrating SMCs result in progression 
of stable plaques, as the cells migrate through the endothelium. This initiates with 
disengagement of ECM adhesion receptors to allow motility of the cell. Following this, 
destruction of the basement membrane creates an intracellular space through which the 
cells can migrate (Hahn and Schwartz et al., 2009).  
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In contrast to the pathological consequences associated with hypertension or high 
mechanical loading on the vessel wall, a physiological level of intraluminal pressure is 
essential for maintenance of homeostasis within the vessel (Birukov et al., 1998). 
Studies have shown mechanical straining is essential for maintaining levels of 
contractile markers in SMCs such as SM α-actin and caldesmon (Tock et al., 2002; 
Wang et al.,2006; Birukov et al., 1998). 
Cyclic strain can also induce expression of SMC specific markers and ultimately 
differentiation in other cells types (Cevallos et al., 2006). 
Attempts to replicate this mechanical environment of blood vessels have been largely 
successful using several unique in vitro models (Brown et al., 2000).   However studies 
have yielded varying results into the functional changes of SMCs in culture exposed to 
cyclic strain. Qi Ying-Xin et al., (2010) observed an increase in SMC migration and 
proliferation when exposed to 15% strain at 1.25 Hz for 24 hours in comparison to cells 
strained at 5%. Similar results were seen in more recent studies which showed cyclic 
strain at 15% stimulating migration through the PI3K/AKT pathway in SMCs. (Bu-
Chun Zhang et al., 2012).  
Contradictory to this, Tock et al., (2003) found that cyclic strain of the same amplitude 
increased VSMC expression of smooth muscle α-actin pertaining to a more contractile, 
less proliferative and migratory phenotype. A lot of the conflicting data can probably be 
attributed to differences in the degree and characteristics of the strain applied as well as 
the starting phenotype of the cells and passage number (Rensen et al., 2007). Although 
these opposing results exist in the literature, it is clearly apparent that cyclic strain does 
indeed regulate SMC function and phenotype. However, to what extent and direction 
still needs to be fully deduced.  
5.1.1 miRNA Regulation of Cell Function 
Nearly all biological processes involved in cell growth and survival is now shown in the 
literature to be regulated to some extent by the still novel moiety, miRNA. As a result 
numerous institutes are investigating the role of these non-coding RNA in SMC 
phenotype and function and consequently the VSMC "miRnome" is becoming 
prominently characterised. W. Sessa’s group has shown the miRNA cluster miR-
143/miR-145 to be a reliable marker for phenotypic modulation within the cell. A high 
level of these miRNA within the cell is directly related to a contractile phenotype. In 
contrast increased expression of other miRNA such as the miR-221/miR-222 cluster and 
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miR-21 is evident in proliferating synthetic SMCs (Davis et al., 2009; Liu et al., 2009; 
Cheng et al., 2007) 
Manipulation of the cell’s miRNA processing machinery, such as knock-out of Dicer or 
Argonaute-2, is proving to be an advantageous first step in implicating their 
involvement in a desired cellular mechanism or function. However, this is very much a 
“blunt instrument” approach. (Suarez et al., 2007; Naoghare et al., 2011) To take true 
advantage of the regulatory influence of miRNA, individual roles in specific biological 
processes must be drawn out from profiling experiments. Once a short list panel of 
miRNA of interest has been established it is possible to elucidate their exact regulatory 
role in a desired process. This can be achieved by implementing loss and gain of 
function experiments with individual or combinations of miRNA. 
Work in this chapter was based on the theory that miRNA facilitate messaging of 
external stimulus or environmental cues into a functional response through signaling 
hubs such as cell-cell and cell-ECM contacts. The external stimulus in this study is 
mechanical cyclic strain which is predominantly sensed through membrane bound 
adhesion molecules such as integrins.  
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Chapter Hypothesis: 
This chapter hypothesis was that cyclic strain alters smooth muscle cell functions such 
as adhesion, migration and proliferation and that these altered cell fates are controlled 
by miRNA regulation. 
Specific aims and Experimental approach 
To test this hypothesis, experiments in this chapter were designed to characterize: 
 Impact of cyclic strain on HAoSMC migration.  
Cells were exposed to 6, 12, 24, 48 and 72 hours of 10% strain at 1Hz. The rate of 
migration of the cells was then compared to their static culture counter parts using the 
xCELLigence impedance based system described in chapter 2. 
 Involvement of miRNA in HAoSMC cell function. 
This was approached by means of an Argonaute 2 (Ago2) knock down using siRNA. 
Without Ago2 to incorporate mature miRNA into RISC, the effector function of 
miRNA is lost. To evaluate how this impacted the SMC phenotype expression of the 
contractile marker, α-actin was quantified by western blot. 
 Involvement of miRNA on HAoSMC phenotype 
Expression levels of contractile marker α-actin were determined in Argonaute2 deficient 
HAoSMCs. 
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5.2 Results  
5.2.1 Impact of cyclic strain on HAoSMC migration. 
HAoSMC migration was monitored using the real time impedance based xCELLigence 
system. Migration was monitored in SMCs exposed to 10% cyclic over a 72 hour time 
course, time points included were 6, 12, 24, 48 and 72 hours as shown in figure 5.1 (A-
E). Plots shown are migration assays using the xCELLigence “CIM” plate. Rate of 
migration is quantified off the slope of the graph over the initial time points, typically 
within the first 5 hours of the experiment. 
 
 
6hr 10% strain vs. static 
 
 
 
12hr 10% strain vs. static 
A. 
B. 
Migration (0-3hrs) 
Migration (0-4hrs) 
 Static adhesion 
 10% strain 
 
 
 Static adhesion 
 10% strain 
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24hr 10% strain vs. static 
 
 
48hr 10% strain vs. static 
 
 
72hr 10% strain vs. static 
 
C. 
D. 
E. 
Migration (0-4hrs) 
Migration (0-4hr 30 min) 
Migration (0-4hr 30 min) 
 Static adhesion 
 10% strain 
 
 
 Static adhesion 
 10% strain 
 
 
 Static adhesion 
 10% strain 
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Figure 5.1 (A-F): xCELLigence Migration plots of HAoSMCs exposed to 10% cyclic strain. 
Figure 5.1 (A-F) show plots of migration generated from the xCELLigence instrument. These 
compare HAoSMCs in static culture to cells exposed to 10% cyclic strain over a 72 hour time 
course. Time points included were; 6hr 10% vs. static (A), 12hr 10% vs. static (B), 24hr 10% 
vs. static (C), 48hr 10% vs. static (D) and finally 72hr 10% vs. static (E). Figure 5.1 F shows a 
quantitative graph of cell migration of strained cells compared against the static control. n=3, 
*P≤0.05 vs. static adhesion; one-way Anova.    
F. 
* 
* 
* 
* 
* 
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5.2.2 Argonaute-2 (Ago2) Knock Down Study. 
This study was designed to investigate the effect of a diminished miRNA effector 
function on HAoSMC functions such as migration, adhesion and proliferation. This was 
achieved by knock down of the Argonaute2 protein which is responsible for 
incorporating mature miRNA into the RNA Induced Silencing Complex (RISC). 
Effective knock down was achieved using both a pre validated siRNA from Ambion 
®
 
and a custom synthesised siRNA, sequence taken from the work of Naoghre et al., 
(2010).  
5.2.2.1 Optimisation of siRNA for Ago2 
The three pre-designed siRNA supplied by Ambion 
® 
and the custom synthesised 
siRNA were tested for their impact on HAoSMC migration using the xCELLigence 
system as shown in figure 5.3 (A-C). Due to the ease of the assay this was done as an 
initial screening for the most efficient siRNA prior to quantification of knock down 
using western blot.    
 
 
 
A. 
B. 
Migration (0-4hrs) 
Migration (0-4hrs) 
Scrambled control 
siRNA1 
 siRNA2 
siRNA3 
 
 
 
 
 
Scrambled control 
 Custom siRNA  
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Figure 5.2 (A-C): Optimisation of siRNA for Ago2.  Figure 5.2 A shows an xCELLigence 
plot of migration with the three pre designed siRNA and a scrambled siRNA control. Green plot 
– scrambled control, Pink plot – siRNA3, Red plot – siRNA1, Blue plot – siRNA2. Rate of 
migration was determined over the initial 4 hours. Figure 5.2 B shows an xCELLigence plot of 
migration with the custom synthesised siRNA and a scrambled control. Green plot – scrambled 
control, Blue plot – Custom siRNA. Rate of migration was determined over the initial 4 hours. 
Figure 5.2 C graph quantifying the rate of migration of HAoSMC transfected with one of the 
four siRNA compared against the migration of cells transfected with scrambled siRNA. The 
increased migration of HAoSMCs transfected with siRNA 2 and the custom siRNA was taken 
as consequence of a reduced miRNA function via the knock down of Ago2. As a result both 
these siRNA were chosen for quantification of knock down by western blot. n=3, *P≤0.05 vs. 
scrambled control; pairwise t-test.  
C. 
* 
* 
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5.2.2.2 Quantification of Ago2 knock down efficiency with siRNA2 and Custom siRNA. 
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Figure 5.3 A&B: Quantification of Ago2 Knock Down with siRNA.  Efficiency of siRNA 
knock down of Ago2 was quantified using western blot (figure 5.3 A). Blot shows expression of 
Ago2 from four sample lysates; including no siRNA control, scrambled siRNA control, pre-
designed siRNA2 and custom synthesised siRNA. Quantification of protein expression was 
achieved using densitometry analysis on bands with Image J software. n=3, *P≤0.05 vs. 
scrambled control; pairwise t-test.  
Ago2      (100kD) 
 
 
GAPDH     (38kD) 
 
 
A. 
B. 
* * 
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5.2.3 Impact of cyclic strain on migration of HAoSMCs with Ago2 knock down  
The physiological response of HAoSMCs to 10% cyclic strain at the earlier time points 
is shown by reduced migration of the cells in figure 5.1 A-C. This correlates to the 
change in expression of contractile markers, chapter 3, and the change in expression of 
miRNA in chapter 4. To globally connect miRNA as the regulators of this response, we 
investigated the implication of knocking down argonaute-2 within the cells. This has the 
effect of reducing miRNA effector function by inhibiting binding of the mature miRNA 
to their target mRNA. These Ago2 deficient cells were then exposed to the migration 
inhibiting 10% cyclic strain as shown in figure 5.1 A-C along with a scrambled control 
and compared against HAoSMCs which had been in static culture, this is outlined in 
figure 5.4.   
 
 
 
 
 
 
A. 
Migration (0-3hr 30min) Doubling Time (9-24hrs) 
Static adhesion 
Ago2 siRNA (strained) 
 Scrambled siRNA (strained) 
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Figure 5.4 A, B&C: Migration of Ago2 deficient HAoSMCs exposed to cyclic strain. Figure 
5.4 (A) is a migration plot generated from the xCELLigence instrument of strained HAoSMCs 
vs. static culture. There are two strained plots, one transfected with a scrambled control siRNA 
and the other transfected with a siRNA for Ago2. Green – Static, Red - Scrambled siRNA 
(Strained) and Blue – Ago2 siRNA (Strained). (B)- Shows rate of migration for each plot as 
compared against HAoSMCs in static culture. Migration was measured over the initial 3-4 
hours. (C)- Graph of doubling time for each plot shown in figure 5.4 A. n=3, *P≤0.05 vs. static 
adhesion; pairwise t-test.  
C. 
B. 
* 
* 
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5.2.4 Impact of cyclic strain on adhesion of HAoSMCs with Ago2 knock down  
 
 
 
Figure 5.5 A & B: Adhesion of Ago2 deficient HAoSMCs exposed to cyclic strain.  Figure 
5.5A shows an adhesion profile, generated from the xCELLigence instrument, of both strained 
HAoSMCs and cells in static culture.There are two strained cell plots, one transfected with 
scrambled siRNA and the other with siRNA for Ago2. Green – Static, Red - Scrambled siRNA 
(Strained) and Blue – Ago2 siRNA (Strained). B shows the level of adhesion of each sample of 
cells as calculated within the initial 1-2 hours of the experiment. 
n=3, *P≤0.05 vs. static adhesion pairwise t-test. 
A. 
B. 
Adhesion (0-~2hrs) 
Static adhesion 
Ago2 siRNA (strained) 
 Scrambled siRNA (strained) 
 
 
 
 
* 
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5.2.5 Effect of miRNA deficiency in HAoSMCs on Scratch Wound Closure. 
A scratch wound was used as a second migration assay to characterise the implications 
of Ago2 knock down in HAoSMCs. Monolayer of cells transfected with a scrambled 
siRNA control and siRNA against Ago2 were scratched using a sterile 10µl tip. 
  
     
   
                        
Figure 5.6 (A-B): Scratch wound closure of Ago2 knock down HAoSMCs.  Shows scratch 
wound to two monolayers of HAoSMCs. Images of the wounded monolayer were taken at 0 
hour (A) and 24 hour (B). Images on the left of each time point are of cells transfected with a 
scrambled siRNA control, images on the right are of cells transfected with siRNA against Ago2.
Scrambled 0hr 
 
Ago2 Knock Down 0hr 
Scrambled 24hr 
 
Ago2 Knock Down 24hr 
A. 
B. 
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5.2.6 Impact of Ago2 knockdown in HAoSMCs on contractile phenotype. 
Expression of the smooth muscle cell contractile marker, α-actin, was assessed using 
western blot as shown in figure 5.7 A & B. This was to elucidate if miRNA deficiency, 
as a result of the Ago2 knockdown in SMCs had any implication on phenotypic 
modulation of the cell. 
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Figure 5.7 A&B: Quantification of α – actin expression in miRNA deficient HAoSMCs.  
Blot shows expression of α-actin from four sample lysates; including no siRNA control, 
scrambled siRNA control, pre designed siRNA2 and custom synthesised siRNA. Quantification 
of protein expression was achieved using densitometry analysis on bands with Image J software. 
n=3, *P≤0.05 vs. scrambled control pairwise t-test. 
A. 
B. 
* 
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5.3 Discussion 
The focus of this chapter was twofold, firstly to test if haemodynamic force, specifically 
cyclic strain, altered HAoSMC function, namely migration. Secondly, to elucidate if 
miRNA were the signaling nexus involved in translating the mechanical stimulus of 
strain into a cellular process or function. 
The following experimental approaches were taken to test the hypothesis that, “cyclic 
strain alters smooth muscle cell functions such as adhesion, migration and proliferation 
and that these altered cell fates are controlled by miRNA regulation.” 
The strain parameters; amplitude, frequency and time points, used in chapters 3 and 4 
were applied to HAoSMCs to evaluate cell migration compared with a static culture 
control using the xCELLigence system. In chapter 4, an altered miRNA signature was 
revealed in HAoSMCs that were exposed to strain compared to static culture. To 
identify the role of miRNA effector functions on regulating changes in cell functions 
following strain, the miRNA regulatory molecule, Argonaute2, was targeted by siRNA. 
Knock down of this gene interferes with miRNA function within the cell. Ago2 
deficient cells were strained along with cells transfected with a scrambled siRNA 
control. The migration of both these cell populations was compared against a static 
control using the xCELLigence system. As a secondary migration assay to the 
xCELLigence, a scratch wound in the cell monolayer was used. Wound closure rate of 
cells transfected with siRNA targeting Ago2 was compared with HAoSMCs transfected 
with a scrambled siRNA control. Finally to assess the implication of reduced miRNA 
function in SMCs on phenotypic modulation, the contractile marker α-actin was 
quantified by western blot.  
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5.3.1 Impact of Cyclic Strain on Cell Function 
Cyclic stretching of VSMCs is a permanent feature in vessels as a direct result of the 
constant pulsatile nature of blood flow. Correct intra-luminal pressure is essential for 
maintaining vessel homeostasis. Mechanical factors also play a positive role in the 
control of the VSMC differentiated phenotype (Birukov et al., 1998). Alterations in the 
level of stretch or strain, associated with increased blood pressure or hypertension, 
however, can lead to a myriad of vascular conditions such as atherosclerosis, pulmonary 
heart disease, myocardial infarction and aortic aneurysms to name but a few. As stated 
earlier, vascular smooth muscle cells are responsible for maintaining this vascular tone 
and vessel resistance to changes in blood pressure. However, smooth muscle cell de-
differentiation resulting in a pro-migratory phenotype is the leading cause of stable 
plaque formation in atherosclerosis. 
Cell migration is a complex and highly orchestrated process, which was described in 
full in chapter 1. In brief, Microfilaments are the main cytoskeletal protein involved in 
cell migration and are composed of the contractile protein actin. Integrins attach to the 
actin cytoskeleton, which stimulates the formation of filopodia and lamellipodia. The 
actin polymerises and presents the membrane to the leading edge of the cell. At this 
point, a combination of actin treadmilling and integrin mediated attachments such as 
focal adhesions, provide traction for the cell to pull itself forward. Cell adhesion 
molecules at the back of the cell also release and contract allowing for cell motility in 
the direction of migration. 
 
Figure 5.8: Dynamics of cell migration. As actin polymerises it extends lamellipodium in the 
direction of migration. Along with this integrins bind to the polymerised actin and form focal 
contacts which work as a molecular clutch. These provide an anchorage point from which the 
cell can gain traction and pull itself forward. Simultaneously to this adhesion points at the rear 
of the cell disengage and retract to allow cell motility. 
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5.3.1.1 Migration 
Work in chapter 3 demonstrated that cyclic strain altered expression of contractile 
markers such as α-actin, smoothelin and calponin. Work in this chapter was carried out 
to ascertain if these changes in contractile marker expression correlate with change in 
cell function, particularly migration. HAoSMCs for this work were strained as described 
in chapter 2.2. A 72 hour 10% strain at 1Hz time course was chosen of which 6, 12, 24, 
48 and 72 hour time points were selected to monitor cell migration. For each time point, 
the cells were lifted from flex cell plates using versene, an EDTA derivative, which 
prevents integrin cleaving. Using trypsin to cleave integrins for detachment would most 
likely have altered the adhesion and migration profile of the cells on the xCELLigence 
system.  Consequently, their various activation states as a result of the strain would have 
been negated. Cells were counted twice using the ADAM cell counter and an average 
was taken. The cell count is crucial for reliability of the system. Cells were then seeded 
onto the migration “SIM” plate at a density of 8,000 cells per well. For each time point, 
the migration of strained cells was compared against a static culture of HAoSMCs 
which were also seeded on to the FlexPlates
® 
without being strained. The migration plot 
for each time point, 6-72 hr, is shown in figure 5.1 (A-E) respectively. The rate of 
migration for each sample is measured from the initial slope of the plot using the RTCA 
software. The level of migration for each time point is graphically represented in figure 
5.1F, all time points are compared relative to the static control. 
The graph reveals that as the cells are strained there is an incremental reduction in the 
migration of HAoSMCs up until 24hours and at this time point the level of migration is 
less than 50% that of the static control. This would implicate 10% strain as a 
physiological stimulus on the cells over the first 24 hours pushing them toward a more 
contractile, quiescent phenotype. Another theory for the reduced level of migration is 
due to an increased expression and activation of integrins, stimulated by the strain, 
facilitating stable adhesions. Deposition of ECM by the cells may also make the 
substrate more “sticky” reducing migration (O’Callaghan et al., 2000).  
At the later time points however, 48hr and 72hr, cell migration rises to ~ 75 % of the 
static control. This increase in migration would suggest the cells are moving back to a 
de-differentiated synthetic state as seen in the static culture. This may be facilitated by 
an increased expression of matrix metalloproteinases (MMP) which degrade the ECM 
allowing the cells to become more mobile. The trend seen in the migration levels of the 
strained cells over the 72 hours is similar to the trend seen in the expression of the 
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contractile markers in chapter 3. That is, 10% cyclic strain at 1Hz of HAoSMCs 
modulates cell phenotype to a more contractile state. This physiological stimulus is 
most evident in cells, which have been strained at these parameters for 24 hours. 
Following this time point the cells shift back on the phenotype spectrum towards the 
synthetic state. However, the migration level still remains lower than that of the static 
culture.  
 
This study outlines the wavering effect of strain on HAoSMC migration. Several other 
groups have also examined the consequences of strain on HAoSMCs, however, these 
studies typically investigate proliferation and DNA synthesis within the cell (Liu et al., 
2007; Kasisis et al., 2005; Qi et al., 2010), and therefore work on SMC migration 
following strain is far less abundant. Nonetheless, the emphasis of these studies is on 
the modulating effect strain has on SMC phenotype, showing that both increase and 
decrease in expression of contractile markers and DNA synthesis is dependent of the 
strain parameters (Sumpio and Banes et al., 1988; Hipper and Isenberg et al., 2000; 
Schulze et al., 2003; Wilson et al., 1993). 
C. Li et al., (2003) demonstrated an increase in mouse SMC migration when exposed to 
5%, 15% and 20% strain, which was mediated mediated by protein kinase C (PKC) . 
Stretch was also shown to enhance SMC motility through the shedding of heparin 
sulfate proteoglycan syndecan 4 from the cell surface (Li and Chaikof et al., 2001). 
Conversely, Zhi-Qiang et al., (2009) showed that application of 10% cyclic strain at 
1Hz for 48 hours significantly inhibited SMC migration, suggesting hyperacetylation 
and deacetylation of histones caused by cyclic strain may play a part in regulating SMC 
migration. This would suggest an explanation to the modulating effect seen on SMC 
function by the chronic strain used in experiments in this thesis. The temporal strain 
may be leading to epigenetic reprogramming of the cell at the later time points, as 
histone modification is one of the main mechanisms of this. In an attempt to establish 
both physiological and pathological strain amplitude, Ying-Xin Qi et al. (2010) 
suggested 15% strain causes a marked increase in migration of RAoSMCs compared to 
cells strained at 5% for 24 hours. This, they believed was regulated via the p38 
pathway.  
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5.3.2 Argonaute 2 (Ago2) siRNA 
The miRNA signature in all vascular cells is becoming increasingly well characterized. 
It is likely there will soon be true therapeutic benefit from suppression or over 
expression of individual or a panel of miRNA implicated in a cardiovascular disorder 
(Callis et al., 2008; J Yue 2011). Currently, the most significant contribution by miRNA 
to therapeutics is by way of biomarkers for disease states. These can be found in a 
multitude of bodily fluids and are a non-invasive method for diagnostic and prognostic 
assays; this is comprehensively reviewed by Stefano et al., (2011).  
However, developing inhibitors or promoters for an extensive panel of miRNA is a time 
consuming and costly task. This approach can also yield disappointing results as 
although deeply conserved, many miRNA express only a modest effect on their target 
mRNA, often less than 2 fold. In fact, miRNA can often be deleted without any obvious 
impact on phenotype (Bartel et al., 2004). Investigations now highlight the likelihood of 
several miRNA working together to co-target an mRNA. This is possible as many 
mRNA 3’UTRs have more than four highly conserved seed sequences. Combined 
targeting by the miRNA creates enough change on the mRNA to constitute a large 
physiological effect (Mukherji et al., 2011; Lliopoulos et al., 2009; Friedman et al., 
2009; Baek et al., 2008).  It is possible for miRNA to also amplify their potency by 
targeting mRNA contained in pathways (Linsley et al., 2007). In order to elicit a 
considerable phenotypic change, it may be advantageous to target all members of a seed 
family (Ebert et al., 2012). 
For this reason, a first step approach to implicating miRNA in a cellular process or 
indeed pathology, often looks at targeting one or more of the of the miRNA biogenesis 
or effector molecules. These are essential for developing a mature functioning miRNA 
as described in detail in chapter 1. 
Initial evidence that miRNA were involved in endothelial cell function surfaced when 
Keubacher et al., (2007) silenced Dicer in vitro to yield impaired angiogenesis on 
matrigel formation. This was one of the first investigations into miRNA involvement in 
endothelial cell function. Later, endothelial cell specific Dicer knockout mice showed 
leaky vessel membrane and ultimate lethality (Suarez et al., 2008).  
However, processing by the biogenesis molecules is not an obligatory step for all 
miRNA. For example when a miRNA is coded in a small intron it is deemed a 
“miRton”. These small miRNA are able to bypass initial processing by Drosha/DSCR8 
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and be exported straight to the cytoplasm for maturation. Recent investigations have 
also revealed that Ago2 is required for the production of mature miRNA but not Dicer 
(Meister et al., 2010).  Argonaute 2 is a crucial element of the RNAi pathway and can 
direct both short interfering (siRNA) and miRNA-mediated gene regulation (Sonoki et 
al., 2005). 
To command greater control over the effector function of miRNA, work in this chapter 
was designed to demonstrate that cyclic strain mediated HAoSMC migration was 
facilitated by miRNA. This was approached through use of siRNA targeting the 
Argonaute2 complex. By knocking down Ago2, a significantly reduced number of 
mature miRNA are introduced into the RISC effectively numbing miRNA mediated cell 
regulation.    
Of the eight Argonaute members, only Ago2 can mediate specific endonucleolytic 
cleavage, leading to mRNA cleavage or translational repression of the target mRNA 
(Cifuentes et al., 2010). For initial optimization of knock down of the Ago2 protein, 
four siRNA were implemented. Three pre-designed Silencer Select
®
 siRNA were 
purchased from Ambion™ and one custom synthesised siRNA also from Ambion™, 
the sequence of which was taken from the work of (Naoghre et al., 2010). This number 
of siRNA targeting the one gene increased the likelihood of achieving an effective level 
of knockdown. Cells were transfected with siRNA as described in chapter 2.2. 
As an initial means of selecting the most efficient siRNA, transfected cells were seeded 
onto an xCELLigence “CIM-Plate”, figure 5.2 A & B, in order to assess the direct effect 
of siRNA for Ago2 on cell migration. This was a less time consuming method than 
western blotting for knock down which would be carried out regardless on selected 
siRNA from this experiment. 
Rate of migration for cells transfected with each siRNA and the scrambled control were 
quantified and shown in figure 5.2 C. From this it was evident migration was increased 
in each sample transfected with the siRNA however siRNA2, from the pre-designed 
siRNA, and the custom siRNA sequence showed a marked increase in migration over 
the scrambled control. 
These two siRNA were selected out for quantification of percentage knock down of 
Ago2 in the cells, this was achieved using western blot, figure 5.3 A. Both siRNA 
appeared to suppress functional levels of Ago2 in the cell by over 75% compared with 
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cells transfected with a scrambled siRNA control; figure 5.3 B. Quantification was 
achieved using densitometry software on the protein bands. A stronger knock down was 
evident in cells transfected with the custom sequence siRNA resulting in this siRNA 
being the one of choice for the remainder of the study. 
To investigate if the reduced migration seen in HAoSMCs strained for 24hours, (figure 
5.1 C) was mediated by miRNA regulation, cells transfected with siRNA for Ago2 and 
cells transfected with a scrambled siRNA control were strained under the same 
conditions. Migration of these two cell populations was compared against cells in static 
culture as shown in figure 5.4.  Cells transfected with scrambled siRNA which were 
strained for 24 hours showed reduced migration compared with the static culture as seen 
before in figure 5.1 C. However, Ago2 knock down cells, which were strained under the 
same conditions show over a 50% increase in migration compared with the static 
control. The migrated cells also demonstrate a significantly reduced doubling time 
compared with both the static culture and the scrambled siRNA strained control as seen 
in figure 5.4C. The reduced expression of Ago2, pertaining to reduced functioning of 
miRNA within the cell, shows to negate the physiological effect of the strain. It would 
suggest that without miRNA silencing, cells are transformed into an un-regulated pro-
migratory phenotype.  
It must be noted that static controls of HAoSMCs transfected with Ago2 and scrambled 
siRNA were not included in this study and the strained cell populations were compared 
against a wildtype static population to determine migration levels. This makes a finite 
conclusion that the Ago2 knock down alone caused the noted increase in migration. 
Only with a redesign of the experiment to include these controls and an expected result 
of increased migration of the static cell population transfected with Ago2 siRNA 
compared to that of the scrambled controls would verify this result. That said the 
secondary migration assay, a static scratch wound in figure 5.7, shows HAoSMCs 
transfected with Ago2 siRNA close the wound at an earlier time point to the scrambled 
control. This strengthens the theory that Ago2 deficient HAoSMCs migrate at a higher 
rate to a scrambled siRNA or wild type control.     
The impact of reduced miRNA function on cell adhesion was also assessed in figure 
5.6. Here, the adhesion is strongest in cells transfected with siRNA Ago2. This is 
indicative of activated adhesion molecules such as syndecans, cadherins, dystrophin-
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glycoprotein complex (DGPC) and integrins, which are essential to allow cell motility 
and traction. 
A second migration assay in the form of a monolayer scratch wound was utilized to 
confirm results seen in figure 5.4. For this, HAoSMCs transfected with siRNA for Ago2 
and a scrambled control were seeded to confluence on a 6 well plate. The cell 
monolayer was wounded with a sterile 10µl pipette tip. Images of the wound were 
subsequently taken at 0hou r and 24 hours post wound, figure 5.6 (A&B). At 24 hours 
the wound in Ago2 deficient cells has closed while the scrambled control still shows 
areas of intracellular space and is not fully closed. This strengthens the work done in 
figure 5.4 on the xCELLigence, showing increased migration in Ago2 deficient 
HAoSMCs. 
The reduced effector function of miRNA in Ago2 deficient HAoSMCs was correlated 
back to the priority list for the 10% strain vs. static comparison in table 4.4, chapter 4. 
Within this shortlist two miRNA presented as promising candidates for further 
investigation, miR-520e and miR-520C-3p. Both are upregulated in the strained 
HAoSMCs where migration is reduced compared to that of the static control. In recent 
work by (Zhang et al., 2011) published in Oncogene levels of miR-520e were shown to 
be dramatically decreased in hepatoma cell lines and in clinical hepatocellular 
carcinoma (HCC) tissues. Suggesting miR-520e may be a novel tumor suppressor 
through targeting of NF-κB-inducing kinase (NIK). Silencing of NIK was able to inhibit 
the growth of hepatoma cells. Within the bioinformatics performed in this thesis miR-
520e was also shown to have multiple predicted targets in pathways concerning with 
cell motility such as; focal adhesion, regulation of actin cytoskeleton and cell cycle. 
However, similar to the implications of cyclic strain on cell function, studies which 
examine the consequences of depleting the mature miRNA pool in a cell are also 
ambiguous. Genetic silencing of Dicer and Drosha in endothelial cells using siRNA 
demonstrated a significant reduction in capillary sprouting and tube formation. 
Migration was also reduced in dicer siRNA transfected cell but interestingly not in 
drosha siRNA transfected cells (Kuehbacher et al., 2007). Angiogenesis and wound 
healing was also reported to be impaired in Dicer diminished endothelial cells (Suarez 
et al., 2008). VSMC proliferation was also significantly inhibited in Dicer knockout 
mice (Pan et al., 2011). Conversely, siRNA mediated knock down of Dicer and Drosha 
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in coronary SMCs significantly augmented both growth factor secretion and cell 
functions such as proliferation, cell cycle and migration 
The ambiguity to the effects of miRNA biogenesis molecule depletion can be attributed 
to the fact that; a global diminishment of miRNA in a cell will lead to suppression of 
miRNA which are pro migratory; miR-24, miR- 26a, and miRNA which inhibit 
migration; miR-221/miR-222, miR-143/miR-145.  
To implicate miRNA regulation in phenotypic modulation of HAoSMCs, the contractile 
marker α-actin was quantified in Ago2 deficient cells using western blot, figure 5.7. 
Levels of α-actin were decreased in the Ago2 deficient cells in comparison to the 
scrambled control. The reduced expression of contractile markers is synonymous with a 
pro migratory synthetic phenotype, which is what was shown in figures 5.4 & 5.6. This 
highlights the role miRNA play in regulating and maintaining VSMC phenotype and 
homeostasis.  The expression of VSMC marker genes were also shown to be 
significantly down regulated in Dicer knockout mice (Pan et al., 2011). 
The conclusion from this study is that altered expression of the key miRNA processing 
molecule, Argonaute 2, seems to regulate HAoSMC function. 
 
5.3.3 Summary and Conclusion 
This chapter looked at the implication cyclic strain has on SMC function, namely 
migration. The migration of cells exposed to 10% cyclic strain over 72 hours was 
monitored over several time points and compared to that of a static culture. This 
revealed cyclic strain reduced cell migration, the effect of which was most evident at 24 
hours where migration of the cells was less than half that of the static culture. However, 
cell migration increased at the 48 and 72 hour time points yet still remained less than 
that of the static culture, ~75%.  
This study showed the modulating effect mechanical force can have on SMC biology; 
the strain is clearly orchestrating the cells into a more contractile, anti migratory 
phenotype. However, this stimulus does not appear to be sustainable as the strain 
becomes more chronic and migration levels increase, perhaps highlighting the 
limitations of the in vitro model 
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To implicate miRNA as key coordinators in the reduced cell migration observed after 
cyclic strain, siRNA were targeted against an essential miRNA biogenesis molecule, 
Argonaute2 (Ago2). This resulted in a numbing of function of mature miRNA within 
the cell. This had a significant effect on cell migration, whereas cells exposed to cyclic 
strain responded with reduced cell migration. Cells transfected with siRNA for Ago2 
exposed to the same strain negated the physiological stimulus and had a marked 
increase in migration even over the static control. This would be indicative of a 
dedifferentiated SMC which was confirmed by protein analysis of the contractile 
marker α-actin. This protein was shown to be reduced in ago2 deficient cells.  
To conclude, cyclic strain, as suggested from results in chapters 3 and 4, has a direct 
impact on HAoSMC function particularly migration. Works in this chapter show 10% 
cyclic strain at 1Hz inhibits migration when compared to static cultured cells. This 
physiological stimulus is most likely transduced into the cytoplasm via membrane 
bound adhesion molecules such as integrins; some preliminary work carried out, 
appendix, shows inhibition of αVβ3 has a profound effect on HAoSMC adhesion. It 
would seem that this entire process is also regulated by the miRNA profile within the 
cell. Studies in this chapter demonstrated that reduced function of these miRNA through 
knock down of Ago2 resulted to negate the physiological stimulus of strain and send the 
cells into a migratory phenotype. Therefore, miRNA regulation is essential for 
HAoSMC response to stimulus.  
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Overall Summary and Conclusion  
All work carried out in this thesis was performed on Human Aortic Smooth Muscle 
Cells (HAoSMCs) taken from the thoracic aorta of a 19 year old Caucasian male.  
The overall hypothesis for this thesis was “cyclic mechanical strain, mediated by 
miRNA regulation, modulates vascular smooth muscle phenotype and ultimately 
function”.  
Experimental work designed to test this hypothesis was divided across three chapters:  
Chapter 3 looked at the affect of cyclic strain on HAoSMC health and phenotype. This 
was approached by quantification of injury markers FGF-2 and TM and the contractile 
markers α-actin, calponin and smoothelin. 
Chapter 4 was concerned with miRNA profiling of HAoSMCs under static and strained 
conditions. The aim of this chapter was to develop a short list of “mechano sensitive” 
miRNA and perform bioinformatics on the individual miRNA. This included target 
prediction and involvement of these targets in biological processes and pathways of 
interest. 
Chapter 5 was designed to correlate any change in expression of contractile markers 
seen in chapter 3, as a result of strain, to an altered cell function. Cell migration was the 
predominant function of interest. This chapter also looked to implement miRNA as the 
facilitators of any altered phenotype or function resulting from strain. This was 
approached by knocking down one of the major miRNA biogenesis molecules, 
Argonaute 2 (Ago2). As a result this is a first principles experiment as it was designed 
to inhibit miRNA regulation globally as opposed to manipulating the shortlisted 
mechano sensitive miRNA from chapter 4. 
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Vascular smooth muscle cells making up the tunica media of the vessel wall are 
responsible for controlling vascular tone and blood pressure within the circulatory 
system. They achieve this by a unique plasticity in which they can modulate their 
phenotype between a synthetic and contractile state (Owens et al., 2004). Characteristics 
of the contractile state are a quiescent cell with an elongated morphology and increased 
expression of contractile markers. The synthetic cell boasts essentially the opposite 
features with increased migration, proliferation a rhomboid morphology and reduced 
expression of contractile markers. Due to the environment they are found VSMCs are 
constantly exposed to mechanical force resulting from the pulsatile nature of blood 
flow. This can be divided into two forms, shear stress and cyclic strain.   
Primary studies for this thesis looked at the impact cyclic strain had on expression of 
contractile markers. After quantifying the mRNA and protein expression levels, it is 
clear cyclic strain increases the abundance of phenotype markers α-actin, smoothelin 
and calponin. This holds for both 5% and 10% levels of cyclic strain amplitude. This 
would suggest cyclic strain is modulating the phenotype of the cells towards a 
contractile state. However, the higher strain, although encouraging a more physiological 
state initially, appears to create a higher degree of cell injury. This is evidenced through 
release of the injury markers FGF-2 and TM.   
To investigate if the miRNA signature or “miRnome” of HAoSMCs was being altered 
by cyclic strain profiling experiments were performed. A temporal study of strain over 
48hours at 10% showed the miRNA profile of the cells undergoes a significant shift in 
expression at ~ 24hours. To validate this, a second profiling study was carried out 
performing biological replicates at this time point as well as looking at how different 
strain amplitudes impacted miRNA expression, these were static culture, 5% strain and 
10% strain. This study generated three priority lists of differentially expressed miRNA 
from comparisons of profiles of 5% vs. static, 10% vs. 5% and 10% vs. static. 
Bioinformatics was performed on the most differentially expressed miRNA in the 
mechano sensitive short lists. This included downloading of in silico predicted targets of 
each miRNA from the online algorithm Targetscan. These putative targets were then 
inputted to DAVID bioinformatics database which mapped their involvement in cellular 
processes pathways of interest.  
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Of these novel shortlisted miRNA, some show predicted involvement in SMC biology, 
such as the vascular smooth muscle cell contraction pathway, namely miR-610 and 
miR-661. Other miRNA selected for bioinformatics, miR-520e, miR- 520c-3p and miR-
373, showed promising target predictions involved in pathways concerning cell 
motility. These included focal adhesion, regulation of actin cytoskeleton, VSMC 
contraction pathway, cell cycle, adherens junction and ECM receptor interaction 
pathway. These miRNA are novel and largely unpublished, therefore providing a 
promising avenue for further investigation. 
It was hoped that in line with generating a short list of mechano sensitive miRNA, the 
profiling experiment would reveal expression of specific miRNA from the literature 
which corresponded to a certain phenotype. However, it appears that the use of miRNA 
expression to identify a VSMC phenotype is ambiguous. For example, miR-1 was 
shown to induce both a contractile and a synthetic phenotype by two different groups. A 
down-regulation of this miRNA in SMCs was shown to coincide with a reduction in 
SMC lineage markers (Xie et al., 2011). Contradictory to this work Jiang et al., (2010) 
demonstrated myocardin induces miR-1 expression, which represses the expression of 
contractile proteins and thereby inhibits the contractility of SMCs. This suggested miR-
1 plays a role in the negative feedback loop in the regulation of contractility induced by 
myocardin. 
In this thesis, the expressions of both the miR-143/miR-145 and miR-221/miR-222 
clusters were decreased compared to that of the static control, at 24 hour 10% strain. In 
case of the miR-143/miR-145 cluster this would suggest a more synthetic phenotype 
(Elia et al., 2009; Sessa et al., 2010). Yet work by Altuvia et al., (2005) and Calin et al., 
(2004) shows that reduction in miR-221/miR-222 cluster expression coincides with a 
more contractile cell. It is apparent from these studies that a “one miRNA one function” 
paradigm is not the case, particularly when assessing SMC phenotype. Instead to truly 
characterise the phenotype of a certain population of SMCs a combination of contractile 
marker expression, cell morphology, the cell miRnome and cell functions should be 
utilised.  
As a result the implication of cyclic strain on SMC function, namely migration was 
investigated. The migration of cells exposed to 10% cyclic strain over 72 hours was 
monitored over several time points and compared to that of a static culture. This 
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revealed cyclic strain reduced cell migration, the effect of which was most evident at 24 
hours where migration of the cells was less than half that of the static culture.  
The increase in contractile marker expression with strain and this reduced migration 
would correspond to a more differentiated phenotype. Another possible explanation for 
the reduced level of migration is strain stimulated deposition of ECM by the cells 
(O’Callaghan et al., 2000). This would have the effect of making the substrate more 
“sticky” reducing migration, especially if there is an increased expression and activation 
of integrins facilitating stable adhesions.  
As the strain reached chronic time points of 48 and 72 hours, cell migration was seen to 
increase, although still remained less than (~75%) that of the static culture. This 
increase in migration would suggest the cells are moving back to a de-differentiated 
synthetic state as seen in the static culture. This may be facilitated by an increased 
expression of matrix metalloproteinases (MMP) which degrade the ECM allowing the 
cells to become more mobile  
This study showed the modulating effect mechanical force can have on SMC biology; 
the strain is clearly orchestrating the cells into a more contractile, anti migratory 
phenotype. However, this stimulus does not appear to be sustainable as the strain 
becomes more chronic and migration levels increase, perhaps highlighting the 
limitations of the in vitro model.  
To implicate miRNA as key coordinators of the reduced cell migration observed after 
cyclic strain, siRNA were targeted against an essential miRNA biogenesis molecule, 
Argonaute2 (Ago2). This resulted in a numbing of function of mature miRNA within 
the cell. This had a significant effect on cell migration, whereas cells exposed to cyclic 
strain responded with reduced cell migration. Cells transfected with siRNA for Ago2 
exposed to the same strain negated the physiological stimulus and had a marked 
increase in migration even over the static control. This would be indicative of a 
dedifferentiated SMC which was confirmed by protein analysis of the contractile 
marker α-actin. This protein was shown to be reduced in ago2 deficient cells.  
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To conclude, cyclic strain has a direct influence on HAoSMC biology. Works from the 
three chapters of this thesis have shown how this haemodynamic force alters a myriad 
of cellular processes from cell injury to phenotypic switching to cell function, 
specifically migration. Loss of function studies using siRNA against Ago2 has shown 
these changes in SMC fate are facilitated and monitored by the novel moiety of miRNA.  
Future Work 
Studies in this thesis looked at amplitude and duration of strain only whereas to take this 
project further the frequency of the strain is most certainly a key contributor, this is 
demonstrated in works by Cheng et al (1997). Greater strain amplitude than 10% is also 
most likely needed to represent a pathological hypertensive model as although cell 
injury was evident through use of TM, the contractile markers still remained elevated in 
cells exposed to 10%. A higher, more pathological 15% was attempted using the in vitro 
model discussed here but resulted in cell rounding and detachment. Follow up 
experiments are also essential as the in silico target predictions are just that, predictions. 
They need to be validated before further research is carried out. Validation can be 
performed through use of loss and gain of function experiments and luciferase reporter 
assays. Targeting of other biogenesis molecules such as drosha, exportin 5 and dicer 
could show the difference between inhibition of miRNA function as seen with the Ago2 
knock down and reduced expression of mature miRNA. 
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Concluding Thoughts 
It would seem the complexity of the molecular mechanisms and stimuli governing 
smooth muscle differentiation gives rise to both conflicting and compounding results 
from several groups. To fully elucidate the phenotype of a particular population of 
SMCs, a battery of tests on contractile marker expression, synthetic marker expression, 
cell morphology, the cell miRnome and functional studies are required. Armed even 
with this data, a subpopulation of cells within a culture may exist where the phenotype 
is at a different stage along the phenotypic spectrum to the remaining population. 
However, work carried out in this chapter was primarily done to establish a shortlisted 
panel of mechano-sensitive miRNA and not to directly implement these with a specific 
HAoSMC phenotype. These mechanically regulated, small, non-coding RNAs may be 
the key to response and adaption of the vessel to altered haemodynamic force.  
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Appendix 
This appendix is composed of additional and or preliminary data for each of the results 
chapters. This data was not essential to test the thesis hypothesis but is rather included 
in the appendix to demonstrate the breadth of the studies performed and potential 
avenues for future work.   
Chapter 3 
ECM Adhesion study  
Inital experiments in chapter 3 were designed to establish the ECM or coating factor 
which provided the longest duration of adhesion for HAoSMCs. The downstream 
objective of this was to allow extended strain studies on the difficult to adhere Flexcell 
plates. Only 12 hour time points of the study was included in chapter 3 for purpose of 
illustration. Figure A1 and A2 show adhesion data over full 72 hour and 60 hour time 
courses respectively. 
 
 
 
 
Figure A1 – xCELLigence plot of HAoSMC adhesion. Plot shows full 72hour time course of 
HAoSMC adhesion profile on several ECM and coating factors. Figure 3.3 shows a 12 hour 
time point of this plot. 
 
288 
 
 
 
Figure A2 – xCELLigence plot of HAoSMC adhesion. Plot shows full 60hour time course of 
HAoSMC adhesion profile on several ECM and coating factors. Figure 3.4 shows a 12 hour 
time point of this plot. 
The extended time scale reveals that fibronectin in figure A1, although initially demonstrates the 
highest adhesion, results in reduced overall adhesion and cell lifting as discussed in chapter 3. 
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Chapter 4 
Complete priority list of miRNA 
Tables A1.1-A1.6 contains the complete shortlist of priority miRNA from each strain 
comparison in the biological replicate study. 
Table A1.1 – 5% vs. Static A Card: Shows entire list of miRNA from A card in 5% vs. Static 
strain comprison which met statistical citeria. 
 
 
hsa-miR-888-4395323              0.008414117               0.080286097 
hsa-miR-520g-4373257              0.004300767               0.015052375 
 
Table A1.2 – 10% vs. Static A Card: Shows entire list of miRNA in 10% vs. static strain 
comprison which met statistical citeria. 
 
 
hsa-miR-618-4380996 2.68E-05 20297.03377 
hsa-miR-375-4373027 0.000238093 8387.503833 
hsa-miR-888-4395323 1.22E-05 703.0431092 
hsa-miR-150-4373127 0.043245376 140.5210172 
ath-miR159a-4373390 0.008146783 42.92528172 
hsa-miR-520e-4373255 0.028916724 3.214904647 
hsa-miR-18a-4395533 0.043322822 0.330272467 
hsa-miR-181a-4373117 0.033745284 0.326129307 
hsa-miR-193a-5p-4395 0.031908623 0.314401817 
hsa-miR-21-4373090 0.033745284 0.313905747 
hsa-miR-199a-5p-4373 0.031908623 0.308976666 
hsa-miR-15b-4373122 0.043322822 0.281042855 
hsa-miR-539-4378103 0.043971755 0.277327145 
hsa-miR-145-4395389 0.037765728 0.273919236 
hsa-miR-654-3p-43953 0.037336656 0.263102902 
hsa-miR-195-4373105 0.027303825 0.261544894 
hsa-miR-379-4373349 0.031908623 0.260681665 
hsa-miR-328-4373049 0.031908623 0.256410548 
hsa-miR-494-4395476 0.031908623 0.251668602 
hsa-miR-29b-4373288 0.022764928 0.237994414 
hsa-miR-655-4381015 0.028916724 0.23725058 
hsa-miR-590-5p-43951 0.037336656 0.237074744 
hsa-miR-370-4395386 0.025294605 0.236803981 
hsa-miR-106b-4373155 0.024259351 0.233680731 
 miRNA Detector      adjusted P. Value ≤ 0.05           Fold Change 
 miRNA Detector      adjusted P. Value ≤ 0.05           Fold Change 
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hsa-miR-652-4395463 0.029629166 0.230784151 
hsa-miR-95-4373011 0.028916724 0.227393249 
hsa-miR-337-5p-43952 0.029368191 0.226991211 
hsa-miR-485-3p-43780 0.031908623 0.225763221 
hsa-miR-340-4395369 0.043322822 0.222515846 
hsa-miR-362-3p-43952 0.016602628 0.222334519 
hsa-miR-29a-4395223 0.022764928 0.213721706 
hsa-miR-744-4395435 0.025294605 0.209701215 
hsa-miR-324-5p-43730 0.025294605 0.199731887 
hsa-miR-210-4373089 0.025294605 0.183793294 
hsa-miR-135b-4395372 0.031908623 0.169398667 
hsa-miR-18b-4395328 0.033745284 0.163665866 
hsa-miR-365-4373194 0.022280611 0.158534193 
hsa-miR-363-4378090 0.031908623 0.12363679 
hsa-miR-148a-4373130 0.027303825 0.116038646 
hsa-miR-671-3p-43954 0.022280611 0.113894188 
hsa-miR-487a-4378097 0.029629166 0.107133045 
hsa-miR-335-4373045 0.005651196 0.087815556 
hsa-miR-654-5p-43810 0.022764928 0.08151309 
hsa-miR-141-4373137 0.029629166 0.056619752 
hsa-miR-518e-4395506 0.043322822 0.055024481 
hsa-miR-501-3p-43955 0.029629166 0.054037801 
hsa-miR-331-5p-43953 0.02176625 0.047716335 
hsa-miR-373-4378073 0.019658174 0.043471724 
hsa-miR-496-4386771 0.008761138 0.031264892 
hsa-miR-302a-4378070 0.043322822 0.021076178 
hsa-miR-518b-4373246 0.018002544 0.017848513 
hsa-miR-198-4395384 0.022961614 0.01748052 
hsa-miR-520g-4373257 0.00097034 0.016112709 
hsa-miR-522-4395524 0.018002544 0.007116154 
hsa-miR-96-4373372 0.029629166 0.007069915 
hsa-miR-188-3p-4395 0.029629166 0.000808063 
hsa-miR-518f-4395499 9.71E-05 5.16E-06 
 
Table A1.3 – 10% vs. 5% A Card: Shows entire list of miRNA in 10% vs. 5% strain 
comprison which met statistical citeria. 
 
 
hsa-miR-618-4380996 5.60E-06 185159.4936 
hsa-miR-888-4395323 9.50E-07 8756.723011 
hsa-miR-375-4373027 0.000497404 2834.577507 
ath-miR159a-4373390 0.000209385 826.0306185 
hsa-miR-10a-4373153 0.014714407 5.124942484 
hsa-miR-520e-4373255 0.009835236 4.572522715 
hsa-miR-125b-4373148 0.045960477 0.380575603 
 miRNA Detector      adjusted P. Value ≤ 0.05           Fold Change 
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hsa-miR-29b-4373288 0.035749209 0.343665259 
hsa-miR-181a-4373117 0.032226054 0.335929589 
hsa-miR-185-4395382 0.040540634 0.31811133 
hsa-miR-221-4373077 0.046262844 0.296324793 
hsa-miR-199a-5p-4373 0.025504795 0.293806519 
hsa-miR-218-4373081 0.046262844 0.292541285 
hsa-miR-18a-4395533 0.026675902 0.282266187 
hsa-miR-127-3p-43731 0.03499719 0.274832422 
hsa-miR-21-4373090 0.023204853 0.270429603 
hsa-miR-30b-4373290 0.04337885 0.267201123 
hsa-miR-654-3p-43953 0.032855765 0.266857404 
hsa-miR-222-4395387 0.032855765 0.259303271 
hsa-miR-132-4373143 0.036514563 0.253359622 
hsa-miR-34a-4395168 0.031393735 0.25244189 
hsa-miR-425-4380926 0.046262844 0.251272338 
hsa-miR-532-3p-43954 0.031370758 0.251187398 
hsa-miR-539-4378103 0.031370758 0.250215153 
hsa-miR-660-4380925 0.031370758 0.247791282 
hsa-miR-30c-4373060 0.046262844 0.245782325 
hsa-miR-106b-4373155 0.01984699 0.245192746 
hsa-miR-24-4373072 0.042161061 0.243385449 
hsa-miR-339-5p-43953 0.048740009 0.241009509 
hsa-miR-15b-4373122 0.025504795 0.226552645 
hsa-miR-379-4373349 0.023204853 0.224338225 
hsa-miR-532-5p-43809 0.038783717 0.223864316 
hsa-miR-27b-4373068 0.025504795 0.220299035 
hsa-miR-345-4395297 0.031370758 0.211611885 
hsa-miR-31-4395390 0.027646841 0.207058012 
hsa-miR-502-3p-43951 0.031370758 0.206717722 
hsa-miR-320-4395388 0.023204853 0.203653053 
hsa-miR-328-4373049 0.018138949 0.202729906 
hsa-miR-193b-4395478 0.023512644 0.201967448 
hsa-miR-369-5p-43731 0.036514563 0.200681508 
hsa-miR-148b-4373129 0.044407914 0.199480743 
hsa-miR-491-5p-43810 0.023559619 0.194605618 
hsa-miR-22-4373079 0.028188765 0.19444535 
hsa-miR-362-3p-43952 0.008659358 0.190551476 
hsa-miR-193a-5p-4395 0.009735756 0.188492077 
hsa-miR-29a-4395223 0.011962396 0.186311116 
hsa-miR-331-3p-43730 0.038946676 0.179829353 
hsa-miR-143-4395360 0.023204853 0.178962246 
hsa-miR-135b-4395372 0.030971428 0.175604322 
hsa-miR-485-3p-43780 0.019810904 0.175067263 
hsa-miR-337-5p-43952 0.013232672 0.166817015 
hsa-miR-758-4395180 0.027646841 0.166572425 
hsa-miR-214-4395417 0.031370758 0.162686725 
hsa-miR-27a-4373287 0.027646841 0.160153861 
hsa-miR-370-4395386 0.009363792 0.159302501 
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hsa-miR-652-4395463 0.011069733 0.154853909 
hsa-miR-145-4395389 0.010960162 0.151332141 
hsa-miR-335-4373045 0.010695184 0.149802573 
hsa-miR-431-4395173 0.019810904 0.142104332 
hsa-miR-484-4381032 0.023559619 0.136397434 
hsa-miR-744-4395435 0.009363792 0.135230052 
hsa-miR-324-5p-43730 0.009363792 0.129227222 
hsa-miR-671-3p-43954 0.014714407 0.115784606 
hsa-miR-365-4373194 0.008659358 0.102125242 
hsa-miR-210-4373089 0.008659358 0.101373098 
hsa-miR-148a-4373130 0.014714407 0.092054363 
hsa-miR-18b-4395328 0.01326892 0.091878459 
hsa-miR-331-5p-43953 0.026675902 0.087811808 
hsa-miR-654-5p-43810 0.009363792 0.047257528 
hsa-miR-496-4386771 0.008558878 0.02884925 
hsa-miR-485-5p-43732 0.031370758 0.016991582 
hsa-miR-887-4395485 0.014714407 0.015578802 
hsa-miR-302a-4378070 0.027646841 0.013014899 
hsa-miR-501-3p-43955 0.006821052 0.007958486 
hsa-miR-518f-4395499 0.000209385 1.66E-05 
 
 
Table A1.4 – 10% vs. 5% B Card: Shows entire list of miRNA in 10% vs. 5% strain 
comprison which met statistical citeria. 
 
hsa-miR-520c-3p-4395 5.09E-05 150.2434709 
hsa-miR-610-4380980 0.006143201 121.0558387 
hsa-miR-564-4380941 0.011041923 118.5591669 
hsa-miR-513-3p-43952 0.016115292 45.80254895 
hsa-let-7f-2*-4395529 0.018066858 40.78959924 
hsa-miR-661-4381009 0.011917494 39.21246247 
hsa-miR-509-3p-43953 0.011917494 31.53671093 
hsa-miR-939-4395293 0.011917494 26.29849576 
hsa-miR-516a-3p-4373 0.011917494 24.26700534 
hsa-miR-144*-4395259 0.018353118 20.4691761 
hsa-miR-572-4381017 0.018365096 20.31884701 
hsa-miR-545*-4395377 0.036850905 18.60895461 
hsa-miR-138-1*-43952 0.015455901 17.74196611 
hsa-miR-206-4373092 0.040814343 17.04761764 
hsa-miR-151-3p-43953 0.011917494 15.64595355 
hsa-miR-519b-3p-4395 0.018365096 13.28558305 
hsa-miR-596-4380959 0.008351598 12.62643834 
hsa-miR-126*-4373269 0.044738036 11.37051654 
hsa-miR-942-4395298 0.011917494 9.12576064 
 miRNA Detector      adjusted P. Value ≤ 0.05           Fold Change 
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Table A1.5 – 10% vs. Static B Card: Shows entire list of miRNA in 5% vs. Static strain 
comprison which met statistical citeria. 
 
 
 
 
 
Table A1.6 – 5% vs. Static B Card: Shows entire list of miRNA in 5% vs. Static strain 
comprison which met statistical citeria. 
 
 
 
 
 
 
 
hsa-miR-596-4380959 0.016115292 8.545503826 
hsa-miR-923-4395264 0.033495659 7.820606073 
hsa-miR-149*-4395275 0.028856462 7.81541337 
hsa-miR-34a*-4395427 0.013388298 7.470314506 
hsa-miR-638-4380986 0.033495659 7.000752196 
hsa-miR-135a*-43953 0.011041923 6.834243052 
hsa-miR-630-4380970 0.024683849 6.73051846 
hsa-miR-650-4381006 0.016115292 5.605555798 
hsa-miR-656-4380920 0.027355236 5.444960195 
hsa-miR-30e-4395334 0.027355236 4.943176599 
hsa-miR-892b-4395325 0.048914058 4.887532435 
RNU43-4373375 0.027355236 4.813549178 
hsa-miR-100*-4395253 0.048914058 4.452552809 
hsa-miR-337-3p-43952 0.016115292 4.424628581 
hsa-miR-432-4373280 0.044738036 4.140888708 
hsa-miR-340*-4395370 0.044738036 4.071414566 
hsa-miR-136*-4395211 0.048914058 4.008121018 
hsa-miR-877-4395402 0.041743228 3.845314394 
hsa-miR-497-4373222 0.045803482 3.540074856 
hsa-miR-378-4395354 0.048914058 3.235326996 
   
 
 
hsa-miR-23b*-4395237 0.014374153 136.408586 
hsa-miR-744*-4395436 0.024862359 99.59164036 
hsa-miR-520c-3p-43955 0.014374153 9.449622002 
hsa-miR-23b*-4395237 0.023049829 97.83123344 
hsa-miR-596-4380959 0.035618543 0.142214688 
hsa-miR-520c-3p-43955 0.003873384 0.062895392 
hsa-miR-610-4380980 0.035618543 0.03407928 
   
 miRNA Detector      adjusted P. Value ≤ 0.05           Fold Change 
 miRNA Detector      adjusted P. Value ≤ 0.05           Fold Change 
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Chapter 5 
Works in chapter 5 were designed to test the implication cyclic strain had on HAoSMC 
function and if found to be altered were miRNA working as molecular switches 
facilitating these changes.  
In addition several exploratory studies, not included in chapter 5, were performed in 
efforts to characterize: 
 Effect of cyclic strain on HAoSMC apoptosis. 
Levels of surface Annexin V were quantified along with the nuclear stain Propidium 
Iodide (PI) to assess levels of apoptosis in cells exposed to 48 hours of 10% cyclic 
strain and cells in static culture.  
 Integrins which are most abundantly activated on the SMC surface. 
Initial investigation into adhesion molecules responsible for transducing the mechanical 
stimulation of the cyclic strain into a cellular response looked at integrins, specifically 
integrins which primarily bind the RGD sequence motif. This was approached using 
synthetic RGD peptides. These were incorporated while seeding SMCs on to 
xCELLigence adhesion plates. A substantially reduced adhesion profile of cells 
incorporated with the peptides would correspond to RGD binding integrins being highly 
expressed on the cell surface.  
 Impact of over expressing FAK and FRNK in SMCs. 
Experiments were also designed to investigate the consequence of over expression of 
focal adhesion kinase (FAK) and its endogenous negative regulator Focal Adhesion 
Non Receptor Kinase (FRNK). Vectors containing FAK and its endogenous inhibitor 
FRNK were transfected into HAoSMCs to evaluate the impact on cell adhesion and 
proliferation. As this study is still in its infancy it has not been included in this chapter 
but preliminary work can be found in the appendix. 
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Apoptosis Study 
To determine if strain regulated apoptosis signaling within the cell, levels of annexin V 
and the nuclear stain Propidium Iodide were quantified using flow cytometry in both a 
static and strained population of cells. Cells were strained at 10% 1Hz for 48 hours.  
This time was chosen to assess if the increase in migration seen in figure 5.1 
corresponded with comproised cell health and death often observed in synthetic cells.  
Levels of apoptotic cells were measured with an Annexin V staining kit as described in 
chapter 2.2. In normal live cells, phosphatidylserine (PS) is located on the cytoplasmic 
surface of the cell membrane. However in apoptotic cells, PS is translocated from the 
inner to the outer leaflet of the plasma membrane, thus exposing PS to the external 
cellular environment. The human anticoagulant, Annexin V, is a 35-36kDa Ca
2+
 
dependent phospholipid-binding protein that has a high affinity for PS. Thus, Annexin 
V labelled with a flurophore can identify apoptotic cells by binding to the exposed PS 
on the outer membrane.  
The assay also incorporated a nuclear dye to measure cell death, red-fluorescent 
propidium iodide (PI). PI is impermeable to live or apoptotic cells. Therefore, after 
staining a cell population with Alexafluor®488 Annexin V and PI, dead cells will show 
red and green fluorescence, apoptotic cells will show green only and live healthy cells 
should show little or no fluorescence.  
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Figure A3 shows sctter plots of Annexin V apoptosis study of HAoSMCs in both static and 
strained culture. 
 
 
 
Figure A3 A&B: Apoptosis assay on static vs. strained HAoSMCs. (A)- Flow cytometry 
analysis of the presence of Annexin V and nuclear stain PI in static (left) and 10% strained 
(right) HAoSMC cultures. Cells were strained for 48hours. Three populations were gated; 
healthy cells, apoptotic cells and dead cells. (B)- shows graphed percentage of total cell 
population for each population identified, healthy, apoptotic and dead cells, for both strained 
and static culture. n=3, no statistical significance between strain and static. 
 
A. 
B. 
10% Strain (48hr) Static Culture  
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Discussion 
With nearly an identical level of live cell population, figure A, between the strained and 
static culture and only a slight increase in the apoptotic cells in static, it was concluded 
that strain was not inducing apoptosis. Similar results were seen by Hipper et al., (2000) 
only 0.2% difference in apoptosis and an identical release of lactate dehydrogenase 
(LDH) in VSMC in static culture and those exposed to 5% strain at 0.5Hz for 48 hours. 
This excluded the possibility of necrosis and influence of apoptosis by the strain. 
Contrary to this however, cyclic strain was reported to increase apoptosis in smooth 
muscle cells coated on collagen type I matrix (Wernig et al., 2003). This highlights and 
goes somewhat to explain varying results reported by different groups, in that assessing 
cell fate and function in response to cyclic stain, or indeed, any other biomechanical 
force, is dependent on its microenvironment, in particular the ECM composition. 
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Integrin Study 
Integrins and ion channels are the membrane molecules predominantly involved in 
“mechano-sensing” by the cells to their environment. Integrins are transmembrane 
molecules consisting of an intracellular and extra cellular domain. They are made up of 
both an alpha and beta glycoprotein subunits which are non-covalently bonded. To date 
there are 18 alpha and 8 beta subunits allowing for a total of 24 different integrin 
compositions. (Plow et al., 2000; Van der Flier & Sonnenberg 2001; Hynes 2002). They 
facilitate ‘inside-out’ and ‘outside-in’ cell signaling and are responsible, in part, for 
integrating the cell with its microenvironment. This can be accomplished through 
engaging with ECM macromolecules or with counter receptors on adjacent cell surfaces 
(Humphries et al., 2006). 
 
 
 
 
 
Figure A4: Integrin receptors are αβ heterodimers; each subunit crosses the cell membrane, 
with the majority of the polypeptide (>1600 amino acids in total) in the extracellular space and 
two short cytoplasmic domains (20–50 amino acids). This schematic depicts the mammalian 
subunits and their αβ associations; 8 β subunits can assort with 18 α subunits to form 24 distinct 
integrins. (Hynes et al., 2002). 
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Activation of the integrin families is mediated by contact with ECM components such 
as fibronectin and collagen which leads to the formation of focal adhesion structures. 
These focal adhesions contain anchorage points for the cell where the cytoplasmic tail 
of the integrin is physically tethered to the actin fibres of the cytoskeleton (A. Katsumi 
& W. Orr et al., 2004; C. Galbraith et al., 2002; Schwartz et al., 2000). They also bind 
with signaling molecules, such talin and paxillin, which become activated in an 
adhesion dependent manner (Burridge et al., 1996). Recruitment of the protein tyrosine 
kinase, FAK, to the integrin rich sites also appears to be central to focal adhesion 
formation. This is paramount to downstream signaling controlling cell migration and 
proliferation. This FAK mediated signaling is modulated by expression of an 
endogenous FAK inhibitor termed FRNK (FAK Related Non Kinase). This is expressed 
as an independent protein and is essentially the carboxyl-terminal noncatalytic domain 
of FAK (Taylor et al., 2001). 
Following strain and Ago2 knock-down experiments, the focus of investigation turned 
to the underlying mechanisms by which “mechano-sensing” is orchestrated by 
HAoSMCs in response to cyclic strain.  As this is attributed to membrane bound 
adhesion molecules, preliminary experiments looked at integrin mediated signaling. 
Initial studies used synthetic RGD peptides, which bind a sub group of integrins (shown 
in diagram below). These were seeded in solution with HAoSMCs onto xCELLigence 
adhesion plates to assess their impact on adhesion of the cell. 
 
 
Figure A5: RGD Receptors.  Schematic showing the combinations of αβ subunits which make 
up RGD binding integrins (8 in total). 
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Effect of RGD peptides (100µM & 200µM concentrations) on HAoSMC adhesion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A6 A, B & C: Adhesion profile of HAoSMCs seeded with RGD peptides. Figure A6 
A shows adhesion profile of HAoSMC incorporated with RGD synthetic peptides. Blue plot – 
No peptide control, Red & Green plot –100µM & 200µM of H-3164 peptide respectively, Light 
Blue & Purple plot 100µM & 200µM of  H-7630 peptide  respectively, Pink & Dark green plot 
–100µM & 200µM of H-3964 peptide. Figure A6 B graph showing level of adhesion of each 
sample compared to the no peptide control. n=3, *P≤0.05 vs. no inhibitor one way anova. 
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Effect of RGD peptides (50µM concentration) on HAoSMC adhesion.  
 
 
 
 
Figure A7 A&B: Adhesion profile of HAoSMCs seeded with RGD peptides. Figure A7 A 
shows the adhesion profile, generated from xCELLigence instrument, of HAoSMCs seeded 
with RGD peptides at 50µM concentration. Blue plot – No peptide inhibitor control, Red plot –
50µM H-3164 peptide, Green plot - 50µM H-7630 peptide, Pink plot - 50µM H-3964 peptide. 
Figure 5.10B shows graphical representations for the level of HAoSMC adhesion seeded with 
each of the peptides. . n=3, *P≤0.05 vs. no inhibitor one way anova. 
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The adhesion experiment in figure A7 (A) was continued over a 96 hour time course to evaluate 
impact of the RGD peptides on the proliferation of HAoSMCs and to evaluate the performance 
of the peptides at longer time points.  
 
 
 
Figure A7 C&D: Proliferation profile of HAoSMCs seeded with RGD peptides. Figure A7 
C- shows the adhesion and proliferation of HAoSMCs seeded with RGD peptides at 50µM 
concentration over 96 hours, plot generated from xCELLigence system. Blue plot – No peptide 
inhibitor control, Red plot –50µM H-3164 peptide, Green plot - 50µM H-7630 peptide, Pink 
plot - 50µM H-3964 peptide.  Figure A7 D graph showing the doubling time of each cell 
sample, including the no inhibitor control and the three RGD peptides. n=3, *P≤0.05 vs. no 
inhibitor one way anova. 
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Discussion. 
Cells making up the vasculature are equipped with an array of receptors and adhesion 
molecules which allow them to detect and respond to the mechanical forces generated 
by pulsatile blood flow (Lehoux et al., 2006). These mechanical stresses are transmitted 
through cell contacts with the substrate; this inherently implicates integrins in 
mechanotransduction (Katsumi et al., 2004). These forces stimulate conformational 
activation of vascular smooth muscle cell integrins, resulting in increased cell binding to 
the ECM (Jalali et al., 2001). Binding of ECM protein ligands by integrins is required 
for intracellular signal transduction induced by mechanical force. RGD binding 
integrins are one of the four major classes of integrin families. They are the most 
promiscuous of the receptors, finding ligands with a multitude of ECM proteins. As the 
name suggest they recognise the arginine-glycine-aspartic acid (RGD) sequence within 
their ligands. Consequently to their prevalence and large array of ligands these adhesion 
molecules were investigated in this thesis to establish their involvement in SMC 
adhesion. 
This was approached through use of synthetic RGD (Arginine, Glycine, Aspartic Acid) 
binding peptides, these compete with substrate ECM for docking sites on RGD 
integrins. Studies have shown it is possible to block alterations in cellular functions 
induced by strain by use of these peptides (Wernig et al., 2003). All five αV integrins, 
two β1integrins (α5, α8) and αIIbβ3 share the ability to recognise ligands containing the 
RGD sequence motif (Humphries et al., 2006).  In this chapter RGD peptides were 
incorporated while seeding HAoSMCs to investigate which integrin is predominantly 
expressed on SMC surface.  
The adhesion and proliferation assays in figures A6 & A7 show HAoSMCs, which have 
been seeded with three soluble RGD peptides.  
Peptides used were purchased from Bachem under their product names of; 
H-7630 – competes against integrins for the RGD fibronectin binding domain. 
H-3164 - competes for fibronectin binding but not vitronectin. 
H-3964 – An RGD peptide which predominantly competes for the αVβ3 integrin. 
Concentrations used in Figure A6 were 100 and 200 µM for each peptide. H-3164 
showed the least change in SMC adhesion and proliferation dynamics compared with 
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the no peptide control. This is likely due to it not competing for the Vitronectin binding 
domain and selectively fibronectin. H-7630, which is not solely binding fibronectin 
shows a higher impact on cell adhesion, however the most notable is H-3964. At these 
concentrations H-3964 inhibits all cell attachment. 
H-3964 competes against integrin αVβ3, which finds ligands on multiple ECM such as 
Fibronectin, Osteopontin, PECAM1, Fibrinogen, Fibrillin, VWF & Thrombospondin is 
highly expressed on SMC surface. Cyclic strain induced cell cycle is thought to be 
mediated through this integrin by release of platelet derived growth factor (Wilson et 
al., 1995). 
A similar study to the one shown in figure A6 is shown in figure A7, this time 
incorporating a lowered peptide concentration of 50µM. At this concentration it was 
possible to achieve cell attachment with the H-3964 peptide, thus allowing investigation 
into the altered cellular dynamics over an extended time course. 
It is evident from both figure A6 & A7 the peptides are effective during the cell 
attachment phase in blocking integrin binding to the culture plate surface. However, as 
the experiment progresses past 48 hours the cell index begins to return to that of the no 
peptide control. Naturally, this can be attributed to cell proliferation, however along 
with proliferation new integrins are most likely being synthesised by the original cell 
population, thus negating the effect of the peptides in conjunction with laying down 
additional ECM, further diluting the impact of the peptides. 
This preliminary study emphasizes the importance of αVβ3 in HAoSMC adhesion 
andsuggests a promising avenue into exploring which cell surface molecules are 
responsible for” mechanosensing” strain.  
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Over expression of FAK and FRNK plasmids in HAoSMCs  
Early stage experimentation into focal adhesion sites as signaling hubs for mechano 
transduction consisted of transfecting plasmids containing the signaling molecules FAK 
and FRNK into the cells using the microporator transfection system described in chapter 
2.2. This allowed assessment of over expression of these proteins on the impact on cell 
adhesion and proliferation. 
 
 
 
 
 
 
 
 
A. 
B. 
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Figure A8 - Plots A&B show 12 and 48 hour time points for adhesion and proliferation assay 
on HAoSMC transfected with FAK and FRNK plasmids. Red plot – HAoSMC transfected with 
FAK plasmid, Green plot – HAoSMC transfected with FRNK. Rate of adhesion is increased in 
HAoSMC transfected with FAK as shown in C compared with FRNK transfected cells. 
Doubling time of FAK transfected cells is reduced when compared with FRNK transfected cells 
(D). n=3.  
C. 
D. 
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Figure A9 - Plots A&B show 12 and 48 hour time points for adhesion and proliferation assay 
on HAoSMC transfected with FAK and FRNK plasmids and wild type control. Red plot – 
HAoSMC transfected with FAK plasmid, Green plot – HAoSMC transfected with FRNK, Blue 
plot – Wild type control. Rate of adhesion is significantly decreased in both plasmid transfected 
cells when compared with wild type control. Adhesion is stronger in HAoSMC transfected with 
FAK as shown in C compared with FRNK transfected cells. Doubling time of FAK and FRNK 
transfected cells is reduced when compared with wild type control (D). n=3 
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Figure A10 – A; HAoSMC stained with FAK Ab conjugated with FITC 2° (10X), B; HAoSMC 
stained for FAK aswell as cell actin fibres stained red with Phalloidin (10X), C & D; HAoSMC 
stained with FAK, Phalloidin and nucleus stained blue with DAPI (10X, 20X respectively). 
 
 
 
 
 
 
 
A. 
B. 
C. D. 
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Discussion 
The focus of this study initially was to optimize transfection of the two plasmids into 
HAoSMCs. This was particularly challenging due to large plasmid size of FAK (˃8kb) 
and the difficult to transfect nature of HAoSMCs. Using the Invitrogen® 
Microporator® a transfection efficiency of ~ 80% was finally reached, figure A10. 
Preliminary over expression experiments showed an increase in adhesion of HAoSMCs 
transfected with FAK compared to those transfected with FRNK, figure A8. This was 
expected as more adhesion molecules within the cell become activated due to the 
abundance of this kinase, leading to an increase in focal contacts and adhesions. 
However when comparing the adhesion of HAoSMCs transfected with either the FAK 
or FRNK plasmid to a vector only control, figure A9, they are both significantly 
reduced. This is potentially due to a damaging effect on the cell health or membrane 
integritiy of HAoSMCs transfected with the plasmids highlighting the need for further 
optimization and investigative studies into cell toxicity associated with plasmid 
transfection.  
 
 
